Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
Clin Infect Dis
    August 2024
  1. LANDETE P, Caliman-Sturdza OA, Lopez-Martin JA, Preotescu L, et al
    A phase III randomized controlled trial of plitidepsin, a marine derived compound, in hospitalized adults with moderate COVID-19.
    Clin Infect Dis. 2024 Aug 26:ciae227. doi: 10.1093.
    >> Share

  2. RINCON-GUEVARA O, Wallace B, Kompaniyets L, Barrett CE, et al
    Association between SARS-CoV-2 infection during pregnancy and gestational diabetes: a claims-based cohort study.
    Clin Infect Dis. 2024 Aug 19:ciae416. doi: 10.1093.
    >> Share

  3. BERTHAUD V, Creech CB, Rostad CA, Carr Q, et al
    Safety and Immunogenicity of an mRNA-1273 Booster in Children.
    Clin Infect Dis. 2024 Aug 19:ciae420. doi: 10.1093.
    >> Share

  4. GRISEL B, Kaur K, Swain S, Gorenshtein L, et al
    The Ethical Obligation to Treat Infectious Patients: A Systematic Review of Reasons.
    Clin Infect Dis. 2024;79:339-347.
    >> Share

  5. WOOTEN D
    The Arrivals Gate at Heathrow Airport.
    Clin Infect Dis. 2024;79:289-291.
    >> Share

  6. TRIBBLE AC, Moorthy GS, Vartanian RJ, Smith MJ, et al
    Pediatric Antimicrobial Stewardship Programs Reduce Antibiotic Use at Combined Adult-Pediatric Hospitals.
    Clin Infect Dis. 2024;79:321-324.
    >> Share

  7. CASADEVALL A, Focosi D, Pirofski LA, Shoham S, et al
    Single monoclonal antibodies should not be used for COVID-19 therapy: a call for antiviral stewardship.
    Clin Infect Dis. 2024 Aug 8:ciae408. doi: 10.1093.
    >> Share

  8. MA KC, Surie D, Lauring AS, Martin ET, et al
    Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024.
    Clin Infect Dis. 2024 Aug 6:ciae405. doi: 10.1093.
    >> Share

    July 2024
  9. VILORIA WINNETT A, Stenzel T, Ismagilov RF
    Validating combination throat-nasal swabs for COVID-19 tests would improve early detection, especially for the most vulnerable.
    Clin Infect Dis. 2024 Jul 23:ciae381. doi: 10.1093.
    >> Share

  10. FAUST JS, Meyerowitz-Katz G
    Is Paxlovid Still Worth It?
    Clin Infect Dis. 2024;79:111-114.
    >> Share

  11. GREEN E, Marcelin JR
    Robust Performance Metrics for Assessing Equitable Clinical Trial Participant Enrollment: Can We Get There?
    Clin Infect Dis. 2024;79:148-150.
    >> Share

  12. CHEYNE A, Muchamore I, Tulunay H, Rojek A, et al
    Community Involvement in an Outbreak-One Year on for Mpox.
    Clin Infect Dis. 2024;79:278-280.
    >> Share

  13. CHERABIE JN, Hazra A
    Community-Informed Approach Remains Critical to Our Mpox Response.
    Clin Infect Dis. 2024;79:280-281.
    >> Share

  14. JILG N, Giganti MJ, Chew KW, Shaw-Saliba K, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jul 17:ciae324. doi: 10.1093.
    >> Share

  15. JOHNSTON TS, Hage C, Abedon AT, Panda S, et al
    Rapid Wane and Recovery of XBB Sublineage Neutralization After Sequential Omicron-based Vaccination in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Jul 2:ciae279. doi: 10.1093.
    >> Share

    June 2024

  16. Rapid Guidelines to Address the Changing COVID-19 Pandemic.
    Clin Infect Dis. 2024;78:e81-e82.
    >> Share

  17. CHONG C, Wee LE, Jin X, Zhang M, et al
    Risks of SARS-CoV-2 JN.1 infection and COVID-19 associated emergency-department (ED) visits/hospitalizations following updated boosters and prior infection: a population-based cohort study.
    Clin Infect Dis. 2024 Jun 26:ciae339. doi: 10.1093.
    >> Share

  18. FUSCO D, Malenica I, Gunthard HF, Gupta SK, et al
    Remdesivir for Treatment of COVID-19 Requiring Oxygen Support: A Cross-Study Comparison from Two Large, Open-Label Studies.
    Clin Infect Dis. 2024 Jun 26:ciae336. doi: 10.1093.
    >> Share

  19. ZENG G, Zhou Y
    Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 26:ciae342. doi: 10.1093.
    >> Share

  20. SISE ME, Santos JR, Goldman JD, Tuttle KR, et al
    Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial.
    Clin Infect Dis. 2024 Jun 24:ciae333. doi: 10.1093.
    >> Share

  21. EPSTEIN L
    An Ounce of Prevention Is Worth a Pound of Cure: The LEAP Fellowship.
    Clin Infect Dis. 2024;78:1542-1543.
    >> Share

  22. DIAMOND C
    The Belt Parkway.
    Clin Infect Dis. 2024;78:1399-1400.
    >> Share

  23. FOWLER VG JR, Durack DT, Suty-Selton C, Miro JM, et al
    Reply to Author.
    Clin Infect Dis. 2024;78:1779.
    >> Share

  24. FUNDERBURG NT, Shive CL, Lederman MM
    Reply to Chen et al.
    Clin Infect Dis. 2024;78:1776-1777.
    >> Share

  25. YAN L, Bui D, Li Y, Rajeevan N, et al
    Identifying Veterans Who Benefit From Nirmatrelvir-Ritonavir: A Target Trial Emulation.
    Clin Infect Dis. 2024 Jun 12:ciae202. doi: 10.1093.
    >> Share

  26. OLTOLINI C, Travi G, Mikulska M
    The impact of prior COVID-19 on non-infectious endothelial complications following allogeneic hematopoietic stem cell transplantation.
    Clin Infect Dis. 2024 Jun 5:ciae307. doi: 10.1093.
    >> Share

  27. NIMGAONKAR I, Flaherty PW, Oshima MU, Hill JA, et al
    Acute Endothelial Complications Post-Allogeneic Hematopoietic Cell Transplant in Patients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Jun 4:ciae310. doi: 10.1093.
    >> Share


  28. Correction to: Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 Jun 4:ciae257. doi: 10.1093.
    >> Share

  29. BOECKH M, Pergam SA, Limaye AP, Englund J, et al
    How Immunocompromised Hosts Were Left Behind in the Quest to Control the Covid-19 Pandemic.
    Clin Infect Dis. 2024 Jun 3:ciae308. doi: 10.1093.
    >> Share

    May 2024
  30. WOLFE DN, Arangies E, David GL, Armstrong B, et al
    Development of Next-Generation COVID-19 Vaccines: BARDA Supported Phase 2b Study Designs.
    Clin Infect Dis. 2024 May 28:ciae286. doi: 10.1093.
    >> Share

  31. HILL JA, Martens MJ, Young JH, Bhavsar K, et al
    SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study.
    Clin Infect Dis. 2024 May 27:ciae291. doi: 10.1093.
    >> Share

  32. LEE TC, Boulware DR
    Is there room for metformin at COVID-19's dinner table? Updated Analysis of Clinical Trials.
    Clin Infect Dis. 2024 May 17:ciae284. doi: 10.1093.
    >> Share

  33. RABIN AS, Marr LC, Blumberg HM
    Doff Thy Gown - Shedding Contact Precautions for COVID-19.
    Clin Infect Dis. 2024 May 15:ciae276. doi: 10.1093.
    >> Share

  34. SCHMITT SK
    IDSA's Letter to the American Board of Internal Medicine.
    Clin Infect Dis. 2024;78:1099-1100.
    >> Share

  35. LEE MSL
    The Pandemic Babies.
    Clin Infect Dis. 2024;78:1088-1089.
    >> Share

  36. HAMILL M, Ghanem KG, Tuddenham S
    Reply to: Cortes-Penfield and Musher.
    Clin Infect Dis. 2024;78:1387-1388.
    >> Share

  37. CASADEVALL A, Focosi D
    Anti-Spike monoclonal antibody monotherapies and immune escape risk minimization strategies.
    Clin Infect Dis. 2024 May 13:ciae254. doi: 10.1093.
    >> Share

  38. ANDREWS JS, Boonyaratanakornkit JB, Krusinska E, Allen S, et al
    Assessment of the Impact of RNase in Patients With Severe Fatigue Related to Post-Acute Sequelae of SARS-CoV-2 Infection (PASC): A Randomized Phase 2 Trial of RSLV-132.
    Clin Infect Dis. 2024 May 10:ciae205. doi: 10.1093.
    >> Share

  39. JORGENSEN SCJ, Brown K, Clarke AE, Schwartz KL, et al
    The Effect of COVID-19 Vaccination on Outpatient Antibiotic Prescribing in Older Adults: A Self-Controlled Risk-Interval Study.
    Clin Infect Dis. 2024 May 3:ciae182. doi: 10.1093.
    >> Share

  40. BRAMANTE CT, Beckman KB, Mehta T, Karger AB, et al
    Favorable Antiviral Effect of Metformin on Severe Acute Respiratory Syndrome Coronavirus 2 Viral Load in a Randomized, Placebo-Controlled Clinical Trial of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae159. doi: 10.1093.
    >> Share

  41. SIEDNER MJ, Sax PE
    Repurposing Revisited: Exploring the Role of Metformin for Treatment of Coronavirus Disease 2019.
    Clin Infect Dis. 2024 May 1:ciae154. doi: 10.1093.
    >> Share

    April 2024

  42. Correction to: Impact of Seasonal Coronavirus Antibodies on Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2024 Apr 30:ciae164. doi: 10.1093.
    >> Share


  43. Correction to: Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in Pathobiology.
    Clin Infect Dis. 2024 Apr 30:ciae166. doi: 10.1093.
    >> Share

  44. VASCONCELOS A, King JD, Nunes-Alves C, Anderson R, et al
    Accelerating Progress Towards the 2030 Neglected Tropical Diseases Targets: How Can Quantitative Modeling Support Programmatic Decisions?
    Clin Infect Dis. 2024;78.
    >> Share

  45. CHUA KP, Fischer MA, Rahman M, Linder JA, et al
    Changes in the Appropriateness of US Outpatient Antibiotic Prescribing After the Coronavirus Disease 2019 Outbreak: An Interrupted Time Series Analysis of 2016-2021 Data.
    Clin Infect Dis. 2024 Apr 22:ciae135. doi: 10.1093.
    >> Share


  46. Correction to: Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
    Clin Infect Dis. 2024 Apr 15:ciae165. doi: 10.1093.
    >> Share

  47. RUBIS AB, Cole M, Tondella ML, Pawloski LC, et al
    Assessing the Impact of the 2020 Council of State and Territorial Epidemiologists Case Definition for Pertussis on Reported Pertussis Cases.
    Clin Infect Dis. 2024 Apr 12:ciae207. doi: 10.1093.
    >> Share

  48. PETROS BA, Milliren CE, Sabeti PC, Ozonoff A, et al
    Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of Severe Acute Respiratory Syndrome Coronavirus 2 Can Be Attributed to Changes in Testing.
    Clin Infect Dis. 2024 Apr 11:ciae140. doi: 10.1093.
    >> Share

  49. SHERMAN A, Tuan J, Cantos VD, Adeyiga O, et al
    COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials.
    Clin Infect Dis. 2024 Apr 10:ciae192. doi: 10.1093.
    >> Share

  50. ZAWADZKA S
    Family Ties and COVID Lies.
    Clin Infect Dis. 2024;78:813-814.
    >> Share

  51. MCAULEY JB
    COVID at the Whiteriver Indian Hospital.
    Clin Infect Dis. 2024;78:815-817.
    >> Share

  52. CHABALA C, Wobudeya E, van der Zalm MM, Kapasa M, et al
    Clinical outcomes in children living with HIV treated for non-severe tuberculosis in the SHINE Trial.
    Clin Infect Dis. 2024 Apr 9:ciae193. doi: 10.1093.
    >> Share

    March 2024
  53. TERZIC V, Miantezila Basilua J, Billard N, de Gastines L, et al
    Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
    Clin Infect Dis. 2024 Mar 29:ciae170. doi: 10.1093.
    >> Share

  54. GOTTLIEB RL, Kalil AC
    True DisCoVeRy of COVID-19 Disease Burden Versus Speculated Antiviral Cardiovascular Risk Requires a Control Group.
    Clin Infect Dis. 2024 Mar 29:ciae172. doi: 10.1093.
    >> Share

  55. ROSTAD CA, Atmar RL, Walter EB, Frey S, et al
    A Phase 2 Clinical Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of Different Prime-Boost Vaccination Schedules of 2013 and 2017 A(H7N9) Inactivated Influenza Virus Vaccines Administered with and without AS03 Adjuvant in Healthy US
    Clin Infect Dis. 2024 Mar 27:ciae173. doi: 10.1093.
    >> Share

  56. FUNK A, Florin TA, Kuppermann N, Finkelstein Y, et al
    Household Transmission Dynamics of Asymptomatic SARS-CoV-2-Infected Children: A Multinational, Controlled Case-Ascertained Prospective Study.
    Clin Infect Dis. 2024 Mar 26:ciae069. doi: 10.1093.
    >> Share

  57. KOLBERG L, Khanijau A, van der Velden FJS, Herberg J, et al
    Raising AWaRe-ness of Antimicrobial Stewardship Challenges in Pediatric Emergency Care: Results from the PERFORM Study Assessing Consistency and Appropriateness of Antibiotic Prescribing Across Europe.
    Clin Infect Dis. 2024;78:526-534.
    >> Share

  58. GOHEEN MM
    Growing Up COVID.
    Clin Infect Dis. 2024;78:496-498.
    >> Share

  59. HAYDEN MK, El Mikati IK, Hanson KE, Englund JA, et al
    Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Serologic Testing.
    Clin Infect Dis. 2024 Mar 15:ciae121. doi: 10.1093.
    >> Share

  60. ROMINE JK, Li H, Coughlin MM, Jones JM, et al
    Hybrid immunity and SARS-CoV-2 antibodies: results of the HEROES-RECOVER prospective cohort study.
    Clin Infect Dis. 2024 Mar 11:ciae130. doi: 10.1093.
    >> Share

  61. ROWAN CM, LaBere B, Young CC, Zambrano LD, et al
    Pre-existing Immunocompromising Conditions and Outcomes of Acute COVID-19 Patients Admitted for Pediatric Intensive Care.
    Clin Infect Dis. 2024 Mar 11:ciae133. doi: 10.1093.
    >> Share

  62. SHRESTHA NK, Burke PC, Nowacki AS, Gordon SM, et al
    Effectiveness of the 2023-2024 Formulation of the Coronavirus Disease 2019 mRNA Vaccine.
    Clin Infect Dis. 2024 Mar 11:ciae132. doi: 10.1093.
    >> Share

  63. WENZEL RP
    Reflections on COVID-19: Solitude and Isolation.
    Clin Infect Dis. 2024 Mar 7:ciae099. doi: 10.1093.
    >> Share

  64. HUYGENS S, GeurtsvanKessel C, Gharbharan A, Bogers S, et al
    Clinical and Virological Outcome of Monoclonal Antibody Therapies Across Severe Acute Respiratory Syndrome Coronavirus 2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2024 Mar 6:ciae026. doi: 10.1093.
    >> Share

  65. NIMGAONKAR I, Yoke LH, Roychoudhury P, Flaherty PW, et al
    Outcomes in Hematopoietic Cell Transplant and Chimeric Antigen Receptor T Cell Therapy Recipients with Pre-Cellular Therapy SARS-CoV-2 Infection.
    Clin Infect Dis. 2024 Mar 1:ciae116. doi: 10.1093.
    >> Share

    February 2024
  66. SHAH MM, Joyce B, Plumb ID, Sahakian S, et al
    Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19.
    Clin Infect Dis. 2024 Feb 27:ciae105. doi: 10.1093.
    >> Share

  67. KARMARKAR EN, Fitzpatrick T, Himmelfarb ST, Chow EJ, et al
    Cluster of non-toxigenic Corynebacterium diphtheriae infective endocarditis and rising background C. diphtheriae cases-Seattle, Washington 2020-2023.
    Clin Infect Dis. 2024 Feb 21:ciae094. doi: 10.1093.
    >> Share

  68. TOWNLEY B, Akin D, Dimaguila GL, Sawires R, et al
    Exploring the infectious contribution to intussusception causality using the effects of COVID-19 lockdowns in Australia: An ecological study.
    Clin Infect Dis. 2024 Feb 20:ciae084. doi: 10.1093.
    >> Share

  69. AGGARWAL NR, Nordwall J, Braun DL, Chung L, et al
    Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19.
    Clin Infect Dis. 2024 Feb 20:ciad780. doi: 10.1093.
    >> Share

  70. TROSEID M
    Viral, Host Factors or Both as Coronavirus Disease 2019 (COVID-19) Biomarkers.
    Clin Infect Dis. 2024 Feb 20:ciad779. doi: 10.1093.
    >> Share

  71. FOLLMANN D, Mateja A, Fay MP, Magaret CA, et al
    Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine.
    Clin Infect Dis. 2024 Feb 19:ciae081. doi: 10.1093.
    >> Share

  72. MONTEJANO R, Arribas JR
    COVID-19 Clinical Trials: Are Adaptive Methodologies the Solution?
    Clin Infect Dis. 2024 Feb 17:ciae079. doi: 10.1093.
    >> Share

  73. GIACOMELLI A, Antinori S, Gori A, Cozzi-Lepri A, et al
    COVID-19: find the right questions to be answered.
    Clin Infect Dis. 2024 Feb 17:ciae078. doi: 10.1093.
    >> Share

  74. KOMOROWSKI AS, Lo CKL, Kapoor AK, Smieja M, et al
    More Than a Decade Since the Latest CONSORT Non-inferiority Trials Extension: Do Infectious Diseases Trials Do Enough?
    Clin Infect Dis. 2024;78:324-329.
    >> Share

  75. TOEPFER AP, Amarin JZ, Spieker AJ, Stewart LS, et al
    Seasonality, clinical characteristics, and outcomes of respiratory syncytial virus disease by subtype among children less than five years old, New Vaccine Surveillance Network, United States, 2016-2020.
    Clin Infect Dis. 2024 Feb 15:ciae085. doi: 10.1093.
    >> Share

  76. HOFMEYER KA, Ventura CL, Armstrong KL, Houchens CR, et al
    Project NexGen: Developing the Next Generation of COVID-19 Vaccines and Therapeutics to Respond to the Present and Prepare for the Future.
    Clin Infect Dis. 2024 Feb 13:ciae073. doi: 10.1093.
    >> Share

  77. MCCONEGHY KW, Hur K, Dahabreh IJ, Jiang R, et al
    Early Mortality After the First Dose of Coronavirus Disease 2019 Vaccination: A Target Trial Emulation.
    Clin Infect Dis. 2024 Feb 6:ciad604. doi: 10.1093.
    >> Share

    January 2024
  78. RYBOLT L, Oehler RL, Khalil FK, Khalil B, et al
    A 22-Year-Old With a Left Apical Chest Mass.
    Clin Infect Dis. 2024;78:199-201.
    >> Share

  79. HSUEH K, Teherani A, Guzman-Cottrill JA
    The Leaders in Epidemiology, Antimicrobial Stewardship, and Public Health (LEAP) Fellowship, a Novel Training Program in Public Health for Infectious Diseases Physicians.
    Clin Infect Dis. 2024 Jan 24:ciad787. doi: 10.1093.
    >> Share

  80. KEEHNER J, Abeles SR, Longhurst CA, Horton LE, et al
    Integrated Genomic and Social Network Analyses of Severe Acute Respiratory Syndrome Coronavirus 2 Transmission in the Healthcare Setting.
    Clin Infect Dis. 2024 Jan 16:ciad738. doi: 10.1093.
    >> Share

  81. NACHMAN S, Aldrovandi G
    Breastfeeding in the United States Among Women With HIV: Con Viewpoint.
    Clin Infect Dis. 2024 Jan 8:ciad778. doi: 10.1093.
    >> Share

  82. HEDBERG P, Valik JK, Halim LA, Alfven T, et al
    Reducing Diagnostic Bias Through Multiplex Polymerase Chain Reaction (PCR) Testing for SARS-CoV-2, Influenza A/B, and RSV.
    Clin Infect Dis. 2024 Jan 4:ciad747. doi: 10.1093.
    >> Share

  83. HARBOE ZB, Holler JG, Eiberg MF, Roed C, et al
    Outcomes of Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant, Influenza, and Respiratory Syncytial Virus on the Dissecting Table: Is Further Dissection Required?
    Clin Infect Dis. 2024 Jan 4:ciad739. doi: 10.1093.
    >> Share

  84. LEVY ME, Burrows E, Chilunda V, Pawloski PA, et al
    SARS-CoV-2 Antiviral Prescribing Gaps Among Non-Hospitalized High-Risk Adults.
    Clin Infect Dis. 2024 Jan 3:ciad796. doi: 10.1093.
    >> Share

    December 2023
  85. LAFONT E, Blez D, Bildan MA, Veyer D, et al
    Nirmatrelvir and Ritonavir combination in COVID-19 patients with advanced chronic kidney disease.
    Clin Infect Dis. 2023 Dec 30:ciad785. doi: 10.1093.
    >> Share

  86. VAN DER VAART TW, Prins JM, Goorhuis A, Lemkes BA, et al
    The utility of risk factors to define complicated Staphylococcus aureus bacteremia in a setting with low MRSA prevalence.
    Clin Infect Dis. 2023 Dec 29:ciad784. doi: 10.1093.
    >> Share

  87. ABEGAZ FA, Dos Santos PT, Mogeni OD, Guarnacci T, et al
    Evaluating Quality Management and Diagnostics Microbiology Performance Within an International External Quality Assessment (EQA) Program Serving National One Health Sector Reference Laboratories Across Asia: Experience Amid the Coronavirus Disease 201
    Clin Infect Dis. 2023;77.
    >> Share

  88. KWON SY, Gautam S, Poudel K, Banneheke H, et al
    Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Clin Infect Dis. 2023;77.
    >> Share

  89. MUSTAFA T, Niazi MRK, Lakdawala Z, Mirza S, et al
    Regional and National Trends in Consumption of Antimicrobials in Pakistan; Pre and Post-COVID (2019-2021).
    Clin Infect Dis. 2023;77.
    >> Share

  90. LESLIE T, Parry C, Ondoa P, Walsh T, et al
    The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience.
    Clin Infect Dis. 2023;77.
    >> Share

  91. POPOVICH KJ, Aureden K, Ham DC, Harris AD, et al
    Reply to Diekema et al. "Are contact precautions "essential" for the prevention of healthcare-associated methicillin-resistant Staphylococcus aureus?".
    Clin Infect Dis. 2023 Dec 20:ciad777. doi: 10.1093.
    >> Share

  92. HAYDEN MK, Hanson KE, Englund JA, Lee MJ, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Molecular Diagnostic Testing.
    Clin Infect Dis. 2023 Dec 19:ciad646. doi: 10.1093.
    >> Share

  93. ROSE MR, Dowdy DW
    High Specificity and Low Prevalence - Important Context for HIV Testing in US Cancer Patients.
    Clin Infect Dis. 2023 Dec 19:ciad774. doi: 10.1093.
    >> Share

  94. SMITH TC
    Long COVID: Alice Evans, Brucellosis, and Reflections on Infectious Causes of Chronic Disease.
    Clin Infect Dis. 2023;77:1644-1647.
    >> Share

  95. SCIENCE M, Orkin J, Maguire B, Bitnun A, et al
    Viral dynamics of the SARS-CoV-2 Omicron Variant in Paediatric Patients; A prospective cohort study.
    Clin Infect Dis. 2023 Dec 12:ciad740. doi: 10.1093.
    >> Share

  96. RYBAK A, Assad Z, Levy C, Bonarcorsi S, et al
    Age-specific resurgence in invasive pneumococcal disease incidence in the COVID-19 pandemic era and its association with respiratory virus and pneumococcal carriage dynamics: a time series analysis.
    Clin Infect Dis. 2023 Dec 6:ciad746. doi: 10.1093.
    >> Share

  97. MAKAM AN
    Unlinking time zero from test-negative controls exaggerates risk from COVID-19.
    Clin Infect Dis. 2023 Dec 6:ciad731. doi: 10.1093.
    >> Share

  98. KOW CS, Ramachandram DS, Hasan SS, Thiruchelvam K, et al
    COVID-19 Vaccination: Safeguarding Against Post-COVID Cardiovascular Complications.
    Clin Infect Dis. 2023 Dec 6:ciad732. doi: 10.1093.
    >> Share

  99. LIM JT, En WL, Tay AT, Pang D, et al
    Unlinking time zero from test-negative date does not influence risk estimates of long-term cardiovascular complications due to COVID-19.
    Clin Infect Dis. 2023 Dec 6:ciad742. doi: 10.1093.
    >> Share

  100. LAVOIE T, Appaneal HJ, LaPlante KL
    Advancements in Novel Live Biotherapeutic Products for Clostridioides difficile Infection Prevention.
    Clin Infect Dis. 2023;77.
    >> Share

  101. LEWIS NM, Zhu Y, Peltan ID, Gaglani M, et al
    Vaccine Effectiveness Against Influenza A-Associated Hospitalization, Organ Failure, and Death: United States, 2022-2023.
    Clin Infect Dis. 2023 Dec 5:ciad677. doi: 10.1093.
    >> Share

  102. HOFFMANN CJ, Shearer K, Kekana B, Kerrigan D, et al
    Reducing HIV-associated post-hospital mortality through home-based care in South Africa: a randomized controlled trial.
    Clin Infect Dis. 2023 Dec 5:ciad727. doi: 10.1093.
    >> Share

    November 2023
  103. JAIN V
    Infection Control and Prevention During the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Nov 30:ciad611. doi: 10.1093.
    >> Share

  104. GRANEROD J, Huang Y, Davies NWS, Sequeira PC, et al
    Global Landscape of Encephalitis: Key Priorities to Reduce Future Disease Burden.
    Clin Infect Dis. 2023;77:1552-1560.
    >> Share

  105. USDAN L, Patel S, Rodriguez H, Xu X, et al
    A Bivalent Omicron-BA.4/BA.5-Adapted BNT162b2 Booster in >/=12-Year-Olds.
    Clin Infect Dis. 2023 Nov 28:ciad718. doi: 10.1093.
    >> Share

  106. LEE N, Nguyen L, Austin PC, Brown KA, et al
    Protection conferred by COVID-19 vaccination, prior SARS-CoV-2 infection, or hybrid immunity against Omicron-associated severe outcomes among community-dwelling adults.
    Clin Infect Dis. 2023 Nov 24:ciad716. doi: 10.1093.
    >> Share

  107. BOULWARE DR
    When Someone Should Do Something About This: How a Cryptococcal Clinical Trialist Became Involved With the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 16:ciad648. doi: 10.1093.
    >> Share

  108. HERBERT C, Manabe YC, Filippaios A, Lin H, et al
    Differential Viral Dynamics by Sex and Body Mass Index During Acute SARS-CoV-2 Infection: Results from a Longitudinal Cohort Study.
    Clin Infect Dis. 2023 Nov 16:ciad701. doi: 10.1093.
    >> Share

  109. SMITH-JEFFCOAT SE, Biddle JE, Talbot HK, Morrisey KG, et al
    Symptoms, viral loads, and rebound among COVID-19 outpatients treated with nirmatrelvir/ritonavir compared to propensity score matched untreated individuals.
    Clin Infect Dis. 2023 Nov 14:ciad696. doi: 10.1093.
    >> Share

  110. KANJILAL S
    Flying Into the Future With Large Language Models.
    Clin Infect Dis. 2023 Nov 14:ciad635. doi: 10.1093.
    >> Share

  111. SPINELLI MA, Christopoulos KA, Moreira CV, Jain JP, et al
    Viral Suppression Trajectories Destabilized After Coronavirus Disease 2019 Among US People With Human Immunodeficiency Virus: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2023 Nov 14:ciad657. doi: 10.1093.
    >> Share

  112. MEYEROWITZ EA, Li Y
    Review: The Landscape of Antiviral Therapy for COVID-19 in the Era of Widespread Population Immunity and Omicron-Lineage Viruses.
    Clin Infect Dis. 2023 Nov 9:ciad685. doi: 10.1093.
    >> Share

  113. SAAG MS
    Coronavirus Disease (COVID) and the Fog of War.
    Clin Infect Dis. 2023 Nov 8:ciad649. doi: 10.1093.
    >> Share

  114. TIPPETT A, Ess G, Hussaini L, Reese O, et al
    Influenza Vaccine Effectiveness Pre-pandemic among Adults Hospitalized with Congestive Heart Failure, Chronic Obstructive Pulmonary Disease, and Older Adults.
    Clin Infect Dis. 2023 Nov 8:ciad679. doi: 10.1093.
    >> Share

  115. KUPPALLI K
    Hostility Unmasked: Scientists on the Frontlines of the Coronavirus Disease 2019 (COVID-19) Pandemic.
    Clin Infect Dis. 2023 Nov 6:ciad623. doi: 10.1093.
    >> Share

  116. HUMPHRIES R, Sefers S, Schmitz J, Seegmiller A, et al
    Clinical Laboratory Experiences During the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2023 Nov 2:ciad622. doi: 10.1093.
    >> Share

  117. ASLAM S
    Phage Therapy in Lung Transplantation: Current Status and Future Possibilities.
    Clin Infect Dis. 2023;77.
    >> Share

    October 2023
  118. KUUT TA, Muller F, Csorba I, Braamse AMJ, et al
    Letter to the editor: Positive effects of cognitive-behavioral therapy targeting severe fatigue following COVID-19 are sustained up to one year after treatment.
    Clin Infect Dis. 2023 Oct 27:ciad661. doi: 10.1093.
    >> Share

  119. HEDBERG P, Karlsson Valik J, Abdel Halim L, Alfven T, et al
    Outcomes of SARS-CoV-2 Omicron Variant Infections Compared with Seasonal Influenza and Respiratory Syncytial Virus Infections in Adults Attending the Emergency Department: A Multicentre Cohort Study.
    Clin Infect Dis. 2023 Oct 26:ciad660. doi: 10.1093.
    >> Share

  120. MONTEJANO R, Soler-Carracedo A, Borobia AM, Martin-Quiros A, et al
    The Current Mismatch between COVID-19 Clinical Trial Design and The Evolving Profile of Hospitalized Patients: A Retrospective Cohort Analysis.
    Clin Infect Dis. 2023 Oct 26:ciad655. doi: 10.1093.
    >> Share

  121. HAMAD Y, Bell TD, Kadri SS
    Shifting Tides: Is It Time to Embrace Adjunctive Corticosteroids for Community-Acquired Pneumonia?
    Clin Infect Dis. 2023 Oct 25:ciad498. doi: 10.1093.
    >> Share

  122. APPEL KS, Geisler R, Maier D, Miljukov O, et al
    A Systematic Review of Predictor Composition, Outcomes, Risk of Bias, and Validation of COVID-19 Prognostic Scores.
    Clin Infect Dis. 2023 Oct 25:ciad618. doi: 10.1093.
    >> Share

  123. RHEE C, Strich JR, Chiotos K, Classen DC, et al
    Improving Sepsis Outcomes in the Era of Pay-for-Performance and Electronic Quality Measures: A Joint IDSA/ACEP/PIDS/SHEA/SHM/SIDP Position Paper.
    Clin Infect Dis. 2023 Oct 13:ciad447. doi: 10.1093.
    >> Share

  124. GREEN SI, Clark JR, Santos HH, Weesner KE, et al
    A Retrospective, Observational Study of 12 Cases of Expanded-Access Customized Phage Therapy: Production, Characteristics, and Clinical Outcomes.
    Clin Infect Dis. 2023;77:1079-1091.
    >> Share

  125. CARAZO S, Guay CA, Skowronski DM, Amini R, et al
    Influenza hospitalization burden by subtype, age, comorbidity and vaccination status: 2012/13 to 2018/19 seasons, Quebec, Canada.
    Clin Infect Dis. 2023 Oct 11:ciad627. doi: 10.1093.
    >> Share

  126. ISLAM J, Hu W
    Heatwaves and Dengue Outbreak in Bangladesh after COVID-19 Pandemic- An Urgent Call for Climate-Driven Early Warning Systems.
    Clin Infect Dis. 2023 Oct 10:ciad625. doi: 10.1093.
    >> Share

  127. STIER EA, Jain M, Joshi H, Darragh TM, et al
    Two-Year Incidence and Cumulative Risk and Predictors of Anal High-Grade Squamous Intraepithelial Lesions (anal precancer) among Women with HIV.
    Clin Infect Dis. 2023 Oct 8:ciad614. doi: 10.1093.
    >> Share

  128. SCHUSTER JE, Hamdan L, Dulek DE, Kitko CL, et al
    The Durability of Antibody Responses of Two Doses of High-Dose Relative to Two Doses of Standard-Dose Inactivated Influenza Vaccine in Pediatric Hematopoietic Cell Transplant Recipients: A Multi-Center Randomized Controlled Trial.
    Clin Infect Dis. 2023 Oct 6:ciad534. doi: 10.1093.
    >> Share

  129. CONLY JM, Loeb M
    SARS-CoV-2 Exposures in a Large Gathering Event and Acquisition of COVID-19 in the Post-Vaccintion Era: A Randomized Trial is Possible During the Pandemic.
    Clin Infect Dis. 2023 Oct 5:ciad609. doi: 10.1093.
    >> Share

  130. LUONG NGUYEN LB, Goupil de Bouille J, Menant L, Noret M, et al
    A randomised controlled trial to study the transmission of SARS-CoV-2 and other respiratory viruses during indoor clubbing events (ANRS0066s ITOC study).
    Clin Infect Dis. 2023 Oct 5:ciad603. doi: 10.1093.
    >> Share

  131. BIERE-RAFI S, Janssen K, Jurgens E, Kooij S, et al
    Is Cognitive Behavioural Therapy Effective for Post-COVID Fatigue?
    Clin Infect Dis. 2023;77:1074-1075.
    >> Share

  132. MCCREARY EK
    Our "Side Hustle".
    Clin Infect Dis. 2023 Oct 4:ciad543. doi: 10.1093.
    >> Share

  133. GOFF DA
    Isolated and Lonely in a Nursing Home During the COVID 19 Pandemic: A Deadly Combination for My Mom.
    Clin Infect Dis. 2023 Oct 4:ciad591. doi: 10.1093.
    >> Share

  134. REGAN NN
    Just Breathe: My First 12 Hours as a Clinician Patient With COVID-19.
    Clin Infect Dis. 2023 Oct 4:ciad573. doi: 10.1093.
    >> Share

  135. MARCELIN GE, Marcelin NL, Marcelin JR, Marcelin A, et al
    Our parents were never home: seeing the pandemic through children's eyes.
    Clin Infect Dis. 2023 Oct 4:ciad564. doi: 10.1093.
    >> Share

    September 2023
  136. FREDIANI JK, Parsons R, McLendon KB, Westbrook AL, et al
    The New Normal: Delayed Peak SARS-CoV-2 Viral Loads Relative to Symptom Onset and Implications for COVID-19 Testing Programs.
    Clin Infect Dis. 2023 Sep 28:ciad582. doi: 10.1093.
    >> Share

  137. GUPTA A, Hughes MD, Cruz JL, Avihingsanon A, et al
    Adverse Pregnancy Outcomes among HIV-infected Women Taking Isoniazid Preventive Therapy During the First Trimester.
    Clin Infect Dis. 2023 Sep 28:ciad583. doi: 10.1093.
    >> Share

  138. LOPEZ BERNAL J, Andrews N, Gower C, Stowe J, et al
    Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From Coronavirus Disease 2019 in Adults Aged >/=70 Years.
    Clin Infect Dis. 2023 Sep 27:ciab881. doi: 10.1093.
    >> Share

  139. LIM JT, En WL, Tay AT, Pang D, et al
    Long-term Cardiovascular, Cerebrovascular, and Other Thrombotic Complications in Coronavirus Disease 2019 Survivors: A Retrospective Cohort Study.
    Clin Infect Dis. 2023 Sep 25:ciad469. doi: 10.1093.
    >> Share

  140. ANDERSSON NW, Thiesson EM, Lassauniere R, Hansen JV, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Postacute Risk of Non-Coronavirus Disease 2019 Infectious Disease Hospitalizations: A Nationwide Cohort Study of Danish Adults Aged >/=50 Years.
    Clin Infect Dis. 2023 Sep 22:ciad531. doi: 10.1093.
    >> Share

  141. WALKER J, McCarty T, McGwin G, Ordaya EE, et al
    Description of Cryptococcosis following SARS-CoV-2 infection: A disease survey through the Mycosis Study Group Education and Research Consortium (MSG-19).
    Clin Infect Dis. 2023 Sep 15:ciad551. doi: 10.1093.
    >> Share

  142. FEYS S, Lagrou K, Lauwers HM, Haenen K, et al
    High burden of COVID-19-associated pulmonary aspergillosis (CAPA) in severely immunocompromised patients requiring mechanical ventilation.
    Clin Infect Dis. 2023 Sep 11:ciad546. doi: 10.1093.
    >> Share

  143. DZIECIOLOWSKA S, Charest H, Roy T, Fafard J, et al
    Timing and Predictors of Loss of Infectivity among Healthcare Workers with Mild Primary and Recurrent COVID-19: a Prospective Observational Cohort Study.
    Clin Infect Dis. 2023 Sep 7:ciad535. doi: 10.1093.
    >> Share

    August 2023
  144. WONG CKH, Lau KTK, Au ICH, Lau EHY, et al
    Comparison of bivalent and monovalent mRNA vaccine boosters.
    Clin Infect Dis. 2023 Aug 30:ciad519. doi: 10.1093.
    >> Share

  145. LAM T, Saso A, Ortiz AT, Hatcher J, et al
    The Socio-Economic and Demographic Risk Factors for SARS-CoV-2 Seropositivity Among Healthcare Workers in a UK Hospital: A Prospective Cohort Study.
    Clin Infect Dis. 2023 Aug 30:ciad522. doi: 10.1093.
    >> Share

  146. GRIGGS EP, Mitchell PK, Lazariu V, Gaglani M, et al
    Clinical epidemiology and risk factors for critical outcomes among vaccinated and unvaccinated adults hospitalized with COVID-19-VISION Network, 10 States, June 2021-March 2023.
    Clin Infect Dis. 2023 Aug 26:ciad505. doi: 10.1093.
    >> Share

  147. BRUMMER LE, Thompson RR, Malhotra A, Shrestha S, et al
    Cost effectiveness of low-complexity screening tests in community-based case-finding for tuberculosis.
    Clin Infect Dis. 2023 Aug 25:ciad501. doi: 10.1093.
    >> Share

  148. GENTRY CA, Nguyen PN, Thind SK, Kurdgelashvili G, et al
    Characteristics and outcomes of US Veterans with immunocompromised conditions at high risk of severe SARS-CoV-2 infection with or without receipt of oral antiviral agents.
    Clin Infect Dis. 2023 Aug 24:ciad504. doi: 10.1093.
    >> Share

  149. KINAMON T, Gopinath R, Waack U, Needles M, et al
    Exploration of a Potential Desirability of Outcome Ranking Endpoint for Complicated Intra-Abdominal Infections Using 9 Registrational Trials for Antibacterial Drugs.
    Clin Infect Dis. 2023;77:649-656.
    >> Share

  150. ZUCKERMAN NS, Bucris E, Keidar-Friedman D, Amsalem M, et al
    Nirmatrelvir resistance - de novo E166V/L50V mutations in an immunocompromised patient treated with prolonged nirmatrelvir/ritonavir monotherapy leading to clinical and virological treatment failure - a case report.
    Clin Infect Dis. 2023 Aug 19:ciad494. doi: 10.1093.
    >> Share

  151. TATE JE, Mwenda JM, Keita AM, Tapsoba TW, et al
    Evaluation of Intussusception Following Pentavalent Rotavirus Vaccine (RotaTeq) Administration in Five Countries in Africa.
    Clin Infect Dis. 2023 Aug 19:ciad492. doi: 10.1093.
    >> Share

  152. SOTO CL, Hsu AJ, Lee JH, Dzintars K, et al
    Identifying Effective Durations of Antibiotic Therapy for the Treatment of Carbapenem-resistant Enterobacterales Bloodstream Infections: A Multicenter Observational Study.
    Clin Infect Dis. 2023 Aug 16:ciad476. doi: 10.1093.
    >> Share

  153. LIANG TJ, Law JLM, Pietschmann T, Ray SC, et al
    Challenge Inoculum for Hepatitis C Virus Controlled Human Infection Model.
    Clin Infect Dis. 2023;77.
    >> Share

  154. CYBULSKI DJ, Matthews Z, Kieffer JW, Casey TM, et al
    Impact of SARS-CoV-2 Arrival Surveillance Screening by Nucleic Acid Amplification Versus Rapid Antigen Detection on Subsequent COVID-19 Infections in Military Trainees.
    Clin Infect Dis. 2023 Aug 10:ciad466. doi: 10.1093.
    >> Share

  155. MOZAFFARI E, Chandak A, Gottlieb RL, Chima-Melton C, et al
    Remdesivir reduced mortality in immunocompromised patients hospitalized for COVID-19 across variant waves: Findings from routine clinical practice.
    Clin Infect Dis. 2023 Aug 9:ciad460. doi: 10.1093.
    >> Share

  156. UNO S, Goto R, Honda K, Uchida S, et al
    The cost-effectiveness of universal asymptomatic preoperative SARS-CoV-2 PCR screening: a cost-utility analysis.
    Clin Infect Dis. 2023 Aug 9:ciad463. doi: 10.1093.
    >> Share

  157. O'LEARY EN, Neuhauser MM, Srinivasan A, Dubendris H, et al
    Impact of the COVID-19 Pandemic on Inpatient Antibiotic Use in the United States, January 2019 through July 2022.
    Clin Infect Dis. 2023 Aug 3:ciad453. doi: 10.1093.
    >> Share

  158. EHRENZELLER S, Chen T, Vaidya V, Rhee C, et al
    Impact of SARS-CoV-2 Prevention Measures on Non-SARS-CoV-2 Hospital-Onset Respiratory Viral Infections: An Incidence Trend Analysis from 2015-2023.
    Clin Infect Dis. 2023 Aug 2:ciad451. doi: 10.1093.
    >> Share

  159. CHAN GCK, Lui GCY, Wong CNS, Yip SST, et al
    Safety Profile and Clinical and Virological Outcomes of Nirmatrelvir-Ritonavir Treatment in Patients With Advanced Chronic Kidney Disease and Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Aug 2:ciad371. doi: 10.1093.
    >> Share

    July 2023
  160. POZZI C, Sarti R, Levi R, Mollura M, et al
    Association between duration of SARS-CoV-2 positivity and long COVID.
    Clin Infect Dis. 2023 Jul 22:ciad434. doi: 10.1093.
    >> Share

  161. SAYAMA Y, Okamoto M, Saito M, Tamaki R, et al
    Lack of zoonotic coronavirus species detected among children hospitalized with pneumonia in the Philippines.
    Clin Infect Dis. 2023 Jul 20:ciad430. doi: 10.1093.
    >> Share

  162. BRUST K, Kobayashi T, Diekema DJ
    Asymptomatic testing of hospital admissions for SARS-CoV-2: Is it OK to stop?
    Clin Infect Dis. 2023 Jul 18:ciad423. doi: 10.1093.
    >> Share

  163. RHEE C, Klompas M, Pak TR, Kohler JR, et al
    In Support of Universal Admission Testing for SARS-CoV-2 During Significant Community Transmission.
    Clin Infect Dis. 2023 Jul 18:ciad424. doi: 10.1093.
    >> Share

  164. NARAYANASAMY S, Curtis LH, Hernandez AF, Woods CW, et al
    Lessons from COVID-19 for Pandemic Preparedness: Proceedings from a Multi-Stakeholder Think Tank.
    Clin Infect Dis. 2023 Jul 12:ciad418. doi: 10.1093.
    >> Share

  165. ALLAN-BLITZ LT, Klausner JD
    SARS-CoV-2 Case-Definitions Must Include Clinical Criteria: Reply to Kojima et al.
    Clin Infect Dis. 2023 Jul 7:ciad413. doi: 10.1093.
    >> Share

  166. ALLEL K, Peters A, Conejeros J, Martinez JRW, et al
    Antibiotic Consumption During the Coronavirus Disease 2019 Pandemic and Emergence of Carbapenemase-Producing Klebsiella pneumoniae Lineages Among Inpatients in a Chilean Hospital: A Time-Series Study and Phylogenomic Analysis.
    Clin Infect Dis. 2023;77.
    >> Share

  167. SOLANKY D, McGovern OL, Edwards JR, Mahon G, et al
    Prescribing of Outpatient Antibiotics Commonly Used for Respiratory Infections Among Adults Before and During the Coronavirus Disease 2019 Pandemic in Brazil.
    Clin Infect Dis. 2023;77.
    >> Share

  168. RAMAY BM, Castillo C, Grajeda L, Santos LF, et al
    Colonization With Antibiotic-Resistant Bacteria in a Hospital and Associated Communities in Guatemala: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    >> Share

  169. BEZERRA CLPAM, Dos Santos EL, Oliveira MS, Dias MBS, et al
    Crude Mortality Associated With the Empirical Use of Polymyxins in Septic Patients in a Setting of High Prevalence of Carbapenem-Resistant Gram-negative Bacteria: Retrospective Analysis of a Cohort.
    Clin Infect Dis. 2023;77.
    >> Share

  170. ARAOS R, Smith RM, Styczynski A, Sanchez F, et al
    High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
    Clin Infect Dis. 2023;77.
    >> Share

  171. PATEL TS, McGovern OL, Mahon G, Osuka H, et al
    Trends in Inpatient Antibiotic Use Among Adults Hospitalized During the Coronavirus Disease 2019 Pandemic in Argentina, Brazil, and Chile, 2018-2021.
    Clin Infect Dis. 2023;77.
    >> Share

  172. KIFFER CRV, Rezende TFT, Costa-Nobre DT, Marinonio ASS, et al
    A 7-Year Brazilian National Perspective on Plasmid-Mediated Carbapenem Resistance in Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii Complex and the Impact of the Coronavirus Disease 2019 Pandemic on Their Occurrence.
    Clin Infect Dis. 2023;77.
    >> Share

  173. FOCOSI D, Franchini M, Nicastri E, Sullivan DJ, et al
    Convalescent Plasma Versus Hyperimmune Immunoglobulins.
    Clin Infect Dis. 2023 Jul 3:ciad406. doi: 10.1093.
    >> Share

  174. BAERENDS EAM, Reekie J, Andreasen SR, Staerke NB, et al
    Omicron variant-specific serological imprinting following BA.1 or BA.4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study.
    Clin Infect Dis. 2023 Jul 1:ciad402. doi: 10.1093.
    >> Share

    June 2023
  175. CRAWFORD JS
    Correspondence in relation to the recently published paper: Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial by Kuut and colleagues.
    Clin Infect Dis. 2023 Jun 30:ciad397. doi: 10.1093.
    >> Share

  176. EVANS ME, Simbartl LA, McCauley BP, Flarida LK, et al
    Active Surveillance and Contact Precautions for Preventing Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections during the COVID-19 Pandemic.
    Clin Infect Dis. 2023 Jun 30:ciad388. doi: 10.1093.
    >> Share

  177. FAUST JS, Kumar A, Shah J, Khadke S, et al
    Oral Nirmatrelvir and Ritonavir for Covid-19 in Vaccinated, Non-Hospitalized Adults, Ages 18-50 Years.
    Clin Infect Dis. 2023 Jun 30:ciad400. doi: 10.1093.
    >> Share

  178. MELGAR M, Abrams JY, Godfred-Cato S, Shah AB, et al
    A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021.
    Clin Infect Dis. 2023 Jun 29:ciad374. doi: 10.1093.
    >> Share

  179. AMBROGGIO L, Cotter J, Hall M, Shapiro DJ, et al
    Management of Pediatric Pneumonia: A Decade After the PIDS/IDSA Guideline.
    Clin Infect Dis. 2023 Jun 23:ciad385. doi: 10.1093.
    >> Share

  180. TROTTIER C, La J, Li LL, Alsoubani M, et al
    Maintaining the Utility of COVID-19 Pandemic Severity Surveillance: Evaluation of Trends in Attributable Deaths and Development and Validation of a Measurement Tool.
    Clin Infect Dis. 2023 Jun 22:ciad381. doi: 10.1093.
    >> Share

  181. UPASANI V, Townsend K, Wu MY, Carr EJ, et al
    Commercial immunoglobulin products contain neutralising antibodies against SARS-CoV-2 spike protein.
    Clin Infect Dis. 2023 Jun 20:ciad368. doi: 10.1093.
    >> Share

  182. SENEFELD JW, Joyner MJ
    SARS-CoV-2 Antibody Replacement Therapy for Immunocompromised Patients.
    Clin Infect Dis. 2023 Jun 20:ciad367. doi: 10.1093.
    >> Share

  183. NAFICY A, Kuxhausen A, Pirrotta P, Leav B, et al
    No immunological interference or safety concerns when adjuvanted recombinant zoster vaccine is coadministered with a COVID-19 mRNA-1273 booster vaccine in adults aged 50 years and older: A randomized trial.
    Clin Infect Dis. 2023 Jun 19:ciad361. doi: 10.1093.
    >> Share

  184. GUAN Y, Puenpatom A, Johnson MG, Zhang Y, et al
    Impact of Molnupiravir Treatment on Patient-Reported Coronavirus Disease 2019 (COVID-19) Symptoms in the Phase 3 MOVe-OUT Trial: A Randomized, Placebo-Controlled Trial.
    Clin Infect Dis. 2023 Jun 19:ciad409. doi: 10.1093.
    >> Share

  185. MONTASTRUC F, de Canecaude C
    Tixagevimab-Cilgavimab Treatment and Cardiovascular Events: Immortal Time Bias.
    Clin Infect Dis. 2023;76:2044-2045.
    >> Share

  186. ISRAEL A, Berkovitch M, Merzon E, Golan-Cohen A, et al
    Glucose-6-phosphate dehydrogenase (G6PD) Deficiency and COVID-19.
    Clin Infect Dis. 2023 Jun 7:ciad348. doi: 10.1093.
    >> Share

  187. WEE LE, Pang D, Chiew C, Tan J, et al
    Long-term real-world protection afforded by third mRNA doses against symptomatic SARS-COV-2 infections, COVID-19-related emergency attendances and hospitalizations amongst older Singaporeans during an Omicron XBB wave.
    Clin Infect Dis. 2023 Jun 6:ciad345. doi: 10.1093.
    >> Share

  188. JILG N, Chew KW, Giganti MJ, Daar ES, et al
    One Week of Oral Camostat Versus Placebo in Non-Hospitalized Adults with Mild-to-Moderate COVID-19: A Randomized Controlled Phase 2 Trial.
    Clin Infect Dis. 2023 Jun 5:ciad342. doi: 10.1093.
    >> Share

    May 2023
  189. LUNDGREN J
    Patients Hospitalized With Coronavirus Disease 2019: A Diverse Population.
    Clin Infect Dis. 2023 May 31:ciad280. doi: 10.1093.
    >> Share

  190. KOJIMA N, Adams K, Self WH, Gaglani M, et al
    Changing Severity and Epidemiology of Adults Hospitalized With Coronavirus Disease 2019 (COVID-19) in the United States After Introduction of COVID-19 Vaccines, March 2021-August 2022.
    Clin Infect Dis. 2023 May 31:ciad276. doi: 10.1093.
    >> Share


  191. Correction to: Relative Effectiveness of Coronavirus Disease 2019 (COVID-19) Vaccination and Booster Dose Combinations Among 18.9 Million Vaccinated Adults During the Early Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Omicron Period-Un
    Clin Infect Dis. 2023 May 30:ciad256. doi: 10.1093.
    >> Share

  192. ASTURIAS EJ, Excler JL, Ackland J, Cavaleri M, et al
    Safety of Streptococcus pyogenes vaccines: Anticipating and Overcoming Challenges for Clinical Trials and Post Marketing Monitoring.
    Clin Infect Dis. 2023 May 26:ciad311. doi: 10.1093.
    >> Share

  193. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019.
    Clin Infect Dis. 2023;76:1735-1737.
    >> Share

  194. TEJERINA F, Palomino R, Catalan P, Sanz A, et al
    Longitudinal Whole-Genome Sequence Characterization of a Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.5 Infection in an Immunocompromised Patient Successfully Treated With Sotrovimab 1000 mg.
    Clin Infect Dis. 2023;76:1872-1874.
    >> Share

  195. BLENNOW O, Vesterbacka J, Tovatt T, Nowak P, et al
    Successful Combination Treatment for Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Clin Infect Dis. 2023;76:1864-1865.
    >> Share

  196. MAOR Y, Shinar E, Izak M, Rahav G, et al
    A Randomized Controlled Study Assessing Convalescent Immunoglobulins versus Convalescent Plasma for Hospitalized COVID-19 Patients.
    Clin Infect Dis. 2023 May 23:ciad305. doi: 10.1093.
    >> Share

  197. GOWTHAMAN P, Vasoo S
    Zinc for the treatment of COVID-19: Yet to prove its mettle?
    Clin Infect Dis. 2023 May 22:ciad303. doi: 10.1093.
    >> Share

  198. YADAW AS, Sahner DK, Sidky H, Afzali B, et al
    Pre-existing autoimmunity is associated with increased severity of COVID-19: A retrospective cohort study using data from the National COVID Cohort Collaborative (N3C).
    Clin Infect Dis. 2023 May 19:ciad294. doi: 10.1093.
    >> Share


  199. Correction to: Association of Upper Respiratory Streptococcus pneumoniae Colonization With Severe Acute Respiratory Syndrome Coronavirus 2 Infection Among Adults.
    Clin Infect Dis. 2023 May 18:ciad191. doi: 10.1093.
    >> Share

  200. ZENG G, Zhou Y
    Association of virus variation and vaccination status with post-acute sequelae after SARS-cov-2 infection.
    Clin Infect Dis. 2023 May 10:ciad292. doi: 10.1093.
    >> Share

  201. GUDIPATI S, Shallal A, Peterson E, Cook B, et al
    Increase in False Positive Fourth Generation HIV Tests in Patients with COVID-19 Disease.
    Clin Infect Dis. 2023 May 9:ciad264. doi: 10.1093.
    >> Share

  202. WAALEWIJN H, Szubert AJ, Wasmann RE, Wiesner L, et al
    First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
    Clin Infect Dis. 2023 May 9:ciad267. doi: 10.1093.
    >> Share

  203. KUUT TA, Muller F, Csorba I, Braamse A, et al
    Efficacy of cognitive behavioral therapy targeting severe fatigue following COVID-19: results of a randomized controlled trial.
    Clin Infect Dis. 2023 May 8:ciad257. doi: 10.1093.
    >> Share

  204. KABORE JL, Laffont B, Diop M, Tardif MR, et al
    Real-World Effectiveness of Nirmatrelvir/Ritonavir on Covid-19-Associated Hospitalization Prevention: A Population-Based Cohort Study in the Province of Quebec, Canada.
    Clin Infect Dis. 2023 May 7:ciad287. doi: 10.1093.
    >> Share

  205. KO JY, Pham H, Anglin O, Chai SJ, et al
    Vaccination Status and Trends in Adult COVID-19-Associated Hospitalizations by Race and Ethnicity, March 2020-August 2022.
    Clin Infect Dis. 2023 May 3:ciad266. doi: 10.1093.
    >> Share

  206. TIMIRE C, Pedrazzoli D, Boccia D, Houben RM, et al
    Use of a sustainable livelihood framework-based measure to estimate socioeconomic impact of tuberculosis on house-holds.
    Clin Infect Dis. 2023 May 3:ciad273. doi: 10.1093.
    >> Share

  207. HASSANZADEH H, Baber J, Begier E, Noriega DC, et al
    Efficacy of a 4-Antigen Staphylococcus aureus Vaccine in Spinal Surgery: The STRIVE Randomized Clinical Trial.
    Clin Infect Dis. 2023 May 1:ciad218. doi: 10.1093.
    >> Share

    April 2023
  208. ADALJA A, McQuillen DP, Meyer D
    How Infectious Disease Experts Impacted the Coronavirus Disease 2019 (COVID-19) Response: Lessons From the Front Lines.
    Clin Infect Dis. 2023 Apr 27:ciad137. doi: 10.1093.
    >> Share

  209. GVINJILIA L, Baliashvili D, Shadaker S, Averhoff F, et al
    Impact of HCV infection and treatment on mortality in the country of Georgia, 2015-2020.
    Clin Infect Dis. 2023 Apr 26:ciad182. doi: 10.1093.
    >> Share

  210. GLEESON SE, Zapata H, Bathgate ME, Emu B, et al
    Building an Infectious Disease Diversity, Equity, and Antiracism (ID2EA) Curriculum: A Single Center's Experience and Reflections.
    Clin Infect Dis. 2023 Apr 20:ciad236. doi: 10.1093.
    >> Share

  211. HAIDAR G, Jacobs JL, Hughes Kramer K, Naqvi A, et al
    Therapy with Allogeneic SARS-CoV-2-specific T-cells for Persistent COVID-19 in Immunocompromised Patients.
    Clin Infect Dis. 2023 Apr 20:ciad233. doi: 10.1093.
    >> Share

  212. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Changes in population immunity against infection and severe disease from SARS-CoV-2 Omicron variants in the United States between December 2021 and November 2022.
    Clin Infect Dis. 2023 Apr 19:ciad210. doi: 10.1093.
    >> Share

  213. ERTEM Z, Nelson RE, Schechter-Perkins EM, Al-Amery A, et al
    Condition-Dependent and Dynamic Impacts of Indoor Masking Policies for COVID-19 Mitigation: A Nationwide, Interrupted Time-Series Analysis.
    Clin Infect Dis. 2023 Apr 19:ciad115. doi: 10.1093.
    >> Share

  214. JOFFE AR, Elliott A, Eapen R, Milburn C, et al
    Is vaccination acting as a placebo in preventing symptoms of Long-COVID?
    Clin Infect Dis. 2023 Apr 19:ciad234. doi: 10.1093.
    >> Share

  215. SWINDELLS S, Eschenauer GA, Nason M, Daar ES, et al
    Letter to the Editor.
    Clin Infect Dis. 2023 Apr 19:ciad229. doi: 10.1093.
    >> Share

  216. SABET N, Omar T, Milovanovic M, Magajane T, et al
    Undiagnosed pulmonary TB and COVID in adults dying at home in a high TB burden setting, before and during pandemic COVID-19: an autopsy study.
    Clin Infect Dis. 2023 Apr 12:ciad212. doi: 10.1093.
    >> Share

  217. OSTROSKY-ZEICHNER L
    COVID-19: Shehecheyanu.
    Clin Infect Dis. 2023 Apr 11:ciad213. doi: 10.1093.
    >> Share

  218. BRANCHE AR, Rouphael NG, Losada C, Baden LR, et al
    Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial.
    Clin Infect Dis. 2023 Apr 10:ciad209. doi: 10.1093.
    >> Share

  219. SCHWARTZ IS, Bahr NC
    Out of Bounds: A Critical Appraisal of the Changing Geography of the Endemic Mycoses.
    Clin Infect Dis. 2023;76:1302-1303.
    >> Share

    March 2023
  220. WERBEL WA, Weld ED, Advani SD, Patel PK, et al
    Your outpatient has COVID-19: what are their treatment options in the current SARS-CoV-2 variant climate?
    Clin Infect Dis. 2023 Mar 31:ciad178. doi: 10.1093.
    >> Share

  221. MACFADDEN DR, Maxwell C, Bowdish D, Bronskill S, et al
    COVID-19 Vaccination is Associated with Reduced Outpatient Antibiotic Prescribing In Older Adults with Confirmed SARS-CoV-2: A Population Wide Cohort Study.
    Clin Infect Dis. 2023 Mar 31:ciad190. doi: 10.1093.
    >> Share

  222. LEVITT JE, Hedlin H, Duong S, Lu D, et al
    Evaluation of acebilustat, a selective inhibitor of leukotriene B4 biosynthesis, for treatment of outpatients with mild-moderate COVID-19 disease: A randomized, double-blind, placebo- controlled Phase 2 trial.
    Clin Infect Dis. 2023 Mar 30:ciad187. doi: 10.1093.
    >> Share

  223. BLOCH EM, Goel R, Zhu X, Patel EU, et al
    COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample.
    Clin Infect Dis. 2023 Mar 29:ciad185. doi: 10.1093.
    >> Share

  224. MIKULSKA M, Sepulcri C, Dentone C, Magne F, et al
    Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients.
    Clin Infect Dis. 2023 Mar 28:ciad181. doi: 10.1093.
    >> Share

  225. FERREIRA VH, Ierullo M, Mavandadnejad F, Kurtesi A, et al
    Omicron BA.4/5 neutralization and T-cell responses in organ transplant recipients after Booster mRNA vaccine: a Multicenter Cohort Study.
    Clin Infect Dis. 2023 Mar 28:ciad175. doi: 10.1093.
    >> Share

  226. PEREZ MOLINA JA, Crespillo-Andujar C, Zamora J, Fernandez-Felix BM, et al
    Contribution of low CD4 cell counts and high HIV viral load to the efficacy of preferred first-line antiretroviral regimens for treating HIV infection: A systematic review and meta-analysis.
    Clin Infect Dis. 2023 Mar 28:ciad177. doi: 10.1093.
    >> Share

  227. VAN EFFELTERRE T, Hens N, White LJ, Gravenstein S, et al
    Modeling Respiratory Syncytial Virus Adult Vaccination in the United States with a Dynamic Transmission Model.
    Clin Infect Dis. 2023 Mar 23:ciad161. doi: 10.1093.
    >> Share

  228. OELTMANN JE, Vohra D, Matulewicz HH, DeLuca N, et al
    Isolation and quarantine for COVID-19 in the United States, 2020-2022.
    Clin Infect Dis. 2023 Mar 22:ciad163. doi: 10.1093.
    >> Share

  229. OSBORN R, Alamri M, Tomic R, Ison MG, et al
    Infectious Complications of Lung Transplant for COVID-Associated Lung Injury (CALI): A Single Center Case-Control Cohort Study.
    Clin Infect Dis. 2023 Mar 21:ciad160. doi: 10.1093.
    >> Share

  230. WANG P, Xing H, Zhang X, Yang J, et al
    Complexity Interactions between Nirmatrelvir/Ritonavir and Voriconazole in Patients with Coronavirus Disease 2019.
    Clin Infect Dis. 2023 Mar 21:ciad159. doi: 10.1093.
    >> Share

  231. CHUNG H, Campitelli MA, Buchan SA, Campigotto A, et al
    Evaluating the impact of statin use on influenza vaccine effectiveness and influenza infection in older adults.
    Clin Infect Dis. 2023 Mar 21:ciad148. doi: 10.1093.
    >> Share

  232. MORI N, Hirai J, Asai N, Mikamo H, et al
    Appropriate outcome settings for the effectiveness of oral zinc treatment for Coronavirus Disease-2019.
    Clin Infect Dis. 2023 Mar 17:ciad153. doi: 10.1093.
    >> Share


  233. Correction to: Single-dose mRNA Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Including Alpha and Gamma Variants: A Test-negative Design in Adults 70 Years and Older in British Columbia, Canada.
    Clin Infect Dis. 2023 Mar 15:ciac607. doi: 10.1093.
    >> Share

  234. LEWER D, Brothers TD, Croxford S, Desai M, et al
    Opioid injection-associated bacterial infections in England, 2002-2021: a time series analysis of seasonal variation and the impact of COVID-19.
    Clin Infect Dis. 2023 Mar 14:ciad144. doi: 10.1093.
    >> Share

  235. KAHLERT CR, Strahm C, Gusewell S, Cusini A, et al
    Post-acute sequelae after SARS-CoV-2 infection by viral variant and vaccination status: a multicenter cross-sectional study.
    Clin Infect Dis. 2023 Mar 11:ciad143. doi: 10.1093.
    >> Share

  236. NIRENBERG E, Perencevich EN
    Understanding and Improving Vaccine Effectiveness Estimates in the Age of Widespread Background Immunity: A Step Towards Improved Science Communication.
    Clin Infect Dis. 2023 Mar 8:ciad124. doi: 10.1093.
    >> Share

  237. RON R, Moreno E, Martinez-Sanz J, Branas F, et al
    CD4/CD8 ratio during HIV treatment: time for routine monitoring?
    Clin Infect Dis. 2023 Mar 8:ciad136. doi: 10.1093.
    >> Share

  238. PATEL R, Tsalik EL, Evans S, Fowler VG, et al
    Clinically Adjudicated Reference Standards for Evaluation of Infectious Diseases Diagnostics.
    Clin Infect Dis. 2023;76:938-943.
    >> Share

  239. MARCELIN JR, Khazanchi R, Lyden E, Cawcutt KA, et al
    Demographic Representation Among Speakers and Program Committee Members at the IDWeek Conference, 2013-2021.
    Clin Infect Dis. 2023;76:897-904.
    >> Share

  240. LEA AN, Leyden WA, Sofrygin O, Marafino BJ, et al
    Human Immunodeficiency Virus Status, Tenofovir Exposure, and the Risk of Poor Coronavirus Disease 19 (COVID-19) Outcomes: Real-World Analysis From 6 United States Cohorts Before Vaccine Rollout.
    Clin Infect Dis. 2023 Mar 2:ciad084. doi: 10.1093.
    >> Share

  241. DEL AMO J
    Question of Whether Tenofovir Disoproxil Fumarate/Emtricitabine Provides Protection Against Clinical Severity of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Mar 2:ciad086. doi: 10.1093.
    >> Share


  242. Correction to: Effectiveness of Paxlovid in Reducing Severe Coronavirus Disease 2019 and Mortality in High-Risk Patients.
    Clin Infect Dis. 2023 Mar 1:ciac702. doi: 10.1093.
    >> Share


  243. Correction to: Effectiveness of Messenger RNA-based Vaccines During the Emergence of the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant.
    Clin Infect Dis. 2023 Mar 1:ciac810. doi: 10.1093.
    >> Share

    February 2023
  244. PANDIT JA, Radin JM, Chiang D, Spencer EG, et al
    The COVID-19 Rebound Study: A Prospective Cohort Study to Evaluate Viral and Symptom Rebound Differences in Participants Treated with Nirmatrelvir Plus Ritonavir Versus Untreated Controls.
    Clin Infect Dis. 2023 Feb 22:ciad102. doi: 10.1093.
    >> Share

  245. SHOHAM S
    COVID-19 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle.
    Clin Infect Dis. 2023 Feb 21:ciad092. doi: 10.1093.
    >> Share

  246. LEVINE AC, Fukuta Y, Huaman MA, Ou J, et al
    COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials.
    Clin Infect Dis. 2023 Feb 21:ciad088. doi: 10.1093.
    >> Share

  247. TEJERINA F, Palomino R, Catalan P, Sanz A, et al
    Longitudinal whole-genome sequence characterization of a persistent SARS-CoV-2 Omicron BA.5 infection in an immunocompromised patient successfully treated with sotrovimab 1000 mg.
    Clin Infect Dis. 2023 Feb 17:ciad090. doi: 10.1093.
    >> Share

  248. NALINTYA E, Sekar P, Kavuma P, Kigozi J, et al
    Effect of Covid-19 lockdowns on identification of advanced HIV disease in outpatient clinics in Uganda.
    Clin Infect Dis. 2023 Feb 17:ciad087. doi: 10.1093.
    >> Share

  249. HEMILA H, Chalker E
    Zinc and COVID-19.
    Clin Infect Dis. 2023 Feb 14:ciad078. doi: 10.1093.
    >> Share

  250. BLENNOW O, Vesterbacka J, Tovatt T, Nowak P, et al
    Successful combination treatment for persistent SARS-CoV-2 infection.
    Clin Infect Dis. 2023 Feb 14:ciad085. doi: 10.1093.
    >> Share

  251. CABRAL SM, Harris AD, Cosgrove SE, Magder LS, et al
    Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries across 825 United States Hospitals, 2019-2020.
    Clin Infect Dis. 2023 Feb 12:ciad077. doi: 10.1093.
    >> Share

  252. FRUTOS AM, Kuan G, Lopez R, Ojeda S, et al
    Infection-induced immunity is associated with protection against SARS-CoV-2 infection and decreased infectivity.
    Clin Infect Dis. 2023 Feb 12:ciad074. doi: 10.1093.
    >> Share

  253. MORAWSKA L, Bahnfleth W, Bluyssen PM, Boerstra A, et al
    COVID-19 and Airborne Transmission: Science Rejected, Lives Lost. Can Society Do Better?
    Clin Infect Dis. 2023 Feb 10:ciad068. doi: 10.1093.
    >> Share


  254. It Is Time to Determine Tocilizumab's Place in Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2023 Feb 10:ciac612. doi: 10.1093.
    >> Share

  255. OKUMURA K, Jyothula S, Kaleekal T, Dhand A, et al
    One-year Outcomes of Lung Transplantation for COVID-19 Associated End Stage Lung Disease in the United States.
    Clin Infect Dis. 2023 Feb 9:ciad072. doi: 10.1093.
    >> Share


  256. Correction to: Coronavirus Disease 2019 [COVID-19] Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study.
    Clin Infect Dis. 2023 Feb 8:ciac632. doi: 10.1093.
    >> Share

  257. KOMPANIYETS L, Wiegand RE, Oyalowo AC, Bull-Otterson L, et al
    Relative effectiveness of COVID-19 vaccination and booster dose combinations among 18.9 million vaccinated adults during the early SARS-CoV-2 Omicron period - United States, January 1, 2022-March 31, 2022.
    Clin Infect Dis. 2023 Feb 8:ciad063. doi: 10.1093.
    >> Share

  258. KORPE P, Ni Z, Kabir M, Alam M, et al
    Prospective cohort study of Cryptosporidium infection and shedding in infants and their households.
    Clin Infect Dis. 2023 Feb 8:ciad059. doi: 10.1093.
    >> Share

  259. WILDENTHAL JA, Atkinson A, Lewis S, Sayood S, et al
    Outcomes of Partial Oral Antibiotic Treatment for Complicated Staphylococcus aureus Bacteremia in People Who Inject Drugs.
    Clin Infect Dis. 2023;76:487-496.
    >> Share

  260. TORRICO F, Gascon J, Ortiz L, Pinto J, et al
    A Phase 2, Randomized, Multicenter, Placebo-Controlled, Proof-of-Concept Trial of Oral Fexinidazole in Adults With Chronic Indeterminate Chagas Disease.
    Clin Infect Dis. 2023;76:e1186-e1194.
    >> Share

  261. MORGAN DJ, Dubberke ER, Hink T, Paszkiewicz G, et al
    The Impact of Universal Glove and Gown Use on Clostridioides Difficile Acquisition: A Cluster-Randomized Trial.
    Clin Infect Dis. 2023;76:e1202-e1207.
    >> Share

  262. SCHIAFFINO F, Colston JM, Paredes Olortegui M, Rengifo Pinedo S, et al
    Antibiotic Use and Stewardship Practices in a Pediatric Community-based Cohort Study in Peru: Shorter Would be Sweeter.
    Clin Infect Dis. 2023;76:e1054-e1061.
    >> Share

  263. JUNKER D, Becker M, Wagner TR, Kaiser PD, et al
    Antibody Binding and Angiotensin-Converting Enzyme 2 Binding Inhibition Is Significantly Reduced for Both the BA.1 and BA.2 Omicron Variants.
    Clin Infect Dis. 2023;76:e240-e249.
    >> Share

  264. BLOCH EM, Focosi D, Shoham S, Senefeld J, et al
    Guidance on the use of convalescent plasma to treat immunocompromised patients with COVID-19.
    Clin Infect Dis. 2023 Feb 6:ciad066. doi: 10.1093.
    >> Share


  265. Correction to: Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Clin Infect Dis. 2023 Feb 3:ciad014. doi: 10.1093.
    >> Share

  266. SCHULTZ JS, Mace KE, Tan KR
    Return to travel in the COVID-19 pandemic recovery period and implications for imported malaria: Reinforcing prevention, early diagnosis, and appropriate treatment of malaria.
    Clin Infect Dis. 2023 Feb 1:ciad061. doi: 10.1093.
    >> Share

    January 2023
  267. HERNANDEZ-TAMAYO C, Qato DM, Jewell MP, Gounder P, et al
    COVID-19 Pandemic Associated Declines and Subsequent Increases in Hepatitis C Virus Treatment Prescriptions in Los Angeles County.
    Clin Infect Dis. 2023 Jan 31:ciad050. doi: 10.1093.
    >> Share

  268. MOLLDREM S
    Research on the Development of SARS-CoV-2 Variants of Concern in People with Advanced HIV Disease Should Highlight Structural Conditions and Avoid Harmful Stereotypes.
    Clin Infect Dis. 2023 Jan 31:ciad048. doi: 10.1093.
    >> Share

  269. GOTTLIEB M, Wang R, Yu H, Spatz ES, et al
    Severe Fatigue and Persistent Symptoms at Three Months Following SARS-CoV-2 Infections During the Pre-Delta, Delta, and Omicron Time Periods: A Multicenter Prospective Cohort Study.
    Clin Infect Dis. 2023 Jan 27:ciad045. doi: 10.1093.
    >> Share

  270. MELICA G, Bartolucci P, Audureau E, Le Corvoisier P, et al
    Immunological efficacy of pneumococcal vaccination including the 13-valent pneumococcal vaccine in adult patients with sickle-cell disease: results of the randomized DREVAC controlled trial.
    Clin Infect Dis. 2023 Jan 27:ciad037. doi: 10.1093.
    >> Share

  271. HAYDEN MK, Hanson KE, Englund JA, Lee F, et al
    The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing.
    Clin Infect Dis. 2023 Jan 26:ciad032. doi: 10.1093.
    >> Share


  272. Correction to: Two-Dose Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Effectiveness With Mixed Schedules and Extended Dosing Intervals: Test-Negative Design Studies From British Columbia and Quebec, Canada.
    Clin Infect Dis. 2023 Jan 18:ciac584. doi: 10.1093.
    >> Share

  273. BONAZZETTI C, Tazza B, Gibertoni D, Pasquini Z, et al
    Relationship between immune response to SARS-CoV2 vaccines and development of breakthrough infection in solid organ transplant recipients: the CONTRAST cohort.
    Clin Infect Dis. 2023 Jan 13:ciad016. doi: 10.1093.
    >> Share

  274. STEELE EJ, Gorczynski RM, Lindley RA, Wickramasinghe NC, et al
    Natural Antibodies and SARS CoV-2 Specific Antibodies in Healthy Asymptomatic Individuals.
    Clin Infect Dis. 2023 Jan 10:ciad004. doi: 10.1093.
    >> Share


  275. Correction to: Longitudinal Immune Response to 3 Doses of Messenger RNA Vaccine Against Coronavirus Disease (COVID-19) in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2023 Jan 6:ciac964. doi: 10.1093.
    >> Share

  276. DALTON AF, Weber ZA, Allen KS, Stenehjem E, et al
    Relationships between social vulnerability and COVID-19 vaccination coverage and vaccine effectiveness.
    Clin Infect Dis. 2023 Jan 6:ciad003. doi: 10.1093.
    >> Share

  277. TITANJI BK
    The Last Mile Problem - COVID-19 Vaccine Coverage Among the Most Socially Vulnerable.
    Clin Infect Dis. 2023 Jan 6:ciad006. doi: 10.1093.
    >> Share

  278. DEDRICK RM, Smith BE, Cristinziano M, Freeman KG, et al
    Phage Therapy of Mycobacterium Infections: Compassionate Use of Phages in 20 Patients With Drug-Resistant Mycobacterial Disease.
    Clin Infect Dis. 2023;76:103-112.
    >> Share

  279. MALCHAIR P, Giol J, Garcia V, Rodriguez O, et al
    Three-day icatibant on top of standard care in patients with COVID-19 pneumonia (ICAT.COVID): a randomized, open-label, phase 2, proof-of-concept trial.
    Clin Infect Dis. 2023 Jan 4:ciac984. doi: 10.1093.
    >> Share

    December 2022

  280. Correction to: Potential Influence of Menstrual Status and Sex Hormones on Female Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Cross-sectional Multicenter Study in Wuhan, China.
    Clin Infect Dis. 2022 Dec 31:ciac576. doi: 10.1093.
    >> Share

  281. HERRING MK, Romine JK, Wesley MG, Ellingson KD, et al
    SARS-CoV-2 infection history and antibody response to three COVID-19 mRNA vaccine doses.
    Clin Infect Dis. 2022 Dec 29:ciac976. doi: 10.1093.
    >> Share

  282. SPATZ ES, Gottlieb M, Wisk LE, Anderson J, et al
    Three-month symptom profiles among symptomatic adults with positive and negative SARS-CoV-2 tests: a prospective cohort study from the INSPIRE group.
    Clin Infect Dis. 2022 Dec 27:ciac966. doi: 10.1093.
    >> Share

  283. ROBERTSON MM, Qasmieh SA, Kulkarni SG, Teasdale CA, et al
    The epidemiology of long COVID in US adults.
    Clin Infect Dis. 2022 Dec 21:ciac961. doi: 10.1093.
    >> Share

  284. VUORIO A, Kovanen PT, Raal F
    Statin Needs to be Continued During Paxlovid Therapy in COVID-19.
    Clin Infect Dis. 2022;75:2281-2282.
    >> Share

  285. ROBINSON ML, Morris CP, Betz JF, Zhang Y, et al
    Impact of SARS-CoV-2 variants on inpatient clinical outcome.
    Clin Infect Dis. 2022 Dec 19:ciac957. doi: 10.1093.
    >> Share

  286. CHOWERS M, Gerassy-Vainberg S, Cohen-Poradosu R, Wiener-Well Y, et al
    The Effect of Macrolides on Mortality in Bacteremic Pneumococcal Pneumonia: A Retrospective, Nationwide Cohort Study, Israel, 2009-2017.
    Clin Infect Dis. 2022;75:2219-2224.
    >> Share

  287. NEHME M, Vetter P, Chappuis F, Kaiser L, et al
    Prevalence of post-COVID Condition 12 Weeks after Omicron Infection Compared to Negative Controls and Association with Vaccination Status.
    Clin Infect Dis. 2022 Dec 15:ciac947. doi: 10.1093.
    >> Share

  288. PRICE AM, Flannery B, Talbot HK, Grijalva CG, et al
    Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season.
    Clin Infect Dis. 2022 Dec 12:ciac941. doi: 10.1093.
    >> Share

  289. HETRICH MK, Oliva J, Wanionek K, Knoll MD, et al
    Epidemiology of human parainfluenza virus type 3 (HPIV-3) and respiratory syncytial virus (RSV) infections in the time of COVID-19: findings from a household cohort in Maryland.
    Clin Infect Dis. 2022 Dec 12:ciac942. doi: 10.1093.
    >> Share

  290. PRUNAS O, Weinberger DM, Pitzer VE, Gazit S, et al
    Waning Effectiveness of the BNT162b2 Vaccine Against Infection in Adolescents in Israel.
    Clin Infect Dis. 2022 Dec 9:ciac315. doi: 10.1093.
    >> Share

  291. EDWARDS KM, Neuzil KM
    Developing mucosal vaccines for SARS-CoV-2: What will it take?
    Clin Infect Dis. 2022 Dec 9:ciac935. doi: 10.1093.
    >> Share

  292. COHEN JI, Dropulic L, Wang K, Gangler K, et al
    Comparison of levels of nasal, salivary, and plasma antibody to SARS-CoV-2 during natural infection and after vaccination.
    Clin Infect Dis. 2022 Dec 9:ciac934. doi: 10.1093.
    >> Share

  293. MUKAE H, Yotsuyanagi H, Ohmagari N, Doi Y, et al
    Efficacy and safety of ensitrelvir in patients with mild-to-moderate COVID-19: the phase 2b part of a randomized, placebo-controlled, phase 2/3 study.
    Clin Infect Dis. 2022 Dec 7:ciac933. doi: 10.1093.
    >> Share

  294. JASSAT W, Abdool Karim SS, Ozougwu L, Welch R, et al
    Trends in Cases, Hospitalization and Mortality Related to the Omicron BA.4/BA.5 Sub-Variants in South Africa.
    Clin Infect Dis. 2022 Dec 1:ciac921. doi: 10.1093.
    >> Share


  295. Correction to: Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of Coronavirus Disease 2019 in Africa.
    Clin Infect Dis. 2022 Dec 1:ciac897. doi: 10.1093.
    >> Share

    November 2022
  296. KAMIDANI S, Garg S, Rolfes MA, Campbell AP, et al
    Epidemiology, Clinical Characteristics, and Outcomes of Influenza-Associated Hospitalizations in US Children Over 9 Seasons Following the 2009 H1N1 Pandemic.
    Clin Infect Dis. 2022;75:1930-1939.
    >> Share

  297. YAN J, Steiger SN, Kodama R, Fender J, et al
    Predictors of COVID-19 hospitalization after sotrovimab in hematologic malignancy patients during the BA.1 Omicron surge.
    Clin Infect Dis. 2022 Nov 29:ciac916. doi: 10.1093.
    >> Share

  298. MOKHTAR S, Parpia AS, Lo NC, Ndeffo-Mbah ML, et al
    Evaluation of the United States definitions for COVID-19 community risk levels.
    Clin Infect Dis. 2022 Nov 26:ciac922. doi: 10.1093.
    >> Share

  299. TADESSE BT, Bravo L, Marks F, Aziz AB, et al
    Impact of vaccination with SCB-2019 COVID-19 vaccine on transmission of SARS-CoV-2 infection: a household contact study in the Philippines.
    Clin Infect Dis. 2022 Nov 26:ciac914. doi: 10.1093.
    >> Share

  300. DAVIS JM, Li JZ
    The Promise and Peril of Anti-SARS-CoV-2 Monoclonal Antibodies.
    Clin Infect Dis. 2022 Nov 22:ciac902. doi: 10.1093.
    >> Share

  301. LEVIN MJ, Ustianowski A, Thomas S, Templeton A, et al
    AZD7442 (Tixagevimab/Cilgavimab) for Post-exposure Prophylaxis of Symptomatic COVID-19.
    Clin Infect Dis. 2022 Nov 22:ciac899. doi: 10.1093.
    >> Share

  302. CASKEY M, Kuritzkes DR
    Monoclonal Antibodies as Long-Acting Products: What Are We Learning From Human Immunodeficiency Virus (HIV) and Coronavirus Disease 2019 (COVID-19)?
    Clin Infect Dis. 2022;75.
    >> Share

  303. PARKER AM, Jackson N, Awasthi S, Kim H, et al
    Association of upper respiratory Streptococcus pneumoniae colonization with SARS-CoV-2 infection among adults.
    Clin Infect Dis. 2022 Nov 19:ciac907. doi: 10.1093.
    >> Share

  304. ALAEDINI A, Wormser GP
    Persistence of SARS-CoV-2 to Explain Long COVID Is Not Consistent with the Available Data.
    Clin Infect Dis. 2022 Nov 17. pii: 6831665. doi: 10.1093.
    >> Share

  305. BIRABAHARAN M, Hill E, Begur M, Kaelber DC, et al
    Cardiovascular outcomes after tixagevimab and cilgavimab use for pre-exposure prophylaxis against COVID-19: a population-based propensity-matched cohort study.
    Clin Infect Dis. 2022 Nov 16. pii: 6830248. doi: 10.1093.
    >> Share

  306. SHAH MM, Spencer BR, Feldstein LR, Haynes JM, et al
    Occupations Associated with SARS-CoV-2 Infection and Vaccination, U.S. Blood Donors, July 2021-December 2021.
    Clin Infect Dis. 2022 Nov 14. pii: 6825618. doi: 10.1093.
    >> Share

  307. PAI MANGALORE R, Ashok A, Lee SJ, Romero L, et al
    Beta-Lactam Antibiotic Therapeutic Drug Monitoring in Critically Ill Patients: A Systematic Review and Meta-Analysis.
    Clin Infect Dis. 2022;75:1848-1860.
    >> Share

  308. BAKER MA, Rhee C, Tucker R, Vaidya V, et al
    Ralstonia pickettii and Pseudomonas aeruginosa Bloodstream Infections Associated With Contaminated Extracorporeal Membrane Oxygenation Water Heater Devices.
    Clin Infect Dis. 2022;75:1838-1840.
    >> Share

  309. MORRIS CP, Eldesouki RE, Sachithanandham J, Fall A, et al
    Omicron Subvariants: Clinical, Laboratory, and Cell Culture Characterization.
    Clin Infect Dis. 2022 Nov 11. pii: 6822482. doi: 10.1093.
    >> Share

  310. BARDA N, Canetti M, Gilboa M, Asraf K, et al
    The Association Between Pre-Booster Vaccination Antibody Levels and the Risk of SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 Nov 11. pii: 6821340. doi: 10.1093.
    >> Share

  311. BLOSSEY AM, Bruckner S, May M, Parzmair GP, et al
    VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including COVID-19 in the Elderly: a phase III randomised, double-blind, placebo-controlled, multicenter clinical study.
    Clin Infect Dis. 2022 Nov 11. pii: 6821343. doi: 10.1093.
    >> Share

  312. OTERO S, Miller ES, Sunderraj A, Shanes ED, et al
    Maternal Antibody Response and Transplacental Transfer Following SARS-CoV-2 Infection or Vaccination in Pregnancy.
    Clin Infect Dis. 2022 Nov 9. pii: 6812657. doi: 10.1093.
    >> Share

  313. YAN VC
    Test 5- versus 10-day remdesivir treatment in immunocompromised patients with COVID-19.
    Clin Infect Dis. 2022 Nov 8. pii: 6809131. doi: 10.1093.
    >> Share

  314. SIEGHART D, Hana CA, Haslacher H, Perkmann T, et al
    MULTI-PARAMETRIC PREDICTION MODELS FOR COVID-19 VACCINE SELECTION: RESULTS OF A COMPARATIVE POPULATION-BASED COHORT STUDY.
    Clin Infect Dis. 2022 Nov 4. pii: 6795267. doi: 10.1093.
    >> Share

  315. BEN ABDALLAH S, Mhalla Y, Trabelsi I, Sekma A, et al
    Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial.
    Clin Infect Dis. 2022 Nov 4. pii: 6795268. doi: 10.1093.
    >> Share

  316. HOLMGAARD FB, Guglielmetti L, Lillebaek T, Andersen AB, et al
    Efficacy and tolerability of concomitant use of bedaquiline and delamanid for multidrug- and extensively drug-resistant tuberculosis: a systematic review and meta-analysis.
    Clin Infect Dis. 2022 Nov 4. pii: 6801118. doi: 10.1093.
    >> Share

  317. SNELL LB, Medina-Alcolea A, Charalampous T, Alder C, et al
    Real-time whole genome sequencing to guide patient-tailored therapy of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Nov 3. pii: 6785897. doi: 10.1093.
    >> Share

  318. TENFORDE MW, Patel MM, Lewis NM, Adams K, et al
    Vaccine effectiveness against influenza A(H3N2)-associated hospitalized illness, United States, 2022.
    Clin Infect Dis. 2022 Nov 3. pii: 6795261. doi: 10.1093.
    >> Share

  319. FORD ES, Simmons W, Karmarkar EN, Yoke LH, et al
    Successful treatment of prolonged, severe COVID-19 lower respiratory tract disease in a B-cell ALL patient with an extended course of remdesivir and nirmatrelvir/ritonavir.
    Clin Infect Dis. 2022 Nov 3. pii: 6795102. doi: 10.1093.
    >> Share

    October 2022
  320. NAJJAR-DEBBINY R, Gronich N, Weber G, Stein N, et al
    Effectiveness of Evusheld in Immunocompromised Patients: Propensity Score-Matched Analysis.
    Clin Infect Dis. 2022 Oct 31. pii: 6780937. doi: 10.1093.
    >> Share

  321. BETTINGER JA, Irvine MA, Shulha HP, Valiquette L, et al
    Adverse Events Following Immunization with mRNA and Viral Vector Vaccines in Individuals with Previous SARS-CoV-2 Infection from the Canadian National Vaccine Safety Network.
    Clin Infect Dis. 2022 Oct 31. pii: 6780916. doi: 10.1093.
    >> Share

  322. WANG L, Calzavara A, Baral S, Smylie J, et al
    Differential patterns by area-level social determinants of health in COVID-19 related mortality and non-COVID-19 mortality: a population-based study of 11.8 million people in Ontario, Canada.
    Clin Infect Dis. 2022 Oct 28. pii: 6776118. doi: 10.1093.
    >> Share

  323. BAHR NC, Skipper CP, Huppler-Hullsiek K, Ssebambulidde K, et al
    Recurrence of symptoms following cryptococcal meningitis - characterizing a diagnostic conundrum with multiple etiologies.
    Clin Infect Dis. 2022 Oct 28. pii: 6776123. doi: 10.1093.
    >> Share

  324. LAI J, Coleman KK, Tai SS, German J, et al
    Exhaled Breath Aerosol Shedding by Highly Transmissible Versus Prior SARS-CoV-2 Variants.
    Clin Infect Dis. 2022 Oct 26. pii: 6773834. doi: 10.1093.
    >> Share

  325. TROTTIER CA, Wong B, Kohli R, Boomsma C, et al
    Dual antiviral therapy for persistent COVID-19 and associated organizing pneumonia in an immunocompromised host.
    Clin Infect Dis. 2022 Oct 25. pii: 6771205. doi: 10.1093.
    >> Share

  326. VINCETI M, Filippini T, Fairweather-Tait S
    A potential role for zinc to enhance treatment for COVID-19?
    Clin Infect Dis. 2022 Oct 25. pii: 6771230. doi: 10.1093.
    >> Share

  327. PENALVA G, Crespo-Rivas JC, Guisado-Gil AB, Rodriguez-Villodres A, et al
    Clinical and ecological impact of an educational program to optimize antibiotic treatments in nursing homes (PROA-SENIOR): a cluster randomized controlled trial and interrupted time-series analysis.
    Clin Infect Dis. 2022 Oct 21. pii: 6765270. doi: 10.1093.
    >> Share

  328. TURBETT SE, Tomkins-Tinch CH, Anahtar MN, Dugdale CM, et al
    Distinguishing SARS-CoV-2 persistence and reinfection: A retrospective cohort study.
    Clin Infect Dis. 2022 Oct 21. pii: 6765222. doi: 10.1093.
    >> Share

  329. CLARKE KEN, Hong K, Schoonveld M, Greenspan AI, et al
    Severity of COVID-19 Hospitalization Outcomes and Patient Disposition Differ by Disability Status and Disability Type.
    Clin Infect Dis. 2022 Oct 19. pii: 6763266. doi: 10.1093.
    >> Share

  330. ASARE K, Andine T, Naicker N, Dorward J, et al
    Impact of point-of-care testing on the management of sexually transmitted infections in South Africa: Evidence from the HVTN702 HIV vaccine trial.
    Clin Infect Dis. 2022 Oct 15. pii: 6761890. doi: 10.1093.
    >> Share

  331. MALOSH RE, McGovern I, Monto AS
    Influenza During the 2010-2020 Decade in the United States: Seasonal Outbreaks and Vaccine Interventions.
    Clin Infect Dis. 2022 Oct 11. pii: 6758391. doi: 10.1093.
    >> Share

  332. LI Y, Harrison LJ, Chew KW, Currier JS, et al
    Nasal and Plasma SARS-CoV-2 RNA Levels are Associated with Timing of Symptom Resolution in the ACTIV-2 Trial of Non-hospitalized Adults with COVID-19.
    Clin Infect Dis. 2022 Oct 10. pii: 6754602. doi: 10.1093.
    >> Share

  333. HEATH PT, Galiza EP, Baxter DN, Boffito M, et al
    Safety and Efficacy of the NVX-CoV2373 COVID-19 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
    Clin Infect Dis. 2022 Oct 10. pii: 6754597. doi: 10.1093.
    >> Share

  334. HAN AX, Girdwood S, Khan S, Sacks JA, et al
    Strategies for using antigen rapid diagnostic tests to reduce transmission of SARS-CoV-2 in low- and middle-income countries: a mathematical modelling study applied to Zambia.
    Clin Infect Dis. 2022 Oct 8. pii: 6754174. doi: 10.1093.
    >> Share

  335. COPPEE R, Sarrasin V, Zaffaroulah R, Bouzayene A, et al
    Nosocomial malaria transmissions resolved by genomic analyses - a retrospective case report study in France (2007-2021).
    Clin Infect Dis. 2022 Oct 8. pii: 6754169. doi: 10.1093.
    >> Share

  336. EPLING BP, Rocco JM, Boswell KL, Laidlaw E, et al
    Clinical, Virologic, and Immunologic Evaluation of Symptomatic Coronavirus Disease 2019 Rebound Following Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Oct 6. pii: 6749408. doi: 10.1093.
    >> Share

  337. FIDLER S, Fox J, Tipoe T, Longet S, et al
    Booster vaccination against SARS-CoV-2 induces potent immune responses in people with HIV.
    Clin Infect Dis. 2022 Oct 5. pii: 6748267. doi: 10.1093.
    >> Share

  338. KOGAN NE, Gantt S, Swerdlow D, Viboud C, et al
    Leveraging Serosurveillance and Postmortem Surveillance to Quantify the Impact of COVID-19 in Africa.
    Clin Infect Dis. 2022 Oct 5. pii: 6748257. doi: 10.1093.
    >> Share

  339. GLIGA S, Luebke N, Killer A, Gruell H, et al
    Rapid selection of sotrovimab escape variants in SARS-CoV-2 Omicron infected immunocompromised patients.
    Clin Infect Dis. 2022 Oct 3. pii: 6746719. doi: 10.1093.
    >> Share

    September 2022
  340. VAUGHN VM, Ratz D, Greene MT, Flanders SA, et al
    Antibiotic Stewardship Strategies and Their Association With Antibiotic Overuse After Hospital Discharge: An Analysis of the Reducing Overuse of Antibiotics at Discharge (Road) Home Framework.
    Clin Infect Dis. 2022;75:1063-1072.
    >> Share

  341. STOCKWELL MS, Reed C, Vargas CY, Wang L, et al
    Five-Year Community Surveillance Study for Acute Respiratory Infections Using Text Messaging: Findings From the MoSAIC Study.
    Clin Infect Dis. 2022;75:987-995.
    >> Share

  342. HOGAN JI, Duerr R, Dimartino D, Marier C, et al
    Remdesivir resistance in transplant recipients with persistent COVID-19.
    Clin Infect Dis. 2022 Sep 26. pii: 6717535. doi: 10.1093.
    >> Share

  343. FLOREA A, Sy LS, Qian L, Ackerson BK, et al
    Effectiveness of mRNA-1273 vaccine booster against COVID-19 in immunocompetent adults.
    Clin Infect Dis. 2022 Sep 22. pii: 6711079. doi: 10.1093.
    >> Share

  344. SCHERER EM, Backer M, Carvajal K, Danziger-Isakov L, et al
    The COVID-19 Pandemic Unmasked the Challenges Faced by Early-Stage Faculty in Infectious Diseases: A Call to Action.
    Clin Infect Dis. 2022 Sep 22. pii: 6710388. doi: 10.1093.
    >> Share

  345. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Molnupiravir in High Risk Patients: a Propensity Score Matched Analysis.
    Clin Infect Dis. 2022 Sep 20. pii: 6708264. doi: 10.1093.
    >> Share

  346. SIANGPHOE U, Baden LR, El Sahly HM, Essink B, et al
    Associations of Immunogenicity and Reactogenicity After SARS-CoV-2 mRNA-1273 Vaccine in COVE and TeenCOVE Trials.
    Clin Infect Dis. 2022 Sep 20. pii: 6708263. doi: 10.1093.
    >> Share

  347. ONO S, Michihata N, Yamana H, Uemura K, et al
    Comparative effectiveness of BNT162b2 and mRNA-1273 booster dose after BNT162b2 primary vaccination against the Omicron variants: A retrospective cohort study using large-scale population-based registries in Japan.
    Clin Infect Dis. 2022 Sep 18. pii: 6696997. doi: 10.1093.
    >> Share

  348. BOULWARE DR, Murray TA, Proper JL, Tignanelli CJ, et al
    Impact of SARS-CoV-2 vaccination and booster on COVID-19 symptom severity over time in the COVID-OUT trial.
    Clin Infect Dis. 2022 Sep 17. pii: 6702474. doi: 10.1093.
    >> Share

  349. DONLAN AN, Mallawaarachi I, Sasson JM, Preissner R, et al
    Dupilumab use is associated with protection from COVID-19 mortality: A retrospective analysis.
    Clin Infect Dis. 2022 Sep 15. pii: 6698736. doi: 10.1093.
    >> Share

  350. ALONSO-NAVARRO R, Cuesta G, Santos M, Cardozo C, et al
    Qualitative Subgenomic RNA to Monitor the Response to Remdesivir in Hospitalized Patients with COVID-19: impact on the length of hospital stay and mortality.
    Clin Infect Dis. 2022 Sep 13. pii: 6696600. doi: 10.1093.
    >> Share

  351. CUOMO RE, Li Z, Purushothaman V, Basavapatna-Shankar C, et al
    Predictors of Time to COVID-19 Infection in the National Basketball Association: A Retrospective Case-Control Study.
    Clin Infect Dis. 2022 Sep 13. pii: 6696551. doi: 10.1093.
    >> Share

  352. KAKIUCHI S, Livorsi DJ, Perencevich EN, Diekema DJ, et al
    Days of Antibiotic Spectrum Coverage: A Novel Metric for Inpatient Antibiotic Consumption.
    Clin Infect Dis. 2022;75:567-576.
    >> Share

  353. MAGNUS MC, Haberg SE, Carlsen EO, Kwong JC, et al
    Pregnancy status at the time of COVID-19 vaccination and incidence of SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Sep 8. pii: 6693880. doi: 10.1093.
    >> Share

  354. KOJIMA N, Klausner JD
    Usage and awareness of antiviral medications for COVID-19 among individuals at risk for severe COVID-19, March 2021 to 1 August 2022.
    Clin Infect Dis. 2022 Sep 7. pii: 6693563. doi: 10.1093.
    >> Share

  355. GOLAN Y, Campos JAS, Woolson R, Cilla D, et al
    Favipiravir in patients with early mild-to-moderate COVID-19: a randomized controlled trial.
    Clin Infect Dis. 2022 Sep 6. pii: 6692456. doi: 10.1093.
    >> Share

  356. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
    Clin Infect Dis. 2022 Sep 5. pii: 6692369. doi: 10.1093.
    >> Share

  357. SWANK Z, Senussi Y, Manickas-Hill Z, Yu XG, et al
    Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.
    Clin Infect Dis. 2022 Sep 2. pii: 6686531. doi: 10.1093.
    >> Share

    August 2022
  358. WIRTH KE, Edwards JK, Feinstein L, Breskin A, et al
    When emulating a trial, do as the trialists do: Missteps in estimating relative effectiveness of a SARS-CoV-2 vaccine booster dose.
    Clin Infect Dis. 2022 Aug 30. pii: 6679241. doi: 10.1093.
    >> Share

  359. HARRIGAN SP, Wilton J, Chong M, Abdia Y, et al
    Clinical severity of Omicron SARS-CoV-2 variant relative to Delta in British Columbia, Canada: A retrospective analysis of whole genome sequenced cases.
    Clin Infect Dis. 2022 Aug 30. pii: 6679248. doi: 10.1093.
    >> Share

  360. YIP TCF, Lui GCY, Lai MSM, Wong VWS, et al
    Impact of the use of oral antiviral agents on the risk of hospitalization in community COVID-19 patients.
    Clin Infect Dis. 2022 Aug 29. pii: 6678124. doi: 10.1093.
    >> Share

  361. GAGLANI M, Kim SS, Naleway AL, Levine MZ, et al
    Effect of Repeat Vaccination on Immunogenicity of Quadrivalent Cell-Culture and Recombinant Influenza Vaccines Among Healthcare Personnel Aged 18-64 Years: A Randomized, Open-Label Trial.
    Clin Infect Dis. 2022 Aug 29. pii: 6678123. doi: 10.1093.
    >> Share

  362. LOHSE ZM, Shapiro JJ, Lednicky JA, Cash MN, et al
    Persistence of SARS-CoV-2 omicron variant in children and utility of rapid antigen testing as an indicator of culturable virus.
    Clin Infect Dis. 2022 Aug 27. pii: 6677545. doi: 10.1093.
    >> Share

  363. FISHER BT, Boge CLK, Xiao R, Shuster S, et al
    Multicenter Prospective Study of Biomarkers for Diagnosis of Invasive Candidiasis in Children and Adolescents.
    Clin Infect Dis. 2022;75:248-259.
    >> Share

  364. KLOMPAS M, Baker MA, Rhee C
    Coronavirus Disease 2019's Challenges to Infection Control Dogma Regarding Respiratory Virus Transmission.
    Clin Infect Dis. 2022;75:e102-e104.
    >> Share

  365. KLEIN B, Harris DA
    Examining the Robustness of 3 Versus 6 Feet of Physical Distancing in Schools: A Reanalysis of van den Berg et al.
    Clin Infect Dis. 2022;75:e310-e311.
    >> Share

  366. FERNANDEZ-DE-LAS-PENAS C
    Are Patients Exhibiting Post-Coronavirus Disease (COVID) Symptoms at 12 months the Same at 5 or 9 Months? The Fluctuating Nature of Post-COVID.
    Clin Infect Dis. 2022;75:e1208.
    >> Share

  367. ADVANI SD, Sickbert-Bennett E, Moehring R, Cromer A, et al
    The Disproportionate Impact of COVID-19 Pandemic on Healthcare-Associated Infections in Community Hospitals: Need for Expanding the Infectious Disease Workforce.
    Clin Infect Dis. 2022 Aug 23. pii: 6673939. doi: 10.1093.
    >> Share

  368. GANATRA S, Dani SS, Ahmad J, Kumar A, et al
    Oral Nirmatrelvir and Ritonavir in Non-hospitalized Vaccinated Patients with Covid-19.
    Clin Infect Dis. 2022 Aug 20. pii: 6672670. doi: 10.1093.
    >> Share

  369. WIEMKEN TL, McGrath LJ, Andersen KM, Khan F, et al
    COVID-19 severity and risk of subsequent cardiovascular events.
    Clin Infect Dis. 2022 Aug 19. pii: 6671924. doi: 10.1093.
    >> Share

  370. NASREEN S, Febriani Y, Velasquez Garcia HA, Zhang G, et al
    Effectiveness of COVID-19 vaccines against hospitalization and death in Canada: A multiprovincial test-negative design study.
    Clin Infect Dis. 2022 Aug 17. pii: 6668859. doi: 10.1093.
    >> Share

  371. PERSON AK, Armstrong WS, Evans T, Fangman JJ, et al
    Principles for Ending HIV as an Epidemic in the United States: A Policy Paper of IDSA and HIVMA.
    Clin Infect Dis. 2022 Aug 15. pii: 6662275. doi: 10.1093.
    >> Share

  372. DELAHOY MJ, Munoz F, Li K, Arriola CS, et al
    SARS-CoV-2 testing and detection during peripartum hospitalizations among a multi-center cohort of pregnant persons, March 2020-February 2021.
    Clin Infect Dis. 2022 Aug 12. pii: 6663759. doi: 10.1093.
    >> Share

  373. PECK H, Anbumurali N, McMahon K, Freeman K, et al
    Detection of influenza in managed quarantine in Australia and the estimated risk of importation.
    Clin Infect Dis. 2022 Aug 12. pii: 6663754. doi: 10.1093.
    >> Share

  374. FJELLTVEIT EB, Blomberg B, Kuwelker K, Zhou F, et al
    Symptom burden and immune dynamics 6 to 18 months following mild SARS-CoV-2 infection -a case-control study.
    Clin Infect Dis. 2022 Aug 12. pii: 6663664. doi: 10.1093.
    >> Share

  375. KARABA AH, Zhou W, Li S, Aytenfisu TY, et al
    Impact of Seasonal Coronavirus Antibodies on SARS-CoV-2 Vaccine Responses in Solid Organ Transplant Recipients.
    Clin Infect Dis. 2022 Aug 12. pii: 6663288. doi: 10.1093.
    >> Share

  376. QASMIEH SA, Robertson MM, Teasdale CA, Kulkarni SG, et al
    Estimating the period prevalence of SARS-CoV-2 infection during the Omicron (BA.1) surge in New York City (NYC), January 1-March 16, 2022.
    Clin Infect Dis. 2022 Aug 12. pii: 6662085. doi: 10.1093.
    >> Share

  377. MOESTRUP KS, Reekie J, Zucco AG, Jensen TO, et al
    Readmissions, post-discharge mortality and sustained recovery among patients admitted to hospital with COVID-19.
    Clin Infect Dis. 2022 Aug 8. pii: 6658187. doi: 10.1093.
    >> Share

  378. FOPPIANO PALACIOS C, Tucker EW, Travassos MA
    COVID-19 burden among unaccompanied minors in United States custody.
    Clin Infect Dis. 2022 Aug 5. pii: 6656047. doi: 10.1093.
    >> Share

  379. AWASTHI M, Golding H, Khurana S
    SARS-CoV-2 hyperimmune intravenous human immunoglobulins neutralizes Omicron subvariants BA.1, BA.2, BA.2.12.1, BA.3 and BA.4/BA.5 for treatment of COVID-19.
    Clin Infect Dis. 2022 Aug 4. pii: 6655744. doi: 10.1093.
    >> Share

  380. KLEYNHANS J, Walaza S, Martinson NA, Neti M, et al
    Household transmission of SARS-CoV-2 from adult index cases living with and without HIV in South Africa, 2020-2021: a case-ascertained, prospective observational household transmission study.
    Clin Infect Dis. 2022 Aug 4. pii: 6655792. doi: 10.1093.
    >> Share

  381. ZAMBRANO LD, Newhams MM, Olson SM, Halasa NB, et al
    BNT162b2 mRNA Vaccination Against COVID-19 is Associated with Decreased Likelihood of Multisystem Inflammatory Syndrome in U.S. Children Ages 5-18 Years.
    Clin Infect Dis. 2022 Aug 4. pii: 6655523. doi: 10.1093.
    >> Share

  382. PRAY IW, Grajewski B, Morris C, Modji K, et al
    Measuring work-related risk of COVID-19: comparison of COVID-19 incidence by occupation and industry - Wisconsin, September 2020-May 2021.
    Clin Infect Dis. 2022 Aug 4. pii: 6655522. doi: 10.1093.
    >> Share

  383. ARASHIRO T, Arima Y, Muraoka H, Sato A, et al
    COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection during Delta-dominant and Omicron-dominant periods in Japan: a multi-center prospective case-control study (FASCINATE study).
    Clin Infect Dis. 2022 Aug 3. pii: 6653543. doi: 10.1093.
    >> Share

  384. VIHTA KD, Pouwels KB, Peto TE, Pritchard E, et al
    Omicron-associated changes in SARS-CoV-2 symptoms in the United Kingdom.
    Clin Infect Dis. 2022 Aug 3. pii: 6653436. doi: 10.1093.
    >> Share

  385. KRISHNA BA, Metaxaki M, Wills MR, Sithole N, et al
    Reduced incidence of Long COVID referrals to the Cambridge University Teaching Hospital Long COVID clinic.
    Clin Infect Dis. 2022 Aug 1. pii: 6652885. doi: 10.1093.
    >> Share

  386. ATCHISON CJ, Moshe M, Brown JC, Whitaker M, et al
    Validity of self-testing at home with rapid SARS-CoV-2 antibody detection by lateral flow immunoassay.
    Clin Infect Dis. 2022 Aug 1. pii: 6652878. doi: 10.1093.
    >> Share

    July 2022
  387. MONTEJANO R, de la Calle-Prieto F, Velasco M, Guijarro C, et al
    Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe COVID-19: The PANCOVID Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jul 30. pii: 6652179. doi: 10.1093.
    >> Share

  388. SINE K, Appaneal H, Dosa D, LaPlante KL, et al
    Antimicrobial Prescribing in the Telehealth Setting: Framework for stewardship during a period of rapid acceleration within primary care.
    Clin Infect Dis. 2022 Jul 30. pii: 6652160. doi: 10.1093.
    >> Share

  389. KERTES J, David SSB, Engel-Zohar N, Rosen K, et al
    Association between AZD7442 (tixagevimab-cilgavimab) administration and SARS-CoV-2 infection, hospitalization and mortality.
    Clin Infect Dis. 2022 Jul 29. pii: 6651663. doi: 10.1093.
    >> Share

  390. MARTINEZ-SANZ J, Serrano-Villar S, Muriel A, Fraile LJG, et al
    Metabolic-related outcomes after switching from tenofovir disoproxil fumarate to tenofovir alafenamide in adults with HIV: a multicenter prospective cohort study.
    Clin Infect Dis. 2022 Jul 29. pii: 6651472. doi: 10.1093.
    >> Share

  391. LEHRNBECHER T, Sack U, Speckmann C, Groll AH, et al
    Longitudinal Immune Response to Three Doses of mRNA Vaccine Against COVID-19 in Pediatric Patients Receiving Chemotherapy for Cancer.
    Clin Infect Dis. 2022 Jul 28. pii: 6651274. doi: 10.1093.
    >> Share

  392. LI H, Gao M, You H, Zhang P, et al
    Association of nirmatrelvir/ritonavir treatment on upper respiratory SARS-CoV-2 RT-PCR negative conversion rates among high-risk patients with COVID-19.
    Clin Infect Dis. 2022 Jul 23. pii: 6649232. doi: 10.1093.
    >> Share

  393. ESPARCIA-PINEDO L, Yarci-Carrion A, Mateo-Jimenez G, Ropero N, et al
    Development of an effective immune response in adults with Down Syndrome after SARS-CoV-2 vaccination.
    Clin Infect Dis. 2022 Jul 23. pii: 6649074. doi: 10.1093.
    >> Share

  394. MALAHE SRK, Hoek RAS, Dalm VASH, Broers AEC, et al
    Clinical characteristics and outcome of immunocompromised patients with COVID-19 caused by the Omicron variant: a prospective observational study.
    Clin Infect Dis. 2022 Jul 23. pii: 6649068. doi: 10.1093.
    >> Share

  395. HUYGENS S, Munnink BO, Gharbharan A, Koopmans M, et al
    Sotrovimab resistance and viral persistence after treatment of immunocompromised patients infected with the SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Jul 22. pii: 6648554. doi: 10.1093.
    >> Share

  396. ROTHBERG MB, Kim P, Shrestha NK, Kojima L, et al
    Protection Against the Omicron Variant Offered by Previous SARS-CoV-2 Infection: A Retrospective Cohort Study.
    Clin Infect Dis. 2022 Jul 22. pii: 6648553. doi: 10.1093.
    >> Share

  397. SAHNI LC, Naioti EA, Olson SM, Campbell AP, et al
    Sustained within-season vaccine effectiveness against influenza-associated hospitalization in children: Evidence from the New Vaccine Surveillance Network, 2015-2016 through 2019-2020.
    Clin Infect Dis. 2022 Jul 22. pii: 6648556. doi: 10.1093.
    >> Share

  398. HATFIELD KM, Baggs J, Wolford H, Fang M, et al
    Effectiveness of COVID-19 vaccination against SARS-CoV-2 Infection among Residents of US Nursing Homes, Before and During the Delta variant Predominance, December 2020 - November 2021.
    Clin Infect Dis. 2022 Jul 20. pii: 6646955. doi: 10.1093.
    >> Share

  399. VIEL KR
    Response to 'Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome'.
    Clin Infect Dis. 2022 Jul 12. pii: 6640218. doi: 10.1093.
    >> Share

  400. HUNYADY P, Streller L, Ruther DF, Groba SR, et al
    Secondary sclerosing cholangitis following COVID-19 disease: a multicenter retrospective study.
    Clin Infect Dis. 2022 Jul 9. pii: 6637421. doi: 10.1093.
    >> Share

  401. MIGUERES M, Dimeglio C, Mansuy JM, Abravanel F, et al
    The influence of the nasopharyngeal viral load on the spread of the Omicron BA.2 variant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633281. doi: 10.1093.
    >> Share

  402. SANDERS JSF, Lianne Messchendorp A, de Vries RD, Baan CC, et al
    Antibody and T-cell responses 6 months after COVID-19 mRNA-1273 vaccination in patients with chronic kidney disease, on dialysis, or living with a kidney transplant.
    Clin Infect Dis. 2022 Jul 7. pii: 6633280. doi: 10.1093.
    >> Share

  403. MAPONGA TG, Jeffries M, Tegally H, Sutherland A, et al
    Persistent SARS-CoV-2 infection with accumulation of mutations in a patient with poorly controlled HIV infection.
    Clin Infect Dis. 2022 Jul 6. pii: 6632801. doi: 10.1093.
    >> Share

  404. MURISON KR, Grima AA, Simmons AE, Tuite AR, et al
    Severity of SARS-CoV-2 Infection in Pregnancy in Ontario: A Matched Cohort Analysis.
    Clin Infect Dis. 2022 Jul 6. pii: 6632524. doi: 10.1093.
    >> Share

  405. DANIEL KELLY J, Lu S, Anglin K, Garcia-Knight M, et al
    Magnitude and determinants of SARS-CoV-2 household transmission: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jul 5. pii: 6631204. doi: 10.1093.
    >> Share

  406. COHEN JM, Carter MJ, Ronny Cheung C, Ladhani S, et al
    Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2.
    Clin Infect Dis. 2022 Jul 5. pii: 6631205. doi: 10.1093.
    >> Share

  407. RIDOLFI F, Peetluk L, Amorim G, Turner M, et al
    TB TREATMENT OUTCOMES IN BRAZIL: DIFFERENT PREDICTORS FOR EACH TYPE OF UNSUCCESSFUL OUTCOME.
    Clin Infect Dis. 2022 Jul 5. pii: 6631480. doi: 10.1093.
    >> Share

  408. BAGGS J, Rose AN, McCarthy NL, Wolford H, et al
    Antibiotic Resistant Infections among COVID-19 Inpatients in U.S. Hospitals.
    Clin Infect Dis. 2022 Jul 2. pii: 6627591. doi: 10.1093.
    >> Share

  409. SAMSON ME, Still WL, Mark-Carew M, Jarris DK, et al
    Utility of a Test to Return Strategy to Identify Individuals with COVID-19 in the Pre-Kindergarten through Grade 12 School Setting - District of Columbia, January 2022.
    Clin Infect Dis. 2022 Jul 1. pii: 6625819. doi: 10.1093.
    >> Share

    June 2022
  410. GOOD MK, Czarnik M, Harmon KG, Aukerman D, et al
    SARS-CoV-2 Infections and Reinfections among Fully Vaccinated and Unvaccinated University Athletes - 15 States, January - November 2021.
    Clin Infect Dis. 2022 Jun 30. pii: 6623463. doi: 10.1093.
    >> Share

  411. MOORING EQ, Newell K, Castrodale L, Tompkins M, et al
    Increased Mortality among Persons with Symptomatic COVID-19 During the Period of SARS-CoV-2 B.1.617.2 (Delta Variant) Predominance-Alaska, November 2020-October 2021.
    Clin Infect Dis. 2022 Jun 29. pii: 6619623. doi: 10.1093.
    >> Share

  412. GLATMAN-FREEDMAN A, Feldman SF, Hershkovitz Y, Kaufman Z, et al
    Vaccine coverage associated with ending a SARS-CoV-2 wave: a retrospective longitudinal analysis.
    Clin Infect Dis. 2022 Jun 28. pii: 6619125. doi: 10.1093.
    >> Share

  413. TAM AR, Zhang RR, Lung KC, Liu R, et al
    Early treatment of high-risk hospitalized COVID-19 patients with a combination of interferon beta-1b and remdesivir: a phase 2 open-label randomized controlled trial.
    Clin Infect Dis. 2022 Jun 28. pii: 6619124. doi: 10.1093.
    >> Share

  414. MOLINE HL, Keaton A, Rice W, Varghese J, et al
    Effectiveness of COVID-19 mRNA vaccines against infection during an outbreak of SARS-CoV-2 Beta (B.1.351) variant in a skilled nursing facility - Virginia, March-April 2021.
    Clin Infect Dis. 2022 Jun 27. pii: 6618595. doi: 10.1093.
    >> Share

  415. IDOKO OT, Usuf E, Okomo U, Wonodi C, et al
    SARS-CoV-2 in Africa: current considerations and future projections.
    Clin Infect Dis. 2022 Jun 25. pii: 6617636. doi: 10.1093.
    >> Share

  416. OH DY, Holzer M, Paraskevopoulou S, Trofimova M, et al
    Advancing Precision Vaccinology by Molecular and Genomic Surveillance of SARS-CoV-2 in Germany, 2021.
    Clin Infect Dis. 2022 Jun 25. pii: 6617635. doi: 10.1093.
    >> Share

  417. BORAH BF, Pringle J, Flaherty M, Oeltmann JE, et al
    High Community Transmission of SARS-CoV-2 Associated with Decreased Contact Tracing Effectiveness for Identifying Persons at Elevated Risk of Infection - Vermont.
    Clin Infect Dis. 2022 Jun 24. pii: 6617336. doi: 10.1093.
    >> Share

  418. ARNALDO P, Mabunda N, Young PW, Tran T, et al
    Prevalence of SARS-CoV-2 antibodies in the Mozambican population: a cross-sectional Serologic study in three cities, July-August 2020.
    Clin Infect Dis. 2022 Jun 24. pii: 6617331. doi: 10.1093.
    >> Share

  419. KUTTY PK, Stuckey MJ, Koumans EH
    Vaccines, Variants, and Vigilance: Strengthening the COVID-19 Public Health Response through Partnerships and Collaborations.
    Clin Infect Dis. 2022 Jun 24. pii: 6617337. doi: 10.1093.
    >> Share

  420. CHOI D, Nielsen J, Waller LA, Patel SA, et al
    The US COVID-19 surveillance environment: An ecological analysis of the relationship of testing adequacy in the context of vaccination.
    Clin Infect Dis. 2022 Jun 24. pii: 6617111. doi: 10.1093.
    >> Share

  421. MORROCCHI E, Pighi C, Pascucci GR, Cotugno N, et al
    Perinatally HIV-infected adolescents and young adults demonstrate distinct BNT162b2 mRNA COVID-19 vaccine immunogenicity.
    Clin Infect Dis. 2022 Jun 23. pii: 6615389. doi: 10.1093.
    >> Share

  422. OHLSEN EC, Yankey D, Pezzi C, Kriss JL, et al
    COVID-19 vaccination coverage, intentions, attitudes and barriers by race/ethnicity, language of interview, and nativity, National Immunization Survey Adult COVID Module, April 22, 2021-January 29, 2022.
    Clin Infect Dis. 2022 Jun 23. pii: 6614630. doi: 10.1093.
    >> Share

  423. BOUTON TC, Atarere J, Turcinovic J, Seitz S, et al
    Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study.
    Clin Infect Dis. 2022 Jun 23. pii: 6614634. doi: 10.1093.
    >> Share

  424. BOUCAU J, Uddin R, Marino C, Regan J, et al
    Characterization of virologic rebound following nirmatrelvir-ritonavir treatment for COVID-19.
    Clin Infect Dis. 2022 Jun 23. pii: 6614635. doi: 10.1093.
    >> Share

  425. TEMTE JL, Barlow S, Temte E, Goss M, et al
    SARS-CoV-2 co-detection with influenza A and other respiratory viruses among school-aged children and their household members- March 12, 2020, to February 22, 2022, Dane County, Wisconsin.
    Clin Infect Dis. 2022 Jun 23. pii: 6614626. doi: 10.1093.
    >> Share

  426. LEVY R, Cohen R, Lev-Shalem L, Eisenkraft A, et al
    A Retrospective Database Analysis of Before and After Social Distancing in Relation to Pediatric Infection Rate and Healthcare Services Usage During the COVID-19 Pandemic.
    Clin Infect Dis. 2022 Jun 20. pii: 6611849. doi: 10.1093.
    >> Share

  427. BROSH-NISSIMOV T, Hussein K, Wiener-Well Y, Orenbuch-Harroch E, et al
    Hospitalized patients with severe COVID-19 during the Omicron wave in Israel - benefits of a fourth vaccine dose.
    Clin Infect Dis. 2022 Jun 20. pii: 6611845. doi: 10.1093.
    >> Share

  428. ZIPFEL CM, Paul P, Gowler CD, Reddy SC, et al
    Modeling the effectiveness of healthcare personnel reactive testing and screening for the SARS-CoV-2 Omicron variant within nursing homes.
    Clin Infect Dis. 2022 Jun 20. pii: 6611848. doi: 10.1093.
    >> Share

  429. STARGEL A, Taylor MM, Zansky S, Spencer K, et al
    Case Investigation and Contact Tracing Efforts from Health Departments in the United States, November 2020-December 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611688. doi: 10.1093.
    >> Share

  430. CARLIN AF, Clark AE, Chaillon A, Garretson AF, et al
    Virologic and Immunologic Characterization of COVID-19 Recrudescence after Nirmatrelvir/Ritonavir Treatment.
    Clin Infect Dis. 2022 Jun 20. pii: 6611663. doi: 10.1093.
    >> Share

  431. ROSKOSKY M, Moni G, Kawakami V, Lambert J, et al
    SARS-CoV-2 Transmission Associated with an Indoor Music Event That Required Proof of Full Vaccination Against COVID-19 Prior to Entry-Seattle, July 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611550. doi: 10.1093.
    >> Share

  432. SABLEROLLES RSG, Rietdijk WJR, Goorhuis A, Postma DF, et al
    Durability of immune responses after boosting in Ad26.COV2.S-primed healthcare workers.
    Clin Infect Dis. 2022 Jun 20. pii: 6611568. doi: 10.1093.
    >> Share

  433. VU DM, Vu DTB, Do TTT, Olmsted AE, et al
    Presence of SARS-CoV-2 Antibodies among Vietnamese Healthcare Workers by Dosing Interval for ChAdOx1 nCoV-19 Vaccine.
    Clin Infect Dis. 2022 Jun 20. pii: 6611567. doi: 10.1093.
    >> Share

  434. KEATING P, Sell J, Chen J, Ackelsberg J, et al
    Delayed Recognition of COVID-19 in New York City: A descriptive analysis of COVID-19 illness prior to February 29, 2020.
    Clin Infect Dis. 2022 Jun 20. pii: 6611571. doi: 10.1093.
    >> Share

  435. KLAASSEN F, Chitwood MH, Cohen T, Pitzer VE, et al
    Population immunity to pre-Omicron and Omicron SARS-CoV-2 variants in US states and counties through December 1, 2021.
    Clin Infect Dis. 2022 Jun 20. pii: 6611479. doi: 10.1093.
    >> Share

  436. GOLD JAW, Ahmad FB, Cisewski JA, Rossen LM, et al
    Increased deaths from fungal infections during the COVID-19 pandemic-National Vital Statistics System, United States, January 2020-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611491. doi: 10.1093.
    >> Share

  437. CZECH-SIOLI M, Gunther T, Robitaille A, Roggenkamp H, et al
    Integration of sequencing and epidemiological data for surveillance of SARS-CoV-2 infections in a tertiary-care hospital.
    Clin Infect Dis. 2022 Jun 19. pii: 6611489. doi: 10.1093.
    >> Share

  438. STRID P, Zapata LB, Tong VT, Zambrano LD, et al
    COVID-19 Severity among Women of Reproductive Age with Symptomatic Laboratory-Confirmed SARS-CoV-2 by Pregnancy Status - United States, Jan 1, 2020 - Dec 25, 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611488. doi: 10.1093.
    >> Share

  439. RICHARDSON VL, Franco MAC, Marquez AB, Valdez LM, et al
    Vaccine effectiveness of CanSino (Adv5-nCoV) COVID-19 vaccine among childcare workers - Mexico, March-December 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611492. doi: 10.1093.
    >> Share

  440. HALASA NB, Spieker AJ, Young CC, Olson SM, et al
    Life-Threatening Complications of Influenza versus COVID-19 in U.S. Children.
    Clin Infect Dis. 2022 Jun 19. pii: 6611483. doi: 10.1093.
    >> Share

  441. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    Kinetics of maternally-derived anti- SARS-CoV-2 antibodies in infants in relation to the timing of antenatal vaccination.
    Clin Infect Dis. 2022 Jun 19. pii: 6611486. doi: 10.1093.
    >> Share

  442. FREE H, Luckhaupt SE, Billock RM, Groenewold MR, et al
    Reported exposures among in-person workers with SARS-CoV-2 infection in 6 states, September 2020-June 2021.
    Clin Infect Dis. 2022 Jun 19. pii: 6611490. doi: 10.1093.
    >> Share

  443. TONG SYC, Mora J, Bowen AC, Cheng MP, et al
    The Staphylococcus aureus Network Adaptive Platform Trial protocol: New tools for an old foe.
    Clin Infect Dis. 2022 Jun 19. pii: 6611482. doi: 10.1093.
    >> Share

  444. RANGANATH N, O'Horo JC, Challener DW, Tulledge-Scheitel SM, et al
    Rebound Phenomenon after Nirmatrelvir/Ritonavir Treatment of Coronavirus Disease-2019 in High-Risk Persons.
    Clin Infect Dis. 2022 Jun 14. pii: 6607746. doi: 10.1093.
    >> Share

  445. MONGE S, Rojas-Benedicto A, Olmedo C, Martin-Merino E, et al
    Effectiveness of a second dose of an mRNA vaccine against SARS-CoV-2 Omicron infection in individuals previously infected by other variants.
    Clin Infect Dis. 2022 Jun 10. pii: 6605647. doi: 10.1093.
    >> Share

  446. WEGRZYN RD, Appiah GD, Morfino R, Milford SR, et al
    Early detection of SARS-CoV-2 variants using traveler-based genomic surveillance at four US airports, September 2021- January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605116. doi: 10.1093.
    >> Share

  447. LIND ML, Schultes OL, Robertson AJ, Houde AJ, et al
    Testing Frequency Matters | An Evaluation of the Diagnostic Performance of a SARS-CoV-2 Rapid Antigen Test in United States Correctional Facilities.
    Clin Infect Dis. 2022 Jun 10. pii: 6605088. doi: 10.1093.
    >> Share

  448. LIM SY, Park S, Kim JY, Kim S, et al
    Comparison of Waning Neutralizing Antibody Responses Against the Omicron Variant 6 Months After Natural SARS-CoV-2 Infection (With/Without subsequent COVID-19 Vaccination) Versus 2-dose COVID-19 Vaccination.
    Clin Infect Dis. 2022 Jun 10. pii: 6605068. doi: 10.1093.
    >> Share

  449. RUHLAND A, Fell A, Holzbauer SM, D'Heilly P, et al
    Exposure Outcomes in Fully Vaccinated Healthcare Personnel with Known SARS-CoV-2 Exposure-Minnesota, January-August 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605065. doi: 10.1093.
    >> Share

  450. MILLER MJ, Himschoot A, Fitch N, Jawalkar S, et al
    Association of Trends in SARS-CoV-2 Seroprevalence and State-Issued Nonpharmaceutical Interventions- United States, August 1, 2020 - March 30, 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605073. doi: 10.1093.
    >> Share

  451. BUSCH MP, Stramer SL, Stone M, Yu EA, et al
    Population-weighted seroprevalence from SARS-CoV-2 infection, vaccination, and hybrid immunity among U.S. blood donations from January-December 2021.
    Clin Infect Dis. 2022 Jun 10. pii: 6605072. doi: 10.1093.
    >> Share

  452. LI ZN, Liu F, Jefferson S, Horner L, et al
    Multiplex Detection of Antibody Landscapes to SARS-CoV-2/Influenza/Common Human Coronaviruses Following Vaccination or Infection with SARS-CoV-2 and Influenza.
    Clin Infect Dis. 2022 Jun 10. pii: 6605070. doi: 10.1093.
    >> Share

  453. MILLER AD, Yousaf AR, Bornstein E, Wu MJ, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) During SARS-CoV-2 Delta and Omicron Variant Circulation- United States, July 2021 - January 2022.
    Clin Infect Dis. 2022 Jun 10. pii: 6605071. doi: 10.1093.
    >> Share

  454. TOP KA, Chen RT, Levy O, Ozonoff A, et al
    Advancing the Science of Vaccine Safety during the COVID-19 Pandemic and Beyond: Launching an International Network of Special Immunization Services.
    Clin Infect Dis. 2022 Jun 9. pii: 6605049. doi: 10.1093.
    >> Share

  455. WAN EYF, Chui CSL, Ng VWS, Wang Y, et al
    mRNA (BNT162b2) COVID-19 vaccination increased risk of Bell's palsy: a nested case control and self-controlled case series study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604461. doi: 10.1093.
    >> Share

  456. BART SM, Curtiss CC, Earnest R, Lobe-Costonis R, et al
    SARS-CoV-2 Outbreak at a College with High COVID-19 Vaccination Coverage-Connecticut, August-September 2021.
    Clin Infect Dis. 2022 Jun 8. pii: 6604453. doi: 10.1093.
    >> Share

  457. LEWIS NM, Self WH, Gaglani M, Ginde AA, et al
    Effectiveness of the Ad26.COV2.S (Johnson & Johnson) COVID-19 Vaccine for Preventing COVID-19 Hospitalizations and Progression to High Disease Severity in the United States.
    Clin Infect Dis. 2022 Jun 8. pii: 6604454. doi: 10.1093.
    >> Share

  458. LEUNG NHL, Cheng SMS, Martin-Sanchez M, Au NYM, et al
    Immunogenicity of a third dose of BNT162b2 to ancestral SARS-CoV-2 & Omicron variant in adults who received two doses of inactivated vaccine.
    Clin Infect Dis. 2022 Jun 8. pii: 6604400. doi: 10.1093.
    >> Share

  459. DOYLE TJ, Kiros GE, Schmitt-Matzen EN, Propper R, et al
    Maternal and perinatal outcomes associated with SARS-CoV-2 infection during pregnancy, Florida, 2020-2021: A retrospective cohort study.
    Clin Infect Dis. 2022 Jun 8. pii: 6604396. doi: 10.1093.
    >> Share

  460. ALHABBAB RY, Algaissi A, Mahmoud AB, Alkayyal AA, et al
    MERS-CoV infection elicits long-lasting specific antibody, T and B cell immune responses in recovered individuals.
    Clin Infect Dis. 2022 Jun 8. pii: 6604398. doi: 10.1093.
    >> Share

  461. NACHEGA JB, Sam-Agudu NA, Machekano RN, Rosenthal PJ, et al
    Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Pregnancy in Sub-Saharan Africa: A 6-Country Retrospective Cohort Analysis.
    Clin Infect Dis. 2022 Jun 8. pii: 6603567. doi: 10.1093.
    >> Share

  462. NACHEGA JB, Sam-Agudu NA, Siedner MJ, Rosenthal PJ, et al
    Prioritizing Pregnant Women for Coronavirus Disease 2019 Vaccination in African Countries.
    Clin Infect Dis. 2022 Jun 8. pii: 6603568. doi: 10.1093.
    >> Share

  463. STRAUS W, Urdaneta V, Esposito DB, Mansi JA, et al
    Analysis of Myocarditis Among 252 Million mRNA-1273 Recipients Worldwide.
    Clin Infect Dis. 2022 Jun 6. pii: 6603291. doi: 10.1093.
    >> Share

  464. RICHTERMAN A, Behrman A, Brennan PJ, O'Donnell JA, et al
    Durability of SARS-CoV-2 mRNA Booster Vaccine Protection Against Omicron Among Health Care Workers with a Vaccine Mandate.
    Clin Infect Dis. 2022 Jun 6. pii: 6603294. doi: 10.1093.
    >> Share

  465. LIN Y, Yue S, Yang Y, Yang S, et al
    Nasal Spray of Neutralizing Monoclonal Antibody 35B5 Confers Potential Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern (VOCs): A Small-scale Clinical Trial.
    Clin Infect Dis. 2022 Jun 6. pii: 6603292. doi: 10.1093.
    >> Share

  466. NAJJAR-DEBBINY R, Gronich N, Weber G, Khoury J, et al
    Effectiveness of Paxlovid in Reducing Severe COVID-19 and Mortality in High Risk Patients.
    Clin Infect Dis. 2022 Jun 2. pii: 6599020. doi: 10.1093.
    >> Share

    May 2022
  467. MARRA AR, Miraglia JL, Malheiros DT, Guozhang Y, et al
    Effectiveness of heterologous COVID-19 vaccine booster dosing in Brazilian healthcare workers, 2021.
    Clin Infect Dis. 2022 May 27. pii: 6594056. doi: 10.1093.
    >> Share

  468. NASH D, Rane MS, Robertson MM, Chang M, et al
    SARS-CoV-2 incidence and risk factors in a national, community-based prospective cohort of U.S. adults.
    Clin Infect Dis. 2022 May 27. pii: 6594058. doi: 10.1093.
    >> Share

  469. ZHAO M, Slotkin R, Sheth AH, Pischel L, et al
    Serum Neutralizing Antibody Titers 12 months after COVID-19 mRNA Vaccination: Correlation to Clinical Variables in an Adult, US-Population.
    Clin Infect Dis. 2022 May 26. pii: 6593314. doi: 10.1093.
    >> Share

  470. PETROS BA, Turcinovic J, Welch NL, White LF, et al
    Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations.
    Clin Infect Dis. 2022 May 25. pii: 6591846. doi: 10.1093.
    >> Share

  471. GRIMA AA, Murison KR, Simmons AE, Tuite AR, et al
    Relative Virulence of SARS-CoV-2 Among Vaccinated and Unvaccinated Individuals Hospitalized with SARS-CoV-2.
    Clin Infect Dis. 2022 May 25. pii: 6591845. doi: 10.1093.
    >> Share

  472. RIDDELL AC, Kele B, Harris K, Bible J, et al
    Generation of novel SARS-CoV-2 variants on B.1.1.7 lineage in three patients with advanced HIV disease.
    Clin Infect Dis. 2022 May 25. pii: 6591841. doi: 10.1093.
    >> Share


  473. Correction to: Investigation of a Suspect Severe Acute Respiratory Syndrome Coronavirus-2 and Influenza A Mixed Outbreak: Lessons Learned for Long-Term Care Facilities Nationwide.
    Clin Infect Dis. 2022 May 24. pii: 6591404. doi: 10.1093.
    >> Share


  474. Correction to: Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa.
    Clin Infect Dis. 2022 May 24. pii: 6591403. doi: 10.1093.
    >> Share

  475. EPSI NJ, Richard SA, Lindholm DA, Mende K, et al
    Understanding 'hybrid immunity': comparison and predictors of humoral immune responses to SARS-CoV-2 infection and COVID-19 vaccines.
    Clin Infect Dis. 2022 May 24. pii: 6591282. doi: 10.1093.
    >> Share

  476. KIM DY, Lin MY, Jennings C, Li H, et al
    Duration of replication-competent SARS-CoV-2 shedding among patients with severe or critical coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2022 May 24. pii: 6590994. doi: 10.1093.
    >> Share

  477. CORRADINI P, Agrati C, Apolone G, Mantovani A, et al
    Humoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
    Clin Infect Dis. 2022 May 24. pii: 6590993. doi: 10.1093.
    >> Share

  478. LOFGREN E, Naumova EN, Gorski J, Naumov Y, et al
    How drivers of seasonality in respiratory infections may impact vaccine strategy: a case study in how COVID-19 may help us solve one of influenza's biggest challenges.
    Clin Infect Dis. 2022 May 24. pii: 6590989. doi: 10.1093.
    >> Share

  479. EYAL N, Gheaus A, Gosseries A, Magalhaes M, et al
    COVID vaccine prioritization in low- and middle-income countries may justifiably depart from high-income countries' age priorities.
    Clin Infect Dis. 2022 May 24. pii: 6590988. doi: 10.1093.
    >> Share

  480. LAGOUSI T, Papadatou I, Strempas P, Chatzikalil E, et al
    PAVING THE WAY TOWARDS PRECISION VACCINOLOGY: THE PARADIGM OF MYOCARDITIS AFTER COVID-19 VACCINATION.
    Clin Infect Dis. 2022 May 24. pii: 6590985. doi: 10.1093.
    >> Share

  481. SHAPIRO JR, Sitaras I, Park HS, Aytenfisu TY, et al
    Association of frailty, age, and biological sex with SARS-CoV-2 mRNA vaccine-induced immunity in older adults.
    Clin Infect Dis. 2022 May 24. pii: 6590987. doi: 10.1093.
    >> Share

  482. ROTTENSTREICH A, Vorontsov O, Alfi O, Zarbiv G, et al
    Maternal and Neonatal SARS-CoV-2 Omicron Variant Neutralization after Antenatal mRNA Vaccination.
    Clin Infect Dis. 2022 May 24. pii: 6590984. doi: 10.1093.
    >> Share

  483. DELAHOY MJ, Ujamaa D, Taylor CA, Cummings C, et al
    Comparison of influenza and COVID-19-associated hospitalizations among children < 18 years old in the United States-FluSurv-NET (October-April 2017-2021) and COVID-NET (October 2020-September 2021).
    Clin Infect Dis. 2022 May 20. pii: 6589788. doi: 10.1093.
    >> Share

  484. LEVIN-RECTOR A, Firestein L, McGibbon E, Sell J, et al
    Reduced Odds of SARS-CoV-2 Reinfection after Vaccination among New York City Adults, July-November 2021.
    Clin Infect Dis. 2022 May 20. pii: 6589783. doi: 10.1093.
    >> Share

  485. TENFORDE MW, Self WH, Zhu Y, Naioti EA, et al
    Protection of mRNA vaccines against hospitalized COVID-19 in adults over the first year following authorization in the United States.
    Clin Infect Dis. 2022 May 17. pii: 6587132. doi: 10.1093.
    >> Share

  486. MARTINUZZI E, Benzaquen J, Guerin O, Leroy S, et al
    A Single Dose of BNT162b2 mRNA Vaccine Induces Airway Immunity in SARS-CoV-2 Naive and recovered COVID-19 subjects.
    Clin Infect Dis. 2022 May 17. pii: 6586846. doi: 10.1093.
    >> Share

  487. SHOHAM S, Bloch EM, Casadevall A, Hanley D, et al
    Transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection: a double-blinded, phase 2 randomized, controlled trial.
    Clin Infect Dis. 2022 May 17. pii: 6586841. doi: 10.1093.
    >> Share

  488. WEITZMAN ER, Kossowsky J, Blakemore LM, Cox R, et al
    Acceptability of a Fentanyl Vaccine to Prevent Opioid Overdose and Need for Personalized Decision-Making.
    Clin Infect Dis. 2022 May 17. pii: 6586840. doi: 10.1093.
    >> Share

  489. ODUMADE OA, van Haren SD, Angelidou A
    Implications of the SARS-CoV-2 pandemic on the epidemiology of pediatric Respiratory Syncytial Virus (RSV) infection.
    Clin Infect Dis. 2022 May 17. pii: 6586842. doi: 10.1093.
    >> Share

  490. WEITZMAN ER, Sherman AC, Levy O
    Pediatric SARS-CoV-2 Vaccines: Perceptions and Attitudes from the FDA Public Commentary.
    Clin Infect Dis. 2022 May 17. pii: 6586838. doi: 10.1093.
    >> Share

  491. COLE KA, Zhou AY, Jones T, Moore WJ, et al
    How to Harness the Power of Social Media for Quality Drug Information in Infectious Diseases: Perspectives on Behalf of the Society of Infectious Diseases Pharmacists.
    Clin Infect Dis. 2022;74.
    >> Share

  492. NEMATOLLAHI S, Minter DJ, Barlow B, Nolan NS, et al
    The Digital Classroom: How to Leverage Social Media for Infectious Diseases Education.
    Clin Infect Dis. 2022;74.
    >> Share

  493. SCHWARTZ IS, McCarty T, Woc-Colburn LE, Titanji BK, et al
    Educational Impact of #IDJClub, a Twitter-Based Infectious Diseases Journal Club.
    Clin Infect Dis. 2022;74.
    >> Share

  494. BARI A, Heymann M, Cohen RJ, Zhao R, et al
    Exploring Coronavirus Disease 2019 Vaccine Hesitancy on Twitter Using Sentiment Analysis and Natural Language Processing Algorithms.
    Clin Infect Dis. 2022;74.
    >> Share

  495. ZENG C, Zhang J, Li Z, Sun X, et al
    Population Mobility and Aging Accelerate the Transmission of Coronavirus Disease 2019 in the Deep South: A County-Level Longitudinal Analysis.
    Clin Infect Dis. 2022;74.
    >> Share

  496. DESAI AN, Ruidera D, Steinbrink JM, Granwehr B, et al
    Misinformation and Disinformation: The Potential Disadvantages of Social Media in Infectious Disease and How to Combat Them.
    Clin Infect Dis. 2022;74.
    >> Share

  497. POH XY, Tan CW, Lee IR, Chavatte JM, et al
    Antibody response of heterologous vs homologous mRNA vaccine boosters against the SARS-CoV-2 Omicron variant: interim results from the PRIBIVAC study, A Randomized Clinical Trial.
    Clin Infect Dis. 2022 May 11. pii: 6583615. doi: 10.1093.
    >> Share

  498. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Correction to: Severe Dysbiosis and Specific Haemophilus and Neisseria Signatures as Hallmarks of the Oropharyngeal Microbiome in Critically Ill Coronavirus Disease 2019 (COVID-19) Patients.
    Clin Infect Dis. 2022 May 10. pii: 6583345. doi: 10.1093.
    >> Share

  499. CONTI MG, Terreri S, Terrin G, Natale F, et al
    SARS-CoV-2 infection versus vaccination in pregnancy: Implications for maternal and infant immunity.
    Clin Infect Dis. 2022 May 10. pii: 6583148. doi: 10.1093.
    >> Share

  500. MOISAN A, Mastrovito B, De Oliveira F, Martel M, et al
    Evidence of transmission and circulation of Deltacron XD recombinant SARS-CoV-2 in Northwest France.
    Clin Infect Dis. 2022 May 10. pii: 6583149. doi: 10.1093.
    >> Share

  501. SPARKE M, Levy O
    Competing responses to global inequalities in access to COVID vaccines: Vaccine Diplomacy and Vaccine Charity Versus Vaccine Liberty.
    Clin Infect Dis. 2022 May 10. pii: 6583150. doi: 10.1093.
    >> Share

  502. ZURCHER K, Abela IA, Stange M, Dupont C, et al
    Alpha variant coronavirus outbreak in a nursing home despite high vaccination coverage: molecular, epidemiological and immunological studies.
    Clin Infect Dis. 2022 May 6. pii: 6582009. doi: 10.1093/cid/ciab1005.
    >> Share

  503. DALAI SC, Dines JN, Snyder TM, Gittelman RM, et al
    Clinical Validation of a Novel T-cell Receptor Sequencing Assay for Identification of Recent or Prior SARS-CoV-2 Infection.
    Clin Infect Dis. 2022 May 6. pii: 6581622. doi: 10.1093.
    >> Share

  504. DOWLING DJ, Levy O
    A Precision Adjuvant Approach to Enhance SARS-CoV-2 Vaccines Optimized for Immunologically Distinct Vulnerable Populations.
    Clin Infect Dis. 2022 May 4. pii: 6580093. doi: 10.1093.
    >> Share

  505. LASSER J, Hell T, Garcia D
    Assessment of the effectiveness of Omicron transmission mitigation strategies for European universities using an agent-based network model.
    Clin Infect Dis. 2022 May 3. pii: 6577094. doi: 10.1093.
    >> Share

  506. BUTT AA, Talisa VB, Shaikh OS, Omer SB, et al
    Relative Vaccine Effectiveness of a SARS-CoV-2 mRNA Vaccine Booster Dose Against the Omicron Variant.
    Clin Infect Dis. 2022 May 3. pii: 6577096. doi: 10.1093.
    >> Share

  507. VERDERESE JP, Henry L, Younossi ZM
    Reply to Bailly et al.
    Clin Infect Dis. 2022;74:1707-1708.
    >> Share

    April 2022
  508. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Correction to: Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574996. doi: 10.1093.
    >> Share

  509. ROSS JA, Malone PK, Levy S
    The Impact of the SARS-CoV-2 Pandemic on Substance Use in the US.
    Clin Infect Dis. 2022 Apr 27. pii: 6574792. doi: 10.1093.
    >> Share

  510. CADNUM JL, Jencson AL, Alhmidi H, Zabarsky TF, et al
    Airflow patterns in double occupancy patient rooms may contribute to roommate-to-roommate transmission of severe acute respiratory syndrome coronavirus 2.
    Clin Infect Dis. 2022 Apr 27. pii: 6574835. doi: 10.1093.
    >> Share

  511. SHRESTHA NK, Shrestha P, Burke PC, Nowacki AS, et al
    Coronavirus Disease 2019 (COVID-19) Vaccine Boosting in Previously Infected or Vaccinated Individuals.
    Clin Infect Dis. 2022 Apr 27. pii: 6574819. doi: 10.1093.
    >> Share

  512. CORVOL H, de Miranda S, Dehillotte C, Lemonnier L, et al
    Cumulative Incidence and Risk Factors for Severe COVID-19 in French People with Cystic Fibrosis.
    Clin Infect Dis. 2022 Apr 27. pii: 6574734. doi: 10.1093.
    >> Share

  513. SHARMA A, Oda G, Holodniy M
    Effectiveness of mRNA-based vaccines during the emergence of SARS-CoV-2 Omicron variant.
    Clin Infect Dis. 2022 Apr 27. pii: 6574744. doi: 10.1093.
    >> Share

  514. BUSKERMOLEN M, Molthof I, Voeten HA, van Twillert J, et al
    Vaccination did not prevent severe COVID in an outbreak among older residents of a nursing home, B.1.617.2 variant, July 2021.
    Clin Infect Dis. 2022 Apr 27. pii: 6574733. doi: 10.1093.
    >> Share

  515. BENFIELD T, Bodilsen J, Brieghel C, Harboe ZB, et al
    Correction to: Improved Survival Among Hospitalized Patients With Coronavirus Disease 2019 (COVID-19) Treated With Remdesivir and Dexamethasone. A Nationwide Population-Based Cohort Study.
    Clin Infect Dis. 2022 Apr 23. pii: 6572821. doi: 10.1093.
    >> Share

  516. GAYLIS NB, Ritter A, Kelly SA, Pourhassan NZ, et al
    Reduced Cell Surface Levels of C-C Chemokine Receptor 5 and Immunosuppression in Long Coronavirus Disease 2019 Syndrome.
    Clin Infect Dis. 2022 Apr 22. pii: 6572226. doi: 10.1093.
    >> Share

  517. HOLUBAR M, Subramanian A, Purington N, Hedlin H, et al
    Favipiravir for treatment of outpatients with asymptomatic or uncomplicated COVID-19: a double-blind randomized, placebo-controlled, phase 2 trial.
    Clin Infect Dis. 2022 Apr 21. pii: 6572081. doi: 10.1093.
    >> Share

  518. SOLERA JT, Arbol BG, Alshahrani A, Bahinskaya I, et al
    Impact of Vaccination and Early Monoclonal Antibody Therapy on COVID-19 Outcomes in Organ Transplant Recipients During the Omicron Wave.
    Clin Infect Dis. 2022 Apr 21. pii: 6571785. doi: 10.1093.
    >> Share

  519. LIANG EN W, Ko KK, Conceicao EP, Aung MK, et al
    Enhanced infection-prevention measures including universal N95 usage and daily testing: the impact on SARS-CoV-2 transmission in cohorted hospital cubicles through successive Delta and Omicron waves.
    Clin Infect Dis. 2022 Apr 21. pii: 6571575. doi: 10.1093.
    >> Share

  520. ZAHRA FT, Grubbs G, Dummer K, Tremoulet AH, et al
    Neutralization of SARS-CoV-2 Omicron and other variants in serum from children with vaccination-induced myocarditis.
    Clin Infect Dis. 2022 Apr 21. pii: 6571576. doi: 10.1093.
    >> Share

  521. LONG SM, Chern A, Cooley V, Chung S, et al
    Temporal Dynamics of Nasopharyngeal and Tracheal SARS-CoV-2 Cycle Thresholds in COVID-19 Patients with Tracheostomy.
    Clin Infect Dis. 2022 Apr 20. pii: 6571468. doi: 10.1093.
    >> Share

  522. LOPEZ MONTESINOS I, Arrieta-Aldea I, Dicastillo A, Zuccarino F, et al
    Comparison of hospitalized COVID-19 and influenza patients requiring supplemental oxygen in a cohort study: clinical impact and resource consumption.
    Clin Infect Dis. 2022 Apr 20. pii: 6571459. doi: 10.1093.
    >> Share

  523. BONENFANT G, Deyoe J, Wong T, Grijalva CG, et al
    Surveillance and correlation of SARS-CoV-2 viral RNA, antigen, virus isolation, and self-reported symptoms in a longitudinal study with daily sampling.
    Clin Infect Dis. 2022 Apr 20. pii: 6571330. doi: 10.1093.
    >> Share

  524. MELGAR M, Haston J, DeCuir J, Cheng Q, et al
    Multisystem inflammatory syndrome in adults (MIS-A): case finding through systematic review of electronic medical records.
    Clin Infect Dis. 2022 Apr 20. pii: 6571412. doi: 10.1093.
    >> Share

  525. DAN J, da Silva Antunes R, Grifoni A, Weiskopf D, et al
    Observations and perspectives on adaptive immunity to SARS-CoV-2.
    Clin Infect Dis. 2022 Apr 20. pii: 6571103. doi: 10.1093.
    >> Share

  526. KIM J, Choe YJ, Jang EJ, Lim DS, et al
    Effectiveness of Booster mRNA Vaccines against SARS-CoV-2 Infection in Elderly Population, South Korea, October 2021 - January 2022.
    Clin Infect Dis. 2022 Apr 19. pii: 6570782. doi: 10.1093.
    >> Share

  527. NANISHI E, Angelidou A, Rotman C, Dowling DJ, et al
    Precision Vaccine Adjuvants for Older Adults: A Scoping Review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570880. doi: 10.1093.
    >> Share

  528. LEVY O, Angelidou A, Idoko O, Lewis NP, et al
    Precision Vaccines: Lessons Learned from the Coronavirus Pandemic.
    Clin Infect Dis. 2022 Apr 19. pii: 6570826. doi: 10.1093.
    >> Share

  529. PLUMMER JT, Contreras D, Zhang W, Binek A, et al
    USA SARS-CoV-2 Epsilon Variant: Though Highly Transmissible has an Adjusted Muted Host T-Cell Response.
    Clin Infect Dis. 2022 Apr 19. pii: 6570676. doi: 10.1093.
    >> Share

  530. WOLDEMESKEL BA, Garliss CC, Aytenfisu TY, Johnston TS, et al
    Discordant antibody and T cell responses to the SARS-CoV-2 Omicron variant in COVID-19 mRNA vaccine recipient.
    Clin Infect Dis. 2022 Apr 19. pii: 6570698. doi: 10.1093.
    >> Share

  531. SKOWRONSKI DM, Febriani Y, Ouakki M, Setayeshgar S, et al
    Two-dose SARS-CoV-2 vaccine effectiveness with mixed schedules and extended dosing intervals: test-negative design studies from British Columbia and Quebec, Canada.
    Clin Infect Dis. 2022 Apr 19. pii: 6570607. doi: 10.1093.
    >> Share

  532. MAEDA H, Saito N, Igarashi A, Ishida M, et al
    Effectiveness of mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections during the Delta variant epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS).
    Clin Infect Dis. 2022 Apr 19. pii: 6570603. doi: 10.1093.
    >> Share

  533. ALYSSA FITZPATRICK A, Cooper C, Vasilunas N, Ritchie B, et al
    Describing the impact of maternal hyperimmune globulin and valaciclovir on the outcomes of CMV infection in pregnancy: a systematic review.
    Clin Infect Dis. 2022 Apr 19. pii: 6570695. doi: 10.1093.
    >> Share

  534. SHERMAN AC, Rouphael N, Baden LR
    COVID-19 Vaccine Trials (and Tribulations): How to improve the process of clinical trials in a pandemic.
    Clin Infect Dis. 2022 Apr 18. pii: 6569988. doi: 10.1093.
    >> Share

  535. MASSO-SILVA JA, Moshensky A, Lam MTY, Odish M, et al
    Correction to: Increased Peripheral Blood Neutrophil Activation Phenotypes and Neutrophil Extracellular Trap Formation in Critically Ill Coronavirus Disease 2019 Patients: A Case Series and Review of the Literature.
    Clin Infect Dis. 2022 Apr 13. pii: 6568031. doi: 10.1093.
    >> Share

  536. DALE AP, Almendares O, Howard B, Burnett E, et al
    Investigation of A SARS-CoV-2 Delta (B.1.617.2) Variant Outbreak Among Residents of a Skilled Nursing Facility and Vaccine Effectiveness Analysis - Maricopa County, Arizona, June-July 2021.
    Clin Infect Dis. 2022 Apr 12. pii: 6567536. doi: 10.1093.
    >> Share

  537. PREMIKHA M, Chiew CJ, Wei WE, Leo YS, et al
    Comparative Effectiveness of mRNA and Inactivated Whole Virus Vaccines against COVID-19 Infection and Severe Disease in Singapore.
    Clin Infect Dis. 2022 Apr 12. pii: 6567428. doi: 10.1093.
    >> Share

  538. PAREDES MI, Lunn SM, Famulare M, Frisbie LA, et al
    Associations between SARS-CoV-2 variants and risk of COVID-19 hospitalization among confirmed cases in Washington State: a retrospective cohort study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567408. doi: 10.1093.
    >> Share

  539. MOLODTSOV IA, Kegeles E, Mitin AN, Mityaeva O, et al
    SARS-CoV-2-specific T cells and antibodies in COVID-19 protection: a prospective study.
    Clin Infect Dis. 2022 Apr 12. pii: 6567222. doi: 10.1093.
    >> Share

  540. TADESSE BT, Khanam F, Ahmed F, Im J, et al
    Prevention of typhoid by Vi conjugate vaccine and achievable improvements in household WASH: Evidence from a cluster-randomized trial in Dhaka, Bangladesh.
    Clin Infect Dis. 2022 Apr 12. pii: 6567455. doi: 10.1093.
    >> Share

  541. BUTT AA, Dargham SR, Loka S, Shaik RM, et al
    COVID-19 Disease Severity in Children Infected with the Omicron Variant.
    Clin Infect Dis. 2022 Apr 11. pii: 6566327. doi: 10.1093.
    >> Share

  542. SKEGGS J, MacPhail A, Korman T, Woolley I, et al
    Reductions in Antibiotic Prescribing in Australia During the SARS-CoV-2 Pandemic: National Prescribing Data.
    Clin Infect Dis. 2022 Apr 11. pii: 6566296. doi: 10.1093.
    >> Share

  543. MARGALIT I, Yelin D, Sagi M, Rahat MM, et al
    Risk factors and multidimensional assessment of long COVID fatigue: a nested case-control study.
    Clin Infect Dis. 2022 Apr 11. pii: 6566295. doi: 10.1093.
    >> Share

  544. RZYMSKI P, Falfushynska H, Fal A
    Vaccination of Ukrainian Refugees: Need for Urgent Action.
    Clin Infect Dis. 2022 Apr 11. pii: 6569707. doi: 10.1093.
    >> Share

  545. KUSEJKO K, Salazar-Vizcaya L, Shah C, Stockle M, et al
    Sustained effect on hepatitis C elimination among men who have sex with men in the Swiss HIV Cohort Study: A systematic re-screening for hepatitis C RNA two years following a nation-wide elimination program.
    Clin Infect Dis. 2022 Apr 11. pii: 6566325. doi: 10.1093.
    >> Share

  546. CAI J, Lin Y, Wu MJ
    Letter to editor regarding "Clinical Presentation and Outcomes of Pregnant Women With Coronavirus Disease 2019: A Systematic Review and Meta-analysis".
    Clin Infect Dis. 2022;74:1319.
    >> Share

  547. RASMUSSEN TA, Ahuja SK, Kuwanda L, Vjecha MJ, et al
    Antiretroviral initiation at >/=800 CD4+ cells/ mm 3 associated with lower HIV reservoir size.
    Clin Infect Dis. 2022 Apr 9. pii: 6565728. doi: 10.1093.
    >> Share

  548. KOLODZIEJ LM, van Lelyveld SFL, Haverkort ME, Mariman R, et al
    High SARS-CoV-2 household transmission rates detected by dense saliva sampling.
    Clin Infect Dis. 2022 Apr 6. pii: 6564312. doi: 10.1093.
    >> Share

  549. GAZIT S, Shlezinger R, Perez G, Lotan R, et al
    SARS-CoV-2 Naturally Acquired Immunity vs. Vaccine-induced Immunity, Reinfections versus Breakthrough Infections: a Retrospective Cohort Study.
    Clin Infect Dis. 2022 Apr 5. pii: 6563799. doi: 10.1093.
    >> Share

  550. ANTINORI A, Cicalini S, Meschi S, Bordoni V, et al
    Humoral and cellular immune response elicited by mRNA vaccination against SARS-CoV-2 in people living with HIV (PLWH) receiving antiretroviral therapy (ART) according with current CD4 T-lymphocyte count.
    Clin Infect Dis. 2022 Apr 2. pii: 6562777. doi: 10.1093.
    >> Share

  551. PARK S, Lim SY, Kim JY, Park H, et al
    Clinical and virological characteristics of SARS-CoV-2 B.1.617.2 (Delta) variant: a prospective cohort study.
    Clin Infect Dis. 2022 Apr 1. pii: 6562005. doi: 10.1093.
    >> Share

    March 2022
  552. GARRETT N, Tapley A, Andriesen J, Seocharan I, et al
    High Asymptomatic Carriage with the Omicron Variant in South Africa.
    Clin Infect Dis. 2022 Mar 30. pii: 6556153. doi: 10.1093.
    >> Share

  553. TANDE AJ, Swift MD, Challener DW, Berbari EF, et al
    Utility of Follow-up COVID-19 Antigen Tests After Acute SARS-CoV-2 Infection Among Healthcare Personnel.
    Clin Infect Dis. 2022 Mar 30. pii: 6555774. doi: 10.1093.
    >> Share

  554. NATHAVITHARANA RR, Mishra H, Sullivan A, Hurwitz S, et al
    Predicting airborne infection risk: Association between personal ambient carbon dioxide level monitoring and incidence of tuberculosis infection in South African health workers.
    Clin Infect Dis. 2022 Mar 26. pii: 6554598. doi: 10.1093.
    >> Share

  555. DOLL MK, Pettigrew SM, Ma J, Verma A, et al
    Effects of Confounding Bias in COVID-19 and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors.
    Clin Infect Dis. 2022 Mar 24. pii: 6553950. doi: 10.1093.
    >> Share

  556. HERNANDEZ AV, Roman YM, Burela PA, Pasupuleti V, et al
    Reply to Banno et al and Padhi et al.
    Clin Infect Dis. 2022;74:1122-1123.
    >> Share

  557. NG OT, Koh V, Chiew CJ, Marimuthu K, et al
    Impact of SARS-CoV-2 Vaccination and Paediatric Age on Delta Variant Household Transmission.
    Clin Infect Dis. 2022 Mar 22. pii: 6551710. doi: 10.1093.
    >> Share

  558. CHANDNA A, Mahajan R, Gautam P, Mwandigha L, et al
    Facilitating safe discharge through predicting disease progression in moderate COVID-19: a prospective cohort study to develop and validate a clinical prediction model in resource-limited settings.
    Clin Infect Dis. 2022 Mar 21. pii: 6551704. doi: 10.1093.
    >> Share

  559. GIMENEZ E, Albert E, Zulaica J, Torres I, et al
    SARS-CoV-2 adaptive immunity in nursing home residents following a third dose of the Comirnaty(R) COVID-19 vaccine.
    Clin Infect Dis. 2022 Mar 21. pii: 6551700. doi: 10.1093.
    >> Share


  560. Erratum to: Risk Factors for Coronavirus Disease 2019 (COVID-19) Death in a Population Cohort Study from the Western Cape Province, South Africa.
    Clin Infect Dis. 2022 Mar 17. pii: 6549865. doi: 10.1093.
    >> Share

  561. EDELSTEIN M, Beiruti KW, Ben-Amram H, Bar-Zeev N, et al
    Antibody-mediated Immunogenicity against SARS-CoV-2 following priming, boosting and hybrid immunity: insights from 11 months of follow-up of a healthcare worker cohort in Israel, December 2020-October 2021.
    Clin Infect Dis. 2022 Mar 12. pii: 6547893. doi: 10.1093.
    >> Share

  562. DOERNBERG SB, Holubar M, Jain V, Weng Y, et al
    Incidence and prevalence of COVID-19 within a healthcare worker cohort during the first year of the SARS-CoV-2 pandemic.
    Clin Infect Dis. 2022 Mar 12. pii: 6547892. doi: 10.1093.
    >> Share

  563. GALLAGHER KME, Leick MB, Larson RC, Berger TR, et al
    Differential T cell immunity to SARS-CoV-2 in mRNA-1273 and BNT162b2 vaccinated individuals.
    Clin Infect Dis. 2022 Mar 12. pii: 6547848. doi: 10.1093.
    >> Share

  564. ALSVED M, Nygren D, Thuresson S, Medstrand P, et al
    SARS-CoV-2 in exhaled aerosol particles from covid-19 cases and its association to household transmission.
    Clin Infect Dis. 2022 Mar 10. pii: 6546685. doi: 10.1093.
    >> Share

  565. FITZGERALD R, Dickinson L, Else L, Fletcher T, et al
    Pharmacokinetics of ss-d-N4-hydroxycytidine, the parent nucleoside of prodrug molnupiravir, in non-plasma compartments of patients with SARS-CoV-2 infection.
    Clin Infect Dis. 2022 Mar 10. pii: 6546684. doi: 10.1093.
    >> Share

  566. CHENG VC, Ip JD, Chu AW, Tam AR, et al
    Rapid spread of SARS-CoV-2 Omicron subvariant BA.2 in a single-source community outbreak.
    Clin Infect Dis. 2022 Mar 10. pii: 6546687. doi: 10.1093.
    >> Share

  567. RIFE MAGALIS B, Rich S, Tagliamonte MS, Mavian C, et al
    SARS-CoV-2 Delta vaccine breakthrough transmissibility in Alachua County, Florida.
    Clin Infect Dis. 2022 Mar 10. pii: 6546683. doi: 10.1093.
    >> Share

  568. WESTBROOK AL, Benedit LC, Frediani JK, Griffiths MA, et al
    Predictive value of isolated symptoms for diagnosis of SARS-CoV-2 infection in children tested during peak circulation of the delta variant.
    Clin Infect Dis. 2022 Mar 10. pii: 6546602. doi: 10.1093.
    >> Share

  569. WOLTER N, Tempia S, von Gottberg A, Bhiman JN, et al
    Seroprevalence of SARS-CoV-2 after the second wave in South Africa in HIV-infected and uninfected persons: a cross-sectional household survey.
    Clin Infect Dis. 2022 Mar 10. pii: 6546682. doi: 10.1093.
    >> Share

  570. LUSTIG Y, Mendelson E, Mandelboim M, Biber A, et al
    Existence of immunological memory response in true sero-negative individuals post COVID-19 molecular diagnosis.
    Clin Infect Dis. 2022 Mar 10. pii: 6546613. doi: 10.1093.
    >> Share

  571. YAU CH, Masuda Y, Ng QX, Teoh SE, et al
    Addressing the Elephant in the Room: Intravenous Injection of COVID-19 mRNA.
    Clin Infect Dis. 2022 Mar 9. pii: 6545850. doi: 10.1093.
    >> Share

  572. BALCELLS ME, Le Corre N, Duran J, Ceballos ME, et al
    Reduced immune response to inactivated SARS-CoV-2 vaccine in a cohort of immunocompromised patients in Chile.
    Clin Infect Dis. 2022 Mar 7. pii: 6543937. doi: 10.1093.
    >> Share

  573. SANDMANN FG, Tessier E, Lacy J, Kall M, et al
    Long-term health-related quality of life in non-hospitalised COVID-19 cases with confirmed SARS-CoV-2 infection in England: Longitudinal analysis and cross-sectional comparison with controls.
    Clin Infect Dis. 2022 Mar 5. pii: 6542727. doi: 10.1093.
    >> Share

  574. MOORLAG SJCFM, Taks E, Ten Doesschate T, van der Vaart TW, et al
    Efficacy of Bacillus Calmette-Guerin vaccination against respiratory tract infections in the elderly during the Covid-19 pandemic.
    Clin Infect Dis. 2022 Mar 5. pii: 6543010. doi: 10.1093.
    >> Share

  575. POLLOCK BD, Storlie CB, Tande AJ, Sampathkumar P, et al
    Real-world incidence of breakthrough COVID-19 hospitalization after vaccination versus natural infection in a large, local, empaneled primary care population using time-to-event analysis.
    Clin Infect Dis. 2022 Mar 5. pii: 6542971. doi: 10.1093.
    >> Share

  576. HURST JH, McCumber AW, Aquino JN, Rodriguez J, et al
    Age-related changes in the nasopharyngeal microbiome are associated with SARS-CoV-2 infection and symptoms among children, adolescents, and young adults.
    Clin Infect Dis. 2022 Mar 5. pii: 6542968. doi: 10.1093.
    >> Share

  577. SARAVOLATZ LD, Depcinski S, Sharma M
    Molnupiravir and Nirmatrelvir-Ritonavir: Oral COVID Antiviral Drugs.
    Clin Infect Dis. 2022 Mar 4. pii: 6542722. doi: 10.1093.
    >> Share

  578. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Vaccine Effectiveness of Three vs. Two Doses of SARS-CoV-2 mRNA Vaccines in a High Risk National Population.
    Clin Infect Dis. 2022 Mar 4. pii: 6542712. doi: 10.1093.
    >> Share

  579. SPINELLI MA, Le Tourneau N, Glidden DV, Hsu L, et al
    Impact of Multi-Component Support Strategies on HIV Virologic Suppression Rates during COVID-19: An Interrupted Time Series Analysis.
    Clin Infect Dis. 2022 Mar 4. pii: 6542721. doi: 10.1093.
    >> Share

  580. BAI AD, Lo CKL, Komorowski AS, Suresh M, et al
    How generalizable are randomized controlled trials (RCTs) in Staphylococcus aureus bacteremia? A description of the mortality gap between RCTs and observational studies.
    Clin Infect Dis. 2022 Mar 4. pii: 6542216. doi: 10.1093.
    >> Share

  581. CHAN JF, Siu GK, Yuan S, Ip JD, et al
    Probable Animal-to-Human Transmission of SARS-CoV-2 Delta Variant AY.127 Causing a Pet Shop-Related COVID-19 Outbreak in Hong Kong.
    Clin Infect Dis. 2022 Mar 2. pii: 6541148. doi: 10.1093.
    >> Share

  582. SPEICH B, Chammartin F, Abela IA, Amico P, et al
    Antibody response in immunocompromised patients after the administration of SARS-CoV-2 vaccine BNT162b2 or mRNA-1273: A randomised controlled trial.
    Clin Infect Dis. 2022 Mar 2. pii: 6540899. doi: 10.1093.
    >> Share

  583. HOENIGL M, Abramovitz D, Flores Ortega RE, Martin NK, et al
    Sustained impact of the COVID-2019 pandemic on HCV treatment initiations in the United States.
    Clin Infect Dis. 2022 Mar 2. pii: 6540915. doi: 10.1093.
    >> Share

  584. FISMAN DN, Tuite AR
    Age-Specific Changes in Virulence Associated with SARS-CoV-2 Variants of Concern.
    Clin Infect Dis. 2022 Mar 2. pii: 6541156. doi: 10.1093.
    >> Share

  585. KOTILOGLU-KARAA E, Kele B, Kulasegaran-Shylini R, Broad CE, et al
    SARS-CoV-2 placental infection is associated with massive perivillous fibrin deposition at the maternal-fetal interface: a preliminary study".
    Clin Infect Dis. 2022 Mar 2. pii: 6540910. doi: 10.1093.
    >> Share

  586. GANDHI M
    Immunity Against the Omicron Variant from Vaccination, Recovery or Both.
    Clin Infect Dis. 2022 Mar 2. pii: 6540839. doi: 10.1093.
    >> Share

  587. SAUD Z, Ponsford M, Bentley K, Cole JM, et al
    Mechanically ventilated patients shed high titre live SARS-CoV2 for extended periods from both the upper and lower respiratory tract.
    Clin Infect Dis. 2022 Mar 1. pii: 6540532. doi: 10.1093.
    >> Share

    February 2022
  588. THURESSON S, Fraenkel CJ, Sasinovich S, Soldemyr J, et al
    Airborne SARS-CoV-2 in hospitals - effects of aerosol-generating procedures, HEPA-filtration units, patient viral load and physical distance.
    Clin Infect Dis. 2022 Feb 28. pii: 6539846. doi: 10.1093.
    >> Share

  589. SIVAPALASINGAM S, Lederer DJ, Bhore R, Hajizadeh N, et al
    Efficacy and Safety of Sarilumab in Hospitalized Patients With COVID-19: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Feb 26. pii: 6537638. doi: 10.1093.
    >> Share

  590. KATONA P, Kullar R, Zhang K
    Bringing Transmission of SARS-CoV-2 to the Surface: Is there a Role for Fomites?
    Clin Infect Dis. 2022 Feb 26. pii: 6537376. doi: 10.1093.
    >> Share

  591. MA KC, Hale JE, Grad YH, Alter G, et al
    Trends in SARS-CoV-2 seroprevalence in Massachusetts estimated from newborn screening specimens.
    Clin Infect Dis. 2022 Feb 25. pii: 6537111. doi: 10.1093.
    >> Share

  592. SIGAL GB, Novak T, Mathew A, Chou J, et al
    Measurement of SARS-CoV-2 antigens in plasma of pediatric patients with acute COVID-19 or MIS-C using an ultrasensitive and quantitative immunoassay.
    Clin Infect Dis. 2022 Feb 25. pii: 6537114. doi: 10.1093.
    >> Share

  593. HELDMAN MR, Kates OS, Safa K, Kotton CN, et al
    Delayed mortality among solid organ transplant recipients hospitalized for COVID-19.
    Clin Infect Dis. 2022 Feb 25. pii: 6536752. doi: 10.1093.
    >> Share

  594. WANG Y, He Y, Tong J, Qin Y, et al
    Erratum to: Characterization of an Asymptomatic Cohort of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infected Individuals Outside of Wuhan, China.
    Clin Infect Dis. 2022 Feb 24. pii: 6535534. doi: 10.1093.
    >> Share

  595. HAIDAR G, Agha M, Bilderback A, Lukanski A, et al
    Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study.
    Clin Infect Dis. 2022 Feb 18. pii: 6530582. doi: 10.1093.
    >> Share

  596. LI C, Ye Z, Zhang AJ, Chan JF, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections by intranasal or testicular inoculation induces testicular damage preventable by vaccination in golden Syrian hamsters.
    Clin Infect Dis. 2022 Feb 18. pii: 6530400. doi: 10.1093.
    >> Share

  597. COOPER DJ, Grigg MJ, Plewes K, Rajahram GS, et al
    The effect of regularly dosed acetaminophen versus no acetaminophen on renal function in Plasmodium knowlesi malaria (PACKNOW): a randomised controlled trial.
    Clin Infect Dis. 2022 Feb 18. pii: 6532035. doi: 10.1093.
    >> Share

  598. BRIZZI A, O'Driscoll M, Dorigatti I
    Refining reproduction number estimates to account for unobserved generations of infection in emerging epidemics.
    Clin Infect Dis. 2022 Feb 17. pii: 6530349. doi: 10.1093.
    >> Share

  599. ROTTENSTREICH A, Zarbiv G, Oiknine-Djian E, Vorontsov O, et al
    The effect of gestational age at BNT162b2 mRNA vaccination on maternal and neonatal SARS-CoV-2 antibody levels.
    Clin Infect Dis. 2022 Feb 16. pii: 6529520. doi: 10.1093.
    >> Share

  600. DU Z, Liu C, Wang C, Xu L, et al
    Reproduction Numbers of SARS-CoV-2 Variants: A Systematic Review and Meta-analysis.
    Clin Infect Dis. 2022 Feb 16. pii: 6529536. doi: 10.1093.
    >> Share

  601. VAN DEN BERG P, Schechter-Perkins EM, Jack RS, Epshtein I, et al
    Corrigendum to: Effectiveness of 3 Versus 6 ft of Physical Distancing for Controlling Spread of Coronavirus Disease 2019 Among Primary and Secondary Students and Staff: A Retrospective, Statewide Cohort Study.
    Clin Infect Dis. 2022 Feb 16. pii: 6529266. doi: 10.1093/cid/ciab1049.
    >> Share

  602. SCHUMACHER CM, Thornton N, Wagner J, Tilchin C, et al
    Sexually Transmitted Infection Transmission Dynamics During the Coronavirus Disease 2019 (COVID-19) Pandemic Among Urban Gay, Bisexual, and Other Men Who Have Sex With Men.
    Clin Infect Dis. 2022 Feb 16. pii: 6520505. doi: 10.1093/cid/ciab1053.
    >> Share

  603. ERLANDSON KM, Fitch KV, McCallum SA, Ribaudo HJ, et al
    Geographical Differences in the Self-Reported Functional Impairment of People with HIV and Associations with Cardiometabolic Risk.
    Clin Infect Dis. 2022 Feb 15. pii: 6528571. doi: 10.1093.
    >> Share

  604. BERSHTEYN A, Dahl AM, Dong TQ, Deming ME, et al
    Self-Assessed Severity as a Determinant of COVID-19 Symptom Specificity: A Longitudinal Cohort Study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527943. doi: 10.1093.
    >> Share

  605. GAO DX, Fisher LD, Miller DR, Geller AC, et al
    Inequities in COVID-19 vaccination rates among adolescents in Massachusetts: a cross-sectional study.
    Clin Infect Dis. 2022 Feb 13. pii: 6527834. doi: 10.1093.
    >> Share

  606. HSU AL, Ohler AM, Goldstein A, Truong S, et al
    Coronavirus Disease 2019 (COVID-19) Disease Severity: Pregnant vs Nonpregnant Women at 82 Facilities.
    Clin Infect Dis. 2022;74:467-471.
    >> Share

  607. DONNELLY MAP, Chuey MR, Soto R, Schwartz NG, et al
    Household transmission of SARS-CoV-2 Alpha variant - United States, 2021.
    Clin Infect Dis. 2022 Feb 11. pii: 6526950. doi: 10.1093.
    >> Share

  608. ZAIA JA
    In the Fog of Coronavirus Disease (COVID).
    Clin Infect Dis. 2022;74:511-512.
    >> Share

  609. NIV Y, Eliakim-Raz N, Bar-Lavi Y, Green M, et al
    Comparing Covid-19 pandemic waves in hospitalized patients - a retrospective, multicenter, cohort study.
    Clin Infect Dis. 2022 Feb 10. pii: 6526377. doi: 10.1093.
    >> Share

  610. BUTT AA, Talisa VB, Yan P, Shaikh OS, et al
    Real-world Effectiveness of the SARS-CoV-2 mRNA Vaccines in Preventing Confirmed Infection in Patients on Chronic Hemodialysis.
    Clin Infect Dis. 2022 Feb 9. pii: 6525466. doi: 10.1093.
    >> Share

  611. CONTOPOULOS-IOANNIDIS DG, Altamirano J, Maldonado Y
    Infectious Diseases-Related Hospitalizations During Oral Polio Vaccine(OPV) and non-OPV immunization periods: An Empirical Evaluation of all Hospital Discharges in California(1985-2010).
    Clin Infect Dis. 2022 Feb 9. pii: 6525447. doi: 10.1093.
    >> Share

  612. TANG W, Chen HL
    Predictors of SARS-CoV-2 infection: is there a comprehensive analysis?
    Clin Infect Dis. 2022 Feb 8. pii: 6524191. doi: 10.1093.
    >> Share

  613. BAKER MA, Rhee C, Tucker R, Badwaik A, et al
    Rapid control of hospital-based SARS-CoV-2 Omicron clusters through daily testing and universal use of N95 respirators.
    Clin Infect Dis. 2022 Feb 7. pii: 6523822. doi: 10.1093.
    >> Share

  614. DRAWZ PE, DeSilva M, Bodurtha P, Benitez GV, et al
    Effectiveness of BNT162b2 and mRNA-1273 Second Doses and Boosters for SARS-CoV-2 infection and SARS-CoV-2 Related Hospitalizations: A Statewide Report from the Minnesota Electronic Health Record Consortium.
    Clin Infect Dis. 2022 Feb 7. pii: 6523820. doi: 10.1093.
    >> Share

  615. LI Z, Lewis B, Berney K, Hallisey E, et al
    Social vulnerability and rurality associated with higher SARS-CoV-2 infection-induced seroprevalence: a nationwide blood donor study, United States, July 2020 - June 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523818. doi: 10.1093.
    >> Share

  616. RISK M, Shen C, Hayek SS, Holevinski L, et al
    Comparative Effectiveness of COVID-19 Vaccines against the Delta Variant.
    Clin Infect Dis. 2022 Feb 7. pii: 6523819. doi: 10.1093.
    >> Share

  617. PERNICIARO S, van der Linden M, Weinberger DM
    Re-emergence of Invasive Pneumococcal Disease in Germany during the Spring and Summer of 2021.
    Clin Infect Dis. 2022 Feb 7. pii: 6523816. doi: 10.1093.
    >> Share

  618. ERAUSQUIN JT, Tan RKJ, Uhlich M, Francis JM, et al
    The International Sexual Health And Reproductive Health Survey (I-SHARE-1): A Multi-Country Analysis of Adults from 30 Countries Prior to and During the Initial COVID-19 Wave.
    Clin Infect Dis. 2022 Feb 7. pii: 6523817. doi: 10.1093.
    >> Share

  619. HELMSDAL G, Hansen OK, Moller LF, Christiansen DH, et al
    Omicron outbreak at a private gathering in the Faroe Islands, infecting 21 of 33 triple-vaccinated healthcare workers.
    Clin Infect Dis. 2022 Feb 3. pii: 6520882. doi: 10.1093.
    >> Share

  620. NEUZIL KM
    Prevention and Control of COVID-19: Where do we go from here?
    Clin Infect Dis. 2022 Feb 3. pii: 6520891. doi: 10.1093.
    >> Share

  621. ONG SWX, Sutjipto S, Lee PH, Dugan C, et al
    Validation of ISARIC 4C mortality and deterioration scores in a mixed vaccination status cohort of hospitalized COVID-19 patients in Singapore.
    Clin Infect Dis. 2022 Feb 3. pii: 6520952. doi: 10.1093.
    >> Share

  622. PISCHEL L, Patel KM, Goshua G, Omer SB, et al
    Adenovirus-based vaccines and thrombosis in pregnancy: A systematic review and meta-analysis.
    Clin Infect Dis. 2022 Feb 2. pii: 6520532. doi: 10.1093.
    >> Share

  623. NOUSHAD M, Al-Awar MS, Al-Saqqaf IS, Nassani MZ, et al
    Lack of access to COVID-19 vaccines could be a greater threat than vaccine hesitancy in low-income and conflict nations: the case of Yemen.
    Clin Infect Dis. 2022 Feb 2. pii: 6520556. doi: 10.1093.
    >> Share

  624. MEIRING S, Tempia S, Bhiman JN, Buys A, et al
    Prolonged shedding of SARS-CoV-2 at high viral loads amongst hospitalised immunocompromised persons living with HIV, South Africa.
    Clin Infect Dis. 2022 Feb 2. pii: 6520530. doi: 10.1093.
    >> Share

  625. CROMER D, Reynaldi A, Steain M, Triccas JA, et al
    Relating in vitro neutralisation level and protection in the CVnCoV (CUREVAC) trial.
    Clin Infect Dis. 2022 Feb 1. pii: 6518223. doi: 10.1093.
    >> Share

  626. IMLAY H, Baum P, Brennan DC, Hanson KE, et al
    Consensus Definitions of BK Polyomavirus Nephropathy in Renal Transplant Recipients for Clinical Trials.
    Clin Infect Dis. 2022 Feb 1. pii: 6518218. doi: 10.1093.
    >> Share

    January 2022
  627. FRIEDMAN N, Levy N, Kaplan O, Padeh G, et al
    Pediatric Hospitalizations after School Reopening during the SARS-CoV-2 Alpha (B.1.1.7) Variant Spread: A Multicenter Cross-sectional Study in Israel.
    Clin Infect Dis. 2022 Jan 29. pii: 6517373. doi: 10.1093.
    >> Share

  628. HOLMDAHL I, Kahn R, Slifka KJ, Dooling K, et al
    Modeling the impact of vaccination strategies for nursing homes in the context of increased SARS-CoV-2 community transmission and variants.
    Clin Infect Dis. 2022 Jan 29. pii: 6517371. doi: 10.1093.
    >> Share

  629. WATKINS LKF, Mitruka K, Dorough L, Bressler SS, et al
    Characteristics of Reported Deaths Among Fully Vaccinated Persons with COVID-19 -United States, January-April 2021.
    Clin Infect Dis. 2022 Jan 29. pii: 6517385. doi: 10.1093.
    >> Share

  630. STRAHM C, Seneghini M, Gusewell S, Egger T, et al
    Symptoms compatible with long-COVID in healthcare workers with and without SARS-CoV-2 infection - results of a prospective multicenter cohort.
    Clin Infect Dis. 2022 Jan 28. pii: 6516835. doi: 10.1093.
    >> Share

  631. PEROFSKY AC, Tempia S, Bingham J, Maslo C, et al
    The direct and indirect effects of the COVID-19 pandemic on private healthcare utilization in South Africa, March 2020 - September 2021.
    Clin Infect Dis. 2022 Jan 27. pii: 6515907. doi: 10.1093.
    >> Share

  632. MARRONE A, Nevola R, Sellitto A, Cozzolino D, et al
    Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515763. doi: 10.1093.
    >> Share

  633. CHIN ET, Leidner D, Zhang Y, Long E, et al
    Effectiveness of COVID-19 vaccines among incarcerated people in California state prisons: retrospective cohort study.
    Clin Infect Dis. 2022 Jan 27. pii: 6515675. doi: 10.1093/cid/ciab1032.
    >> Share

  634. SPAULDING AC, Zawitz C
    Vaccination in Prisons and Jails: Corrections Needed in Future Plans.
    Clin Infect Dis. 2022 Jan 27. pii: 6515673. doi: 10.1093/cid/ciab1031.
    >> Share

  635. LAWRENZ J, Xie Q, Zech F, Weil T, et al
    SARS-CoV-2 Vaccination boosts Neutralizing Activity against Seasonal Human Coronaviruses.
    Clin Infect Dis. 2022 Jan 25. pii: 6515378. doi: 10.1093.
    >> Share

  636. MURUGESAN K, Jagannathan P, Altamirano J, Maldonado YA, et al
    Long Term Accuracy of SARS-CoV-2 Interferon-gamma Release Assay and its Application in Household Investigation.
    Clin Infect Dis. 2022 Jan 25. pii: 6515439. doi: 10.1093.
    >> Share

  637. MICHELI V, Bracchitta F, Rizzo A, Mancon A, et al
    First identification of the new SARS-CoV-2 Omicron variant (B.1.1.529) in Italy.
    Clin Infect Dis. 2022 Jan 21. pii: 6513588. doi: 10.1093/cid/ciab1044.
    >> Share

  638. ROWAN SE, McCormick DW, Wendel KA, Scott T, et al
    Lower Prevalence of SARS-CoV-2 Infection Among People Experiencing Homelessness Tested in Outdoor Encampments Compared with Overnight Shelters - Denver, Colorado, June - July 2020.
    Clin Infect Dis. 2022 Jan 18. pii: 6510919. doi: 10.1093.
    >> Share

  639. HUANG YA, Zhu W, Wiener J, Kourtis AP, et al
    Impact of COVID-19 on HIV Preexposure Prophylaxis Prescriptions in the United States - A Time Series Analysis.
    Clin Infect Dis. 2022 Jan 18. pii: 6510912. doi: 10.1093.
    >> Share

  640. PILZ S
    Contributions to the mitigation of the COVID-19 pandemic.
    Clin Infect Dis. 2022 Jan 17. pii: 6509528. doi: 10.1093.
    >> Share

  641. KRONFLI N, Dussault C, Maheu-Giroux M, Halavrezos A, et al
    Seroprevalence and risk factors for SARS-CoV-2 among incarcerated adult men in Quebec, Canada (2021).
    Clin Infect Dis. 2022 Jan 17. pii: 6509066. doi: 10.1093.
    >> Share

  642. SHOJI K, Tsuzuki S, Akiyama T, Matsunaga N, et al
    Clinical characteristics and outcomes of COVID-19 in pregnant women: a propensity score matched analysis of the data from the COVID-19 Registry Japan.
    Clin Infect Dis. 2022 Jan 17. pii: 6509063. doi: 10.1093.
    >> Share

  643. LIU J, Laurie MT, Rubio L, Vazquez SE, et al
    SARS-CoV-2 transmission dynamics and immune responses in a household of vaccinated persons.
    Clin Infect Dis. 2022 Jan 17. pii: 6509064. doi: 10.1093.
    >> Share

  644. SEXTON ME, Waggoner JJ, Carmola LR, Nguyen PV, et al
    Rapid detection and characterization of SARS-CoV-2 omicron variant in a returning traveler.
    Clin Infect Dis. 2022 Jan 17. pii: 6509065. doi: 10.1093.
    >> Share

  645. MUSSI-PINHATA MM, Ward S, Laimon L, Pelton SI, et al
    Effect of Maternal Vaccination of PCV-10, PPV-23 or Placebo on the Immunogenicity of PCV-10 in HIV-exposed Uninfected Infants: A Randomized Clinical Trial.
    Clin Infect Dis. 2022 Jan 17. pii: 6509061. doi: 10.1093.
    >> Share

  646. SHRESTHA NK, Burke PC, Nowacki AS, Terpeluk P, et al
    Necessity of COVID-19 Vaccination in Persons Who Have Already Had COVID-19.
    Clin Infect Dis. 2022 Jan 13. pii: 6507165. doi: 10.1093.
    >> Share

  647. BAILIE CR, Tseng YY, Carolan L, Kirk MD, et al
    Trend in sensitivity of SARS-CoV-2 serology one year after mild and asymptomatic COVID-19: unpacking potential bias in seroprevalence studies.
    Clin Infect Dis. 2022 Jan 13. pii: 6506584. doi: 10.1093.
    >> Share

  648. WARREN BG, Nelson A, Barrett A, Addison B, et al
    SARS-CoV-2 Environmental contamination in hospital rooms is uncommon using viral culture techniques.
    Clin Infect Dis. 2022 Jan 12. pii: 6505265. doi: 10.1093.
    >> Share

  649. TODD FOJO A, Wallengren E, Schnure M, Dowdy DW, et al
    Potential Effects of the COVID-19 Pandemic on HIV Transmission: A Modeling Study in 32 US Cities.
    Clin Infect Dis. 2022 Jan 7. pii: 6500774. doi: 10.1093/cid/ciab1029.
    >> Share

  650. HEFTDAL LD, Schultz M, Lange T, Knudsen AD, et al
    Incidence of positive SARS-CoV-2 PCR after COVID-19 vaccination with up to eight months of follow-up: Real life data from the Capital Region of Denmark.
    Clin Infect Dis. 2022 Jan 7. pii: 6500168. doi: 10.1093.
    >> Share

  651. JANI IV, Peter TF
    Nucleic Acid Point-of-Care Testing to Improve Diagnostic Preparedness.
    Clin Infect Dis. 2022 Jan 7. pii: 6500010. doi: 10.1093.
    >> Share

  652. PARHIZKAR H, Dietz L, Olsen-Martinez A, Horve PF, et al
    Quantifying environmental mitigation of aerosol viral load in a controlled chamber with participants diagnosed with COVID-19.
    Clin Infect Dis. 2022 Jan 6. pii: 6498295. doi: 10.1093.
    >> Share

  653. LI X, Chan JM, Lam B, Lung DC, et al
    COVID-19 mRNA vaccines delay the onset of breakthrough infections with less radiographic abnormalities.
    Clin Infect Dis. 2022 Jan 4. pii: 6497432. doi: 10.1093/cid/ciab1062.
    >> Share

  654. MARUKI T, Iwamoto N, Kanda K, Okumura N, et al
    Two cases of breakthrough SARS-CoV-2 infections caused by the Omicron variant (B.1.1.529 lineage) in international travelers to Japan.
    Clin Infect Dis. 2022 Jan 3. pii: 6494531. doi: 10.1093/cid/ciab1072.
    >> Share

  655. REDDY KP, Kruse GR, Lee S, Shuter J, et al
    Tobacco Use and Treatment of Tobacco Dependence Among People with HIV: A Practical Guide for Clinicians.
    Clin Infect Dis. 2022 Jan 3. pii: 6494528. doi: 10.1093/cid/ciab1069.
    >> Share

  656. JAKOBSEN A, Skov MT, Larsen L, Petersen PT, et al
    Herpes simplex virus 2 meningitis in adults: A prospective, nationwide, population-based cohort study.
    Clin Infect Dis. 2022 Jan 3. pii: 6494530. doi: 10.1093/cid/ciab1071.
    >> Share

    December 2021
  657. STEIN D, Oviedo-Orta E, Kampman WA, McGinniss J, et al
    Compassionate Use of REGEN-COV (R) in Patients with COVID-19 and Immunodeficiency-Associated Antibody Disorders.
    Clin Infect Dis. 2021 Dec 31. pii: 6491226. doi: 10.1093/cid/ciab1059.
    >> Share

  658. YAMAMOTO S, Maeda K, Matsuda K, Tanaka A, et al
    COVID-19 breakthrough infection and post-vaccination neutralizing antibody among healthcare workers in a referral hospital in Tokyo: a case-control matching study.
    Clin Infect Dis. 2021 Dec 24. pii: 6482345. doi: 10.1093/cid/ciab1048.
    >> Share

  659. ANDREJKO KL, Pry J, Myers JF, Openshaw J, et al
    Predictors of SARS-CoV-2 infection following high-risk exposure.
    Clin Infect Dis. 2021 Dec 21. pii: 6473597. doi: 10.1093/cid/ciab1040.
    >> Share

  660. SACHDEV DD, Chew Ng R, Sankaran M, Ernst A, et al
    Contact tracing outcomes among household contacts of fully vaccinated COVID-19 patients - San Francisco, California, January 29-July 2, 2021.
    Clin Infect Dis. 2021 Dec 20. pii: 6470866. doi: 10.1093/cid/ciab1042.
    >> Share

  661. TYNER HL, Burgess JL, Grant L, Gaglani M, et al
    Neutralizing Antibody Response to Pseudotype SARS-CoV-2 Differs between mRNA-1273 and BNT162b2 COVID-19 Vaccines and by History of SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Dec 20. pii: 6470720. doi: 10.1093/cid/ciab1038.
    >> Share

  662. PERSAD G, Peek ME, Shah SK
    Fair Allocation of Scarce Therapies for COVID-19.
    Clin Infect Dis. 2021 Dec 18. pii: 6469906. doi: 10.1093/cid/ciab1039.
    >> Share

  663. LUO CH, Morris CP, Sachithanandham J, Amadi A, et al
    Infection with the SARS-CoV-2 Delta Variant is Associated with Higher Recovery of Infectious Virus Compared to the Alpha Variant in both Unvaccinated and Vaccinated Individuals.
    Clin Infect Dis. 2021 Dec 18. pii: 6469786. doi: 10.1093.
    >> Share

  664. LU L, Mok BW, Chen LL, Chan JM, et al
    Neutralization of SARS-CoV-2 Omicron variant by sera from BNT162b2 or Coronavac vaccine recipients.
    Clin Infect Dis. 2021 Dec 16. pii: 6463504. doi: 10.1093/cid/ciab1041.
    >> Share

  665. MUDENDA V, Mumba C, Pieciak RC, Mwananyanda L, et al
    Histopathological Evaluation of Deceased Persons in Lusaka, Zambia With or Without Coronavirus Disease 2019 (COVID-19) Infection: Results Obtained From Minimally Invasive Tissue Sampling.
    Clin Infect Dis. 2021;73.
    >> Share

  666. BASSAT Q, Varo R, Hurtado JC, Marimon L, et al
    Minimally Invasive Tissue Sampling as an Alternative to Complete Diagnostic Autopsies in the Context of Epidemic Outbreaks and Pandemics: The Example of Coronavirus Disease 2019 (COVID-19).
    Clin Infect Dis. 2021;73.
    >> Share

  667. DUARTE-NETO AN, Ferraz da Silva LF, Monteiro RAA, Theodoro Filho J, et al
    Ultrasound-Guided Minimally Invasive Tissue Sampling: A Minimally Invasive Autopsy Strategy During the COVID-19 Pandemic in Brazil, 2020.
    Clin Infect Dis. 2021;73.
    >> Share

  668. GOCO NJ, McClure EM, Rakislova N, Bassat Q, et al
    Minimally Invasive Tissue Sampling Surveillance Alliance-Facilitating the Expansion of Pathology-Based Mortality Surveillance.
    Clin Infect Dis. 2021;73.
    >> Share

  669. RAKISLOVA N, Rodrigo-Calvo MT, Marimon L, Ribera-Cortada I, et al
    Minimally Invasive Tissue Sampling Findings in 12 Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73.
    >> Share

  670. GARIBALDI BT, Wang K, Robinson ML, Betz J, et al
    Real-World Effectiveness Of Remdesivir In Adults Hospitalized With Covid-19: A Retrospective, Multicenter Comparative Effectiveness Study.
    Clin Infect Dis. 2021 Dec 15. pii: 6463010. doi: 10.1093/cid/ciab1035.
    >> Share

  671. DANINO D, Ben-Shimol S, Van Der Beek BA, Givon-Lavi N, et al
    Decline in Pneumococcal Disease in Young Children during the COVID-19 Pandemic in Israel Associated with Suppression of seasonal Respiratory Viruses, despite Persistent Pneumococcal Carriage: A Prospective Cohort Study.
    Clin Infect Dis. 2021 Dec 14. pii: 6460745. doi: 10.1093/cid/ciab1014.
    >> Share

  672. BRUNEAU T, Wack M, Poulet G, Robillard N, et al
    Circulating ubiquitous RNA, a highly predictive and prognostic biomarker in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Dec 11. pii: 6459561. doi: 10.1093.
    >> Share

  673. BART SM, Harizaj A, Pearson CL, Conteh T, et al
    SARS-CoV-2 Delta outbreak among fully vaccinated nursing home residents likely initiated by a fully vaccinated staff member - Connecticut, July-August 2021.
    Clin Infect Dis. 2021 Dec 10. pii: 6459157. doi: 10.1093/cid/ciab1025.
    >> Share

  674. KHAN K, Lustig G, Bernstein M, Archary D, et al
    Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV.
    Clin Infect Dis. 2021 Dec 10. pii: 6459255. doi: 10.1093/cid/ciab1008.
    >> Share

  675. ROCCO JM, Mallarino-Haeger C, Randolph AH, Ray SM, et al
    Hyperinflammatory syndromes after SARS-CoV-2 mRNA vaccination in individuals with underlying immune dysregulation.
    Clin Infect Dis. 2021 Dec 10. pii: 6459155. doi: 10.1093/cid/ciab1024.
    >> Share

  676. FERNANDEZ-GONZALEZ M, Agullo V, Padilla S, Garcia JA, et al
    Clinical performance of a standardized SARS-CoV-2 interferon-gamma release assay for simple detection of T-cell responses after infection or vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6459152. doi: 10.1093/cid/ciab1021.
    >> Share

  677. BUTT AA, Yan P, Shaikh OS, Mayr FB, et al
    Rate and Risk Factors for Severe/Critical Disease Among Fully Vaccinated Persons with Breakthrough SARS-CoV-2 Infection in a High-risk National Population.
    Clin Infect Dis. 2021 Dec 10. pii: 6459161. doi: 10.1093/cid/ciab1023.
    >> Share

  678. SHIN HS, Kim Y, Kang J, Um J, et al
    Longitudinal Analysis of Memory T cell Responses in Survivors of Middle East respiratory syndrome.
    Clin Infect Dis. 2021 Dec 10. pii: 6459149. doi: 10.1093/cid/ciab1019.
    >> Share

  679. TANG L, Cherry S, Tuomanen EI, Roubidoux EK, et al
    Host predictors of broadly cross-reactive antibodies against SARS-CoV-2 variants of concern differ between infection and vaccination.
    Clin Infect Dis. 2021 Dec 10. pii: 6458694. doi: 10.1093.
    >> Share

  680. SHAW ER, Rosen LB, Cheng A, Dobbs K, et al
    Temporal Dynamics of Anti-Type 1 Interferon Autoantibodies in COVID-19 Patients.
    Clin Infect Dis. 2021 Dec 7. pii: 6455230. doi: 10.1093/cid/ciab1002.
    >> Share

  681. ENDO A
    Estimated Sensitivity Values of Severe Acute Respiratory Syndrome Coronavirus 2 Tests from Cross-sectional Data Warrant Caution Due to Unvalidated Model Assumptions.
    Clin Infect Dis. 2021;73:e3984-e3985.
    >> Share

  682. THOMAS BR
    Does Expert Opinion Trump Evidence?
    Clin Infect Dis. 2021;73:e3982-e3983.
    >> Share

  683. LOHR B, Niemann D, Verheyen J
    Bamlanivimab Treatment Leads to Rapid Selection of Immune Escape Variant Carrying the E484K Mutation in a B.1.1.7-Infected and Immunosuppressed Patient.
    Clin Infect Dis. 2021;73:2144-2145.
    >> Share

  684. SPINELLI MA, Peluso MJ, Lynch KL, Yun C, et al
    Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study.
    Clin Infect Dis. 2021 Dec 5. pii: 6453392. doi: 10.1093/cid/ciab1009.
    >> Share

  685. MILLER AD, Zambrano LD, Yousaf AR, Abrams JY, et al
    Multisystem Inflammatory Syndrome in Children-United States, February 2020-July 2021.
    Clin Infect Dis. 2021 Dec 5. pii: 6453395. doi: 10.1093/cid/ciab1007.
    >> Share

  686. PANNUS P, Neven KY, De Craeye S, Heyndrickx L, et al
    Poor antibody response to BioNTech/Pfizer COVID-19 vaccination in SARS-CoV-2 naive residents of nursing homes.
    Clin Infect Dis. 2021 Dec 3. pii: 6448839. doi: 10.1093.
    >> Share

  687. KIM P, Gordon SM, Sheehan MM, Rothberg MB, et al
    Duration of SARS-CoV-2 Natural Immunity and Protection against the Delta Variant: A Retrospective Cohort Study.
    Clin Infect Dis. 2021 Dec 3. pii: 6448857. doi: 10.1093.
    >> Share

  688. JOSEPH NT, Satten GA, Williams RE, Haddad LB, et al
    The Effect of Antiretroviral Therapy for the Treatment of HIV-1 in Pregnancy on Gestational Weight Gain.
    Clin Infect Dis. 2021 Dec 3. pii: 6448917. doi: 10.1093.
    >> Share

    November 2021
  689. GRUNAU B, Asamoah-Boaheng M, Lavoie PM, Karim ME, et al
    A Higher Antibody Response Is Generated With a 6- to 7-Week (vs Standard) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Dosing Interval.
    Clin Infect Dis. 2021 Nov 30. pii: 6446287. doi: 10.1093.
    >> Share

  690. ZAVALA M, Ireland G, Amin-Chowdhury Z, Ramsay ME, et al
    Acute and persistent symptoms in children with PCR-confirmed SARS-CoV-2 infection compared to test-negative children in England: active, prospective, national surveillance.
    Clin Infect Dis. 2021 Nov 29. pii: 6446232. doi: 10.1093.
    >> Share

  691. BELAY ED, Godfred Cato S, Rao AK, Abrams J, et al
    Multisystem Inflammatory Syndrome in Adults after SARS-CoV-2 infection and COVID-19 vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445178. doi: 10.1093.
    >> Share

  692. CHUA GT, Kwan MYW, Chui CSL, Smith RD, et al
    Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty Vaccination.
    Clin Infect Dis. 2021 Nov 28. pii: 6445179. doi: 10.1093.
    >> Share

  693. DIMEGLIO C, Herin F, Da-Silva I, Porcheron M, et al
    Post-vaccination SARS-CoV-2 antibody kinetics and protection duration.
    Clin Infect Dis. 2021 Nov 27. pii: 6444809. doi: 10.1093.
    >> Share

  694. SAHANIC S, Tymoszuk P, Ausserhofer D, Rass V, et al
    Phenotyping of acute and persistent COVID-19 features in the outpatient setting: exploratory analysis of an international cross-sectional online survey.
    Clin Infect Dis. 2021 Nov 26. pii: 6440836. doi: 10.1093.
    >> Share

  695. CORREA H, Soslow JH, Dendy JM, Creech CB, et al
    Acute myopericarditis post intravenous injection of COVID-19 mRNA vaccine differs from viral myocarditis.
    Clin Infect Dis. 2021 Nov 26. pii: 6443709. doi: 10.1093.
    >> Share

  696. LI C, Chen Y, Zhao Y, Christopher Lung D, et al
    Corrigendum to: Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model.
    Clin Infect Dis. 2021 Nov 25. pii: 6438764. doi: 10.1093.
    >> Share

  697. GAZIT S, Mizrahi B, Kalkstein N, Neuberger A, et al
    BNT162b2 mRNA Vaccine Effectiveness Given Confirmed Exposure: Analysis of Household Members of COVID-19 Patients.
    Clin Infect Dis. 2021 Nov 24. pii: 6437962. doi: 10.1093.
    >> Share

  698. MOLLAN KR, Eron JJ, Krajewski TJ, Painter W, et al
    Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Virus in Symptomatic Coronavirus Disease 2019 (COVID-19) Outpatients: Host, Disease, and Viral Correlates.
    Clin Infect Dis. 2021 Nov 23. pii: 6433715. doi: 10.1093.
    >> Share

  699. STRATHDEE SA, Abramovitz D, Harvey-Vera A, Vera CF, et al
    Correlates of Coronavirus Disease 2019 (COVID-19) Vaccine Hesitancy Among People Who Inject Drugs in the San Diego-Tijuana Border Region.
    Clin Infect Dis. 2021 Nov 22. pii: 6433374. doi: 10.1093.
    >> Share

  700. CHUAH CH, Chow TS, Hor CP, Cheng JT, et al
    Efficacy of Early Treatment with Favipiravir on Disease Progression among High Risk COVID-19 Patients: A Randomized, Open-Label Clinical Trial.
    Clin Infect Dis. 2021 Nov 19. pii: 6432025. doi: 10.1093.
    >> Share

  701. CANADAY DH, Oyebanji OA, Keresztesy D, Payne M, et al
    Significant Reduction in Vaccine-Induced Antibody Levels and Neutralization Activity Among Healthcare Workers and Nursing Home Residents 6 Months Following Coronavirus Disease 2019 BNT162b2 mRNA Vaccination.
    Clin Infect Dis. 2021 Nov 19. pii: 6432026. doi: 10.1093.
    >> Share

  702. GILNER J, Kansal N, Biggio JR, Delaney S, et al
    Universal SARS-CoV-2 testing for obstetric inpatient units across the United States.
    Clin Infect Dis. 2021 Nov 17. pii: 6430425. doi: 10.1093.
    >> Share

  703. MADELON N, Lauper K, Breville G, Sabater Royo I, et al
    Robust T cell responses in anti-CD20 treated patients following COVID-19 vaccination: a prospective cohort study.
    Clin Infect Dis. 2021 Nov 17. pii: 6430423. doi: 10.1093.
    >> Share

  704. TEN DOESSCHATE T, Kuiper S, van Nieuwkoop C, Hassing RJ, et al
    Fosfomycin versus ciprofloxacin as oral stepdown treatment for Escherichia coli febrile urinary tract infection in women: a randomised, placebo-controlled, double blind, multicenter trial.
    Clin Infect Dis. 2021 Nov 16. pii: 6429720. doi: 10.1093.
    >> Share

  705. AKINBAMI LJ, Biggerstaff BJ, Chan PA, McGibbon E, et al
    Reinfection with SARS-CoV-2 among previously infected healthcare personnel and first responders.
    Clin Infect Dis. 2021 Nov 15. pii: 6428613. doi: 10.1093.
    >> Share

  706. LYNCH JB, Davitkov P, Anderson DJ, Bhimraj A, et al
    Infectious Diseases Society of America Guidelines on Infection Prevention for Healthcare Personnel Caring for Patients with Suspected or Known COVID-19.
    Clin Infect Dis. 2021 Nov 15. pii: 6428563. doi: 10.1093.
    >> Share

  707. HARRIS TG, Jaszi E, Lamb MR, Laudari CA, et al
    Effects of the COVID-19 Pandemic on HIV Services: Findings from 11 Sub-Saharan African Countries.
    Clin Infect Dis. 2021 Nov 15. pii: 6428385. doi: 10.1093.
    >> Share

  708. SHEN Z, Xiao Y, Kang L, Ma W, et al
    Corrigendum to: Genomic Diversity of Severe Acute Respiratory Syndrome-Coronavirus 2 in Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021 Nov 13. pii: 6427503. doi: 10.1093.
    >> Share

  709. LI ZJ, Yu LJ, Zhang HY, Shan CX, et al
    Broad impacts of COVID-19 pandemic on acute respiratory infections in China: an observational study.
    Clin Infect Dis. 2021 Nov 12. pii: 6426178. doi: 10.1093.
    >> Share

  710. BEAN DJ, Monroe J, Turcinovic J, Moreau Y, et al
    SARS-CoV-2 reinfection associates with unstable housing and occurs in the presence of antibodies.
    Clin Infect Dis. 2021 Nov 10. pii: 6424810. doi: 10.1093.
    >> Share

  711. VIHTA KD, Pouwels KB, Peto T, Pritchard E, et al
    Symptoms and SARS-CoV-2 positivity in the general population in the UK.
    Clin Infect Dis. 2021 Nov 8. pii: 6423489. doi: 10.1093.
    >> Share

  712. LIEN CE, Kuo TY, Lin YJ, Lian WC, et al
    Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern.
    Clin Infect Dis. 2021 Nov 5. pii: 6421519. doi: 10.1093.
    >> Share

  713. PEREZ Y, Levy ER, Joshi AY, Virk A, et al
    Myocarditis Following COVID-19 mRNA Vaccine: A Case Series and Incidence Rate Determination.
    Clin Infect Dis. 2021 Nov 3. pii: 6420408. doi: 10.1093.
    >> Share

  714. GRENINGER AL, Dien Bard J, Colgrove RC, Graf EH, et al
    Clinical and Infection Prevention Applications of SARS-CoV-2 Genotyping: An IDSA/ASM Consensus Review Document.
    Clin Infect Dis. 2021 Nov 3. pii: 6420112. doi: 10.1093.
    >> Share

  715. SHERMAN AC, Desjardins M, Cheng CA, Bausk B, et al
    SARS-CoV-2 mRNA Vaccines in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Immunogenicity and Reactogenicity.
    Clin Infect Dis. 2021 Nov 2. pii: 6415965. doi: 10.1093.
    >> Share

  716. BOSCH W, Cowart JB, Bhakta S, Carter RE, et al
    COVID-19 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida through August 2021.
    Clin Infect Dis. 2021 Nov 2. pii: 6415962. doi: 10.1093.
    >> Share

  717. LIU K, Ai S, Song S, Zhu G, et al
    Corrigendum to: Population Movement, City Closure in Wuhan, and Geographical Expansion of the COVID-19 Infection in China in January 2020.
    Clin Infect Dis. 2021 Nov 1. pii: 6414998. doi: 10.1093.
    >> Share

    October 2021
  718. CONWAY MORRIS A, Sharrocks K, Bousfield R, Kermack L, et al
    The removal of airborne SARS-CoV-2 and other microbial bioaerosols by air filtration on COVID-19 surge units.
    Clin Infect Dis. 2021 Oct 30. pii: 6414657. doi: 10.1093.
    >> Share

  719. DOUGAN M, Azizad M, Mocherla B, Gottlieb RL, et al
    A randomized, placebo-controlled clinical trial of bamlanivimab and etesevimab together in high-risk ambulatory patients with COVID-19 and validation of the prognostic value of persistently high viral load.
    Clin Infect Dis. 2021 Oct 28. pii: 6413724. doi: 10.1093.
    >> Share

  720. LEDNICKY JA, Tagliamonte MS, White SK, Blohm GM, et al
    Isolation of a Novel Recombinant Canine Coronavirus from a Visitor to Haiti: Further Evidence of Transmission of Coronaviruses of Zoonotic Origin to Humans.
    Clin Infect Dis. 2021 Oct 28. pii: 6413759. doi: 10.1093.
    >> Share

  721. YANG B, Tsang TK, Gao H, Lau EHY, et al
    Universal community nucleic acid testing for COVID-19 in Hong Kong reveals insights into transmission dynamics: a cross-sectional and modelling study.
    Clin Infect Dis. 2021 Oct 28. pii: 6413763. doi: 10.1093.
    >> Share

  722. HORITA N, Kato H, Watanabe K, Hara Y, et al
    Declined mortality due to seasonal influenza in Japan during the coronavirus disease 2019 pandemic.
    Clin Infect Dis. 2021 Oct 28. pii: 6413653. doi: 10.1093.
    >> Share

  723. WILLIAMS LR, Ferguson NM, Donnelly CA, Grassly NC, et al
    Measuring vaccine efficacy against infection and disease in clinical trials: sources and magnitude of bias in COVID-19 vaccine efficacy estimates.
    Clin Infect Dis. 2021 Oct 26. pii: 6410688. doi: 10.1093.
    >> Share

  724. MUHSEN K, Maimon N, Mizrahi A, Bodenneimer O, et al
    Effectiveness of BNT162b2 mRNA COVID-19 vaccine against acquisitions of SARS-CoV-2 among health care workers in long-term care facilities: a prospective cohort study.
    Clin Infect Dis. 2021 Oct 26. pii: 6410737. doi: 10.1093.
    >> Share

  725. DE CASTILHOS J, Zamir E, Hippchen T, Rohrbach R, et al
    Severe dysbiosis and specific Haemophilus and Neisseria signatures as hallmarks of the oropharyngeal microbiome in critically ill COVID-19 patients.
    Clin Infect Dis. 2021 Oct 25. pii: 6409876. doi: 10.1093.
    >> Share

  726. WOLDEMESKEL BA, Garliss CC, Blankson JN
    mRNA Vaccine-Elicited SARS-CoV-2-Specific T cells Persist at 6 Months and Recognize the Delta Variant.
    Clin Infect Dis. 2021 Oct 25. pii: 6409907. doi: 10.1093.
    >> Share

  727. WALDMAN SE, Buehring T, Escobar DJ, Gohil SK, et al
    Secondary Cases of Delta-Variant COVID-19 Among Vaccinated Healthcare Workers with Breakthrough Infections is Rare.
    Clin Infect Dis. 2021 Oct 25. pii: 6409806. doi: 10.1093.
    >> Share

  728. BHIMRAJ A, Morgan RL, Shumaker AH, Lavergne V, et al
    Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-Edged Swords.
    Clin Infect Dis. 2021 Oct 20. pii: 6398590. doi: 10.1093.
    >> Share

  729. BHIMRAJ A, Morgan RL, Shumaker AH, Baden L, et al
    Lessons learned from COVID-19 therapies: Critical perspectives from the IDSA COVID-19 treatment guideline panel.
    Clin Infect Dis. 2021 Oct 20. pii: 6398589. doi: 10.1093.
    >> Share

  730. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Yassine HM, et al
    Severity, criticality, and fatality of the SARS-CoV-2 Beta variant.
    Clin Infect Dis. 2021 Oct 17. pii: 6398699. doi: 10.1093.
    >> Share

  731. BROSSEAU LM, Escandon K, Ulrich AK, Rasmussen AL, et al
    SARS-CoV-2 Dose, Infection, and Disease Outcomes for COVID-19 - A Review.
    Clin Infect Dis. 2021 Oct 15. pii: 6397523. doi: 10.1093.
    >> Share

  732. ROBILOTTI EV, Whiting K, Lucca A, Poon C, et al
    Clinical and Genomic Characterization of SARS CoV-2 infections in mRNA Vaccinated Health Care Personnel in New York City.
    Clin Infect Dis. 2021 Oct 13. pii: 6396142. doi: 10.1093.
    >> Share

  733. PELUSO MJ, Thomas IJ, Munter SE, Deeks SG, et al
    Lack of Antinuclear Antibodies in Convalescent COVID-19 Patients with Persistent Symptoms.
    Clin Infect Dis. 2021 Oct 7. pii: 6383256. doi: 10.1093.
    >> Share

  734. ZHANG J, Lin H, Ye B, Zhao M, et al
    One-year sustained cellular and humoral immunities of COVID-19 convalescents.
    Clin Infect Dis. 2021 Oct 5. pii: 6381561. doi: 10.1093.
    >> Share

  735. KLOMPAS M, Ye S, Vaidya V, Ochoa A, et al
    Association between Airborne Infection Isolation Room Utilization Rates and Healthcare Worker COVID-19 Infections in Two Academic Hospitals.
    Clin Infect Dis. 2021 Oct 2. pii: 6380290. doi: 10.1093.
    >> Share

  736. BAILLY B, Pere H, Veyer D, Berceanu A, et al
    Persistent COVID-19 in an immunocompromised host treated by SARS-CoV-2-specific monoclonal antibodies.
    Clin Infect Dis. 2021 Oct 1. pii: 6379055. doi: 10.1093.
    >> Share

  737. MOZAFFARI E, Chandak A, Zhang Z, Liang S, et al
    Remdesivir treatment in hospitalized patients with COVID-19: a comparative analysis of in-hospital all-cause mortality in a large multi-center observational cohort.
    Clin Infect Dis. 2021 Oct 1. pii: 6378778. doi: 10.1093.
    >> Share

  738. ZHU N, Rawson TM, Mookerjee S, Price JR, et al
    Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage.
    Clin Infect Dis. 2021 Oct 1. pii: 6378783. doi: 10.1093.
    >> Share

    September 2021
  739. JAAFAR R, Aherfi S, Wurtz N, Grimaldier C, et al
    Corrigendum to: Correlation Between 3790 Quantitative Polymerase Chain Reaction-Positives Samples and Positive Cell Cultures, Including 1941 Severe Acute Respiratory Syndrome Coronavirus 2 Isolates.
    Clin Infect Dis. 2021 Sep 29. pii: 6377803. doi: 10.1093.
    >> Share

  740. FORD N, Vitoria M, Doherty M
    WHO guidance to support HIV care models during the Covid-19 era.
    Clin Infect Dis. 2021 Sep 24. pii: 6374892. doi: 10.1093.
    >> Share

  741. STAUFT CB, Tegenge M, Khurana S, Lee Y, et al
    Pharmacokinetics and Efficacy of Human Hyperimmune Intravenous Immunoglobulin Treatment of SARS-CoV-2 Infection in Adult Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 23. pii: 6374486. doi: 10.1093.
    >> Share

  742. LESIEUR E, Torrents J, Fina F, Zandotti C, et al
    Congenital infection of SARS-CoV-2 with intrauterine foetal death: a clinicopathological study with molecular analysis.
    Clin Infect Dis. 2021 Sep 23. pii: 6374309. doi: 10.1093.
    >> Share

  743. ZHU F, Jin P, Zhu T, Wang W, et al
    Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial.
    Clin Infect Dis. 2021 Sep 22. pii: 6374123. doi: 10.1093.
    >> Share

  744. FRALEY E, LeMaster C, Khanal S, Banerjee D, et al
    Prior infection and age impacts antibody persistence after SARS-CoV-2 mRNA vaccine.
    Clin Infect Dis. 2021 Sep 22. pii: 6373987. doi: 10.1093.
    >> Share

  745. HASAN ALI O, Bomze D, Risch L, Brugger SD, et al
    Erratum to: Severe Coronavirus Disease 2019 (COVID-19) is Associated With Elevated Serum Immunoglobulin (Ig) A and Antiphospholipid IgA Antibodies.
    Clin Infect Dis. 2021 Sep 22. pii: 6373914. doi: 10.1093.
    >> Share

  746. HU M, Wang J, Lin H, Ruktanonchai CW, et al
    Risk of SARS-CoV-2 Transmission among Air Passengers in China.
    Clin Infect Dis. 2021 Sep 21. pii: 6373518. doi: 10.1093.
    >> Share

  747. CHAUHAN L, Pattee J, Ford J, Thomas C, et al
    A Multi-center, Prospective, Observational-cohort controlled study of Clinical Outcomes following COVID-19 Convalescent plasma therapy in hospitalized COVID-19 patients.
    Clin Infect Dis. 2021 Sep 21. pii: 6373512. doi: 10.1093.
    >> Share

  748. WHITTAKER C, Watson OJ, Alvarez-Moreno C, Angkasekwinai N, et al
    Understanding the Potential Impact of Different Drug Properties On SARS-CoV-2 Transmission and Disease Burden: A Modelling Analysis.
    Clin Infect Dis. 2021 Sep 21. pii: 6373521. doi: 10.1093.
    >> Share

  749. BUENO SM, Abarca K, Gonzalez PA, Galvez NMS, et al
    Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine in a Subgroup of Healthy Adults in Chile.
    Clin Infect Dis. 2021 Sep 19. pii: 6372423. doi: 10.1093.
    >> Share

  750. CHAN JF, Poon VK, Chan CC, Chik KK, et al
    Low Environmental Temperature Exacerbates Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Golden Syrian Hamsters.
    Clin Infect Dis. 2021 Sep 18. pii: 6372264. doi: 10.1093.
    >> Share

  751. MAN NIU M, Cao Y, Li RX, Fan GZ, et al
    Outcome heterogeneity in COVID-19 patients receiving tocilizumab.
    Clin Infect Dis. 2021 Sep 17. pii: 6371851. doi: 10.1093.
    >> Share

  752. MOON RC, Mackey RH, Cao Z, Emont S, et al
    Is COVID-19 Less Deadly Now? -- Trends of In-Hospital Mortality Among Hospitalized COVID-19 Patients in the United States.
    Clin Infect Dis. 2021 Sep 17. pii: 6371824. doi: 10.1093.
    >> Share

  753. ANANWORANICH J, Mogg R, Dunne MW, Bassyouni M, et al
    Randomized study of rivaroxaban vs. placebo on disease progression and symptoms resolution in high-risk adults with mild COVID-19.
    Clin Infect Dis. 2021 Sep 15. pii: 6370549. doi: 10.1093.
    >> Share

  754. STRUTNER J, Ramchandar N, Dubey S, Gamboa M, et al
    Comparison of RT-PCR Cycle Threshold Values from Respiratory Specimens in Symptomatic and Asymptomatic Children with SARS-CoV-2 Infection.
    Clin Infect Dis. 2021 Sep 15. pii: 6370557. doi: 10.1093.
    >> Share

  755. PECHTER E, Lessin N, Brosseau L
    Schools and Coronavirus Disease 2019 Prevention.
    Clin Infect Dis. 2021;73:e1403-e1404.
    >> Share

  756. ADENAIYE OO, Lai J, de Mesquita PJB, Hong F, et al
    Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection.
    Clin Infect Dis. 2021 Sep 14. pii: 6370149. doi: 10.1093.
    >> Share

  757. PAMPA-ESPINOZA L, Silva-Valencia J, Fernandez M, Padilla-Rojas C, et al
    Reinfections are more frequent than currently considered in countries with high incidence of COVID-19 cases due to stringent definitions.
    Clin Infect Dis. 2021 Sep 11. pii: 6368494. doi: 10.1093.
    >> Share

  758. BAROCAS JA, Savinkina A, Lodi S, Epstein RL, et al
    Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study.
    Clin Infect Dis. 2021 Sep 9. pii: 6367757. doi: 10.1093.
    >> Share

  759. TO KK, Li X, Lung DC, Ip JD, et al
    False COVID-19 cases due to contamination by inactivated virus vaccine.
    Clin Infect Dis. 2021 Sep 9. pii: 6367446. doi: 10.1093.
    >> Share

  760. LEE M
    Lack of Severe Acute Respiratory Syndrome Coronavirus 2 Neutralization by Antibodies to Seasonal Coronaviruses: Making Sense of the Coronavirus Disease 2019 Pandemic.
    Clin Infect Dis. 2021;73:e1212-e1213.
    >> Share

  761. KULKARNI O, Narreddy S, Zaveri L, Kalal IG, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein.
    Clin Infect Dis. 2021;73:e1239-e1241.
    >> Share

  762. GUARALDI G, Milic J, Martinez E, Kamarulzaman A, et al
    Human Immunodeficiency Virus (HIV) Care Models During the Coronavirus Disease 2019 (COVID-19) Era.
    Clin Infect Dis. 2021;73:e1222-e1227.
    >> Share

  763. GRINT DJ, Wing K, Houlihan C, Gibbs HP, et al
    Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England.
    Clin Infect Dis. 2021 Sep 6. pii: 6365124. doi: 10.1093.
    >> Share

  764. WYNBERG E, van Willigen HDG, Dijkstra M, Boyd A, et al
    Evolution of COVID-19 symptoms during the first 12 months after illness onset.
    Clin Infect Dis. 2021 Sep 2. pii: 6362727. doi: 10.1093.
    >> Share

  765. FEDER KA, Patel A, Vepachedu VR, Dominguez C, et al
    Association of E484K spike protein mutation with SARS-CoV-2 infection in vaccinated persons---Maryland, January - May 2021.
    Clin Infect Dis. 2021 Sep 2. pii: 6362726. doi: 10.1093.
    >> Share

  766. SNYMAN J, Hwa SH, Krause R, Muema D, et al
    Similar antibody responses against SARS-CoV-2 in HIV uninfected and infected individuals on antiretroviral therapy during the first South African infection wave.
    Clin Infect Dis. 2021 Sep 2. pii: 6362722. doi: 10.1093.
    >> Share

  767. TAGLIAMONTE MS, Mavian C, Zainabadi K, Cash MN, et al
    Rapid emergence and spread of SARS-CoV-2 gamma (P.1) variant in Haiti.
    Clin Infect Dis. 2021 Sep 2. pii: 6359631. doi: 10.1093.
    >> Share

  768. STRICH JR, Tian X, Samour M, King CS, et al
    Fostamatinib for the treatment of hospitalized adults with COVD-19 A randomized trial.
    Clin Infect Dis. 2021 Sep 1. pii: 6358811. doi: 10.1093.
    >> Share

  769. SHAW J, Hanley S, Stewart T, Salmon DA, et al
    Health Care Personnel (HCP) attitudes about COVID-19 vaccination after emergency use authorization.
    Clin Infect Dis. 2021 Sep 1. pii: 6357694. doi: 10.1093.
    >> Share

    August 2021
  770. MARTINEZ DA, Klein EY, Parent C, Prieto D, et al
    Latino Household Transmission of SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 31. pii: 6360016. doi: 10.1093.
    >> Share

  771. CARAZO S, Talbot D, Boulianne N, Brisson M, et al
    Single-dose mRNA vaccine effectiveness against SARS-CoV-2 in healthcare workers extending 16 weeks post-vaccination: a test-negative design from Quebec, Canada.
    Clin Infect Dis. 2021 Aug 30. pii: 6359881. doi: 10.1093.
    >> Share

  772. XIN H, Li Y, Wu P, Li Z, et al
    Estimating the latent period of coronavirus disease 2019 (COVID-19).
    Clin Infect Dis. 2021 Aug 28. pii: 6359063. doi: 10.1093.
    >> Share

  773. KNOWLTON KU
    Insights from a murine model of COVID-19 mRNA vaccination-induced myopericarditis: Could accidental intravenous vaccine injection induce myopericarditis?
    Clin Infect Dis. 2021 Aug 28. pii: 6359059. doi: 10.1093.
    >> Share

  774. GOTTLIEB L, Fridkin SK
    It's hard to measure success while caring for surges in COVID-19 hospitalizations.
    Clin Infect Dis. 2021 Aug 28. pii: 6359066. doi: 10.1093.
    >> Share

  775. MACK CD, Tai C, Sikka R, Grad YH, et al
    SARS-CoV-2 Reinfection: A Case Series from a 12-Month Longitudinal Occupational Cohort.
    Clin Infect Dis. 2021 Aug 28. pii: 6359055. doi: 10.1093.
    >> Share

  776. ONG SWX, Chiew CJ, Ang LW, Mak TM, et al
    Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).
    Clin Infect Dis. 2021 Aug 23. pii: 6356459. doi: 10.1093.
    >> Share

  777. NARAYANAN S, Chua JV, Baddley JW
    COVID-19 associated Mucormycosis (CAM): risk factors and mechanisms of disease.
    Clin Infect Dis. 2021 Aug 22. pii: 6356215. doi: 10.1093.
    >> Share

  778. WONG CKH, Lau KTK, Au ICH, Xiong X, et al
    Optimal timing of remdesivir initiation in hospitalized COVID-19 patients administered with dexamethasone.
    Clin Infect Dis. 2021 Aug 22. pii: 6356217. doi: 10.1093.
    >> Share

  779. PETTI S
    Undetected and relatively sustained SARS-CoV-2 circulation worldwide during the year 2019.
    Clin Infect Dis. 2021 Aug 22. pii: 6356216. doi: 10.1093.
    >> Share

  780. MARR LC, Tang JW
    A Paradigm Shift to Align Transmission Routes with Mechanisms.
    Clin Infect Dis. 2021 Aug 20. pii: 6355601. doi: 10.1093.
    >> Share

  781. MAIER HE, Kuan G, Saborio S, Bustos Carrillo FA, et al
    Clinical spectrum of SARS-CoV-2 infection and protection from symptomatic re-infection.
    Clin Infect Dis. 2021 Aug 19. pii: 6354980. doi: 10.1093.
    >> Share

  782. BALTAS I, Boshier FAT, Williams CA, Bayzid N, et al
    Post-vaccination COVID-19: A case-control study and genomic analysis of 119 breakthrough infections in partially vaccinated individuals.
    Clin Infect Dis. 2021 Aug 19. pii: 6354928. doi: 10.1093.
    >> Share

  783. DUNAY MA, McClain SL, Holloway RL, Norris SLW, et al
    Pre-Hospital Administration of Remdesivir during a SARS-CoV-2 Outbreak in a Skilled Nursing Facility.
    Clin Infect Dis. 2021 Aug 19. pii: 6354937. doi: 10.1093.
    >> Share

  784. DAWOOD FS, Varner M, Tita A, Newes-Adeyi G, et al
    Incidence, Clinical Characteristics, and Risk Factors of SARS-CoV-2 Infection among Pregnant Individuals in the United States.
    Clin Infect Dis. 2021 Aug 19. pii: 6354856. doi: 10.1093.
    >> Share

  785. FINTZI J, Bonnett T, Sweeney DA, Huprikar NA, et al
    Deconstructing the Treatment Effect of Remdesivir in the Adaptive COVID-19 Treatment Trial-1: Implications for Critical Care Resource Utilization.
    Clin Infect Dis. 2021 Aug 19. pii: 6354746. doi: 10.1093.
    >> Share

  786. DIAZ GA, Christensen AB, Pusch T, Goulet D, et al
    Remdesivir and Mortality in Patients with COVID-19.
    Clin Infect Dis. 2021 Aug 19. pii: 6352176. doi: 10.1093.
    >> Share

  787. LI C, Chen Y, Zhao Y, Lung DC, et al
    Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model.
    Clin Infect Dis. 2021 Aug 18. pii: 6353927. doi: 10.1093.
    >> Share

  788. LIU T, Wu D, Yan W, Wang X, et al
    Twelve-month systemic consequences of COVID-19 in patients discharged from hospital: a prospective cohort study in Wuhan, China.
    Clin Infect Dis. 2021 Aug 14. pii: 6352408. doi: 10.1093.
    >> Share

  789. DIMEGLIO C, Herin F, Da-Silva I, Jougla I, et al
    Heterologous ChAdOx1-S/BNT162b2 vaccination: neutralizing antibody response to SARS-CoV-2.
    Clin Infect Dis. 2021 Aug 12. pii: 6349304. doi: 10.1093.
    >> Share

  790. CERAMI C, Popkin-Hall ZR, Rapp T, Tompkins K, et al
    Household transmission of SARS-CoV-2 in the United States: living density, viral load, and disproportionate impact on communities of color.
    Clin Infect Dis. 2021 Aug 12. pii: 6349288. doi: 10.1093.
    >> Share

  791. CALDERON-PARRA J, Munez-Rubio E, Fernandez-Cruz A, Garcia Sanchez MC, et al
    Incidence, clinical presentation, relapses and outcome of SARS-CoV-2 infection in patients treated with anti-CD20 monoclonal antibodies.
    Clin Infect Dis. 2021 Aug 12. pii: 6348942. doi: 10.1093.
    >> Share

  792. PAULES CI, Gallagher SK, Rapaka RR, Davey RT, et al
    Remdesivir for the prevention of invasive mechanical ventilation or death in COVID-19 - A post-hoc analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
    Clin Infect Dis. 2021 Aug 11. pii: 6348134. doi: 10.1093.
    >> Share

  793. JACOBS JL, Bain W, Naqvi A, Staines B, et al
    SARS-CoV-2 Viremia is Associated with COVID-19 Severity and Predicts Clinical Outcomes.
    Clin Infect Dis. 2021 Aug 10. pii: 6347519. doi: 10.1093.
    >> Share

  794. CLIPMAN SJ, Wesolowski A, Mehta SH, Cobey S, et al
    Improvements in SARS-CoV-2 Testing Cascade in the US: Data from Serial Cross-sectional Assessments.
    Clin Infect Dis. 2021 Aug 10. pii: 6347429. doi: 10.1093.
    >> Share

  795. BAKER MA, Sands KE, Huang SS, Kleinman K, et al
    The Impact of COVID-19 on Healthcare-Associated Infections.
    Clin Infect Dis. 2021 Aug 9. pii: 6346721. doi: 10.1093.
    >> Share

  796. NORTH CM, Barczak A, Goldstein RH, Healy BC, et al
    Determining the Incidence of Asymptomatic SARS-CoV-2 among Early Recipients of COVID-19 Vaccines: A Prospective Cohort Study of Healthcare Workers before, during and after Vaccination [DISCOVER-COVID-19].
    Clin Infect Dis. 2021 Aug 7. pii: 6345339. doi: 10.1093.
    >> Share

  797. TENFORDE MW, Patel MM, Ginde AA, Douin DJ, et al
    Effectiveness of SARS-CoV-2 mRNA Vaccines for Preventing Covid-19 Hospitalizations in the United States.
    Clin Infect Dis. 2021 Aug 6. pii: 6343399. doi: 10.1093.
    >> Share

  798. BANNO M, Tsujimoto Y, Ishikane M
    Need for more randomized controlled trials with rigorous methodology to confirm that ivermectin is not a viable option for the treatment of coronavirus disease.
    Clin Infect Dis. 2021 Aug 6. pii: 6343415. doi: 10.1093.
    >> Share

  799. COLEMAN KK, Tay DJW, Sen Tan K, Ong SWX, et al
    Viral Load of SARS-CoV-2 in Respiratory Aerosols Emitted by COVID-19 Patients while Breathing, Talking, and Singing.
    Clin Infect Dis. 2021 Aug 6. pii: 6343417. doi: 10.1093.
    >> Share

  800. PADHI S, Pati A, Panda AK
    Effect of ivermectin in the treatment of COVID-19: A trial sequential analysis highlighted the requirement of additional randomized controlled trials.
    Clin Infect Dis. 2021 Aug 6. pii: 6343157. doi: 10.1093.
    >> Share

  801. LAWANDI A, Warner S, Sun J, Demirkale CY, et al
    Suspected SARS-CoV-2 Reinfections: Incidence, Predictors, and Healthcare Use among Patients at 238 U.S. Healthcare Facilities, June 1, 2020- February 28, 2021.
    Clin Infect Dis. 2021 Aug 5. pii: 6342166. doi: 10.1093.
    >> Share

  802. BIGGERSTAFF M, Slayton RB, Johansson MA, Butler JC, et al
    Improving Pandemic Response: Employing Mathematical Modeling to Confront COVID-19.
    Clin Infect Dis. 2021 Aug 3. pii: 6338173. doi: 10.1093.
    >> Share

  803. FOURATI S, Bailly B, Le Bouter A, Guilpain L, et al
    Differential anti-S antibody titers in vaccinated residents during an outbreak of SARS-CoV-2 variant B.1.351 (beta) in an elderly nursing home.
    Clin Infect Dis. 2021 Aug 3. pii: 6338175. doi: 10.1093.
    >> Share

  804. XIANG F, Sun J, Chen PH, Han P, et al
    Early Elevation of Fibrosis-4 Liver Fibrosis Score Is Associated With Adverse Outcomes Among Patients With Coronavirus Disease 2019.
    Clin Infect Dis. 2021;73:e594-e601.
    >> Share

  805. LI P, Ikram A, Peppelenbosch MP, Ma Z, et al
    Systematically Mapping Clinical Features of Infections With Classical Endemic Human Coronaviruses.
    Clin Infect Dis. 2021;73:554-555.
    >> Share

  806. CASADEVALL A, Joyner MJ, Pirofski LA
    Implications of Coronavirus Disease 2019 (COVID-19) Antibody Dynamics for Immunity and Convalescent Plasma Therapy.
    Clin Infect Dis. 2021;73:e540-e542.
    >> Share

  807. GIL E, Martyn E, Rokadiya S, Jain S, et al
    Bacterial Coinfection in COVID-19.
    Clin Infect Dis. 2021;73:e843-e845.
    >> Share

    July 2021
  808. CHOW K, Aslam A, McClure T, Singh J, et al
    Risk of Healthcare-Associated Transmission of SARS-CoV-2 in Hospitalized Cancer Patients.
    Clin Infect Dis. 2021 Jul 30. pii: 6331919. doi: 10.1093.
    >> Share

  809. MACCANNELL T, Batson J, Bonin B, Kc A, et al
    Genomic epidemiology and transmission dynamics of SARS-CoV-2 in congregate healthcare facilities in Santa Clara